{"idB": "906709_12_item1a_p32_s0", "idA": "906709_11_item1a_p0_s0", "sentA": "any degree of certainty the duration and completion costs of our research and development projects, anticipated completion dates or when and to what extent we will receive cash inflows from a collaboration arrangement or the commercialization of a drug candidate.", "sentB": "When we sign a collaborative development agreement or license agreement to develop a drug candidate with a pharmaceutical or biotechnology company, the pharmaceutical or biotechnology company is generally expected to:", "type": 1, "words": ["<tag1>", "any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate.", "<tag2>", "When", "we", "sign", "a", "collaborative", "development", "agreement", "or", "license", "agreement", "to", "develop", "a", "drug", "candidate", "with", "a", "pharmaceutical", "or", "biotechnology", "company,", "the", "pharmaceutical", "or", "biotechnology", "company", "is", "generally", "expected", "to:", "<tag3>"], "wordsA": ["any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate."], "wordsB": ["When", "we", "sign", "a", "collaborative", "development", "agreement", "or", "license", "agreement", "to", "develop", "a", "drug", "candidate", "with", "a", "pharmaceutical", "or", "biotechnology", "company,", "the", "pharmaceutical", "or", "biotechnology", "company", "is", "generally", "expected", "to:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s6", "idA": "906709_11_item1a_p0_s0", "sentA": "any degree of certainty the duration and completion costs of our research and development projects, anticipated completion dates or when and to what extent we will receive cash inflows from a collaboration arrangement or the commercialization of a drug candidate.", "sentB": "Our strategy also calls for us to undertake increased research and development activities and to manage an increasing number of relationships with partners and other third parties, while simultaneously managing the capital necessary to support this strategy.", "type": 1, "words": ["<tag1>", "any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate.", "<tag2>", "Our", "strategy", "also", "calls", "for", "us", "to", "undertake", "increased", "research", "and", "development", "activities", "and", "to", "manage", "an", "increasing", "number", "of", "relationships", "with", "partners", "and", "other", "third", "parties,", "while", "simultaneously", "managing", "the", "capital", "necessary", "to", "support", "this", "strategy.", "<tag3>"], "wordsA": ["any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate."], "wordsB": ["Our", "strategy", "also", "calls", "for", "us", "to", "undertake", "increased", "research", "and", "development", "activities", "and", "to", "manage", "an", "increasing", "number", "of", "relationships", "with", "partners", "and", "other", "third", "parties,", "while", "simultaneously", "managing", "the", "capital", "necessary", "to", "support", "this", "strategy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s17", "idA": "906709_11_item1a_p0_s0", "sentA": "any degree of certainty the duration and completion costs of our research and development projects, anticipated completion dates or when and to what extent we will receive cash inflows from a collaboration arrangement or the commercialization of a drug candidate.", "sentB": "If we issue convertible notes or enter into a term loan arrangement, the payment of principal and interest on such indebtedness may limit funds available for our business activities such as the continued advancement of our research and development pipeline, and such indebtedness could impose covenants that restrict our ability to operate our business.", "type": 1, "words": ["<tag1>", "any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate.", "<tag2>", "If", "we", "issue", "convertible", "notes", "or", "enter", "into", "a", "term", "loan", "arrangement,", "the", "payment", "of", "principal", "and", "interest", "on", "such", "indebtedness", "may", "limit", "funds", "available", "for", "our", "business", "activities", "such", "as", "the", "continued", "advancement", "of", "our", "research", "and", "development", "pipeline,", "and", "such", "indebtedness", "could", "impose", "covenants", "that", "restrict", "our", "ability", "to", "operate", "our", "business.", "<tag3>"], "wordsA": ["any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate."], "wordsB": ["If", "we", "issue", "convertible", "notes", "or", "enter", "into", "a", "term", "loan", "arrangement,", "the", "payment", "of", "principal", "and", "interest", "on", "such", "indebtedness", "may", "limit", "funds", "available", "for", "our", "business", "activities", "such", "as", "the", "continued", "advancement", "of", "our", "research", "and", "development", "pipeline,", "and", "such", "indebtedness", "could", "impose", "covenants", "that", "restrict", "our", "ability", "to", "operate", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p20_s7", "idA": "906709_11_item1a_p10_s1", "sentA": "The recognized gain on debt extinguishment is net of transaction costs of $1.0 million and accelerated amortization of our deferred financing costs of $1.1 million.", "sentB": "In 2006, we entered into a litigation settlement related to an intellectual property dispute with the University of Alabama in Huntsville pursuant to which we paid $11.0 million and agreed to pay an additional $10.0 million in equal $1.0 million installments over ten years ending with the last payment due on July 1, 2016.", "type": 1, "words": ["<tag1>", "The", "recognized", "gain", "on", "debt", "extinguishment", "is", "net", "of", "transaction", "costs", "of", "$1.0", "million", "and", "accelerated", "amortization", "of", "our", "deferred", "financing", "costs", "of", "$1.1", "million.", "<tag2>", "In", "2006,", "we", "entered", "into", "a", "litigation", "settlement", "related", "to", "an", "intellectual", "property", "dispute", "with", "the", "University", "of", "Alabama", "in", "Huntsville", "pursuant", "to", "which", "we", "paid", "$11.0", "million", "and", "agreed", "to", "pay", "an", "additional", "$10.0", "million", "in", "equal", "$1.0", "million", "installments", "over", "ten", "years", "ending", "with", "the", "last", "payment", "due", "on", "July", "1,", "2016.", "<tag3>"], "wordsA": ["The", "recognized", "gain", "on", "debt", "extinguishment", "is", "net", "of", "transaction", "costs", "of", "$1.0", "million", "and", "accelerated", "amortization", "of", "our", "deferred", "financing", "costs", "of", "$1.1", "million."], "wordsB": ["In", "2006,", "we", "entered", "into", "a", "litigation", "settlement", "related", "to", "an", "intellectual", "property", "dispute", "with", "the", "University", "of", "Alabama", "in", "Huntsville", "pursuant", "to", "which", "we", "paid", "$11.0", "million", "and", "agreed", "to", "pay", "an", "additional", "$10.0", "million", "in", "equal", "$1.0", "million", "installments", "over", "ten", "years", "ending", "with", "the", "last", "payment", "due", "on", "July", "1,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s20", "idA": "906709_11_item1a_p11_s0", "sentA": "We have financed our operations primarily through revenue from product sales, royalties and research and development contracts, as well as public and private placements of debt and equity.", "sentB": "Provisions of our certificate of incorporation and bylaws, as well as provisions of Delaware law, could make it more difficult for a third party to acquire us, even though such acquisitions may be beneficial to our stockholders.", "type": 1, "words": ["<tag1>", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "research", "and", "development", "contracts,", "as", "well", "as", "public", "and", "private", "placements", "of", "debt", "and", "equity.", "<tag2>", "Provisions", "of", "our", "certificate", "of", "incorporation", "and", "bylaws,", "as", "well", "as", "provisions", "of", "Delaware", "law,", "could", "make", "it", "more", "difficult", "for", "a", "third", "party", "to", "acquire", "us,", "even", "though", "such", "acquisitions", "may", "be", "beneficial", "to", "our", "stockholders.", "<tag3>"], "wordsA": ["We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "research", "and", "development", "contracts,", "as", "well", "as", "public", "and", "private", "placements", "of", "debt", "and", "equity."], "wordsB": ["Provisions", "of", "our", "certificate", "of", "incorporation", "and", "bylaws,", "as", "well", "as", "provisions", "of", "Delaware", "law,", "could", "make", "it", "more", "difficult", "for", "a", "third", "party", "to", "acquire", "us,", "even", "though", "such", "acquisitions", "may", "be", "beneficial", "to", "our", "stockholders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s5", "idA": "906709_11_item1a_p11_s3", "sentA": "These letters of credit will expire during 2011 and are secured by investments of similar amounts.", "sentB": "We and our contract manufacturers are required in certain cases to maintain compliance with current good manufacturing practices (cGMP), including cGMP guidelines applicable to active pharmaceutical ingredients, and are subject to inspections by the FDA or comparable agencies in other jurisdictions to confirm such compliance.", "type": 1, "words": ["<tag1>", "These", "letters", "of", "credit", "will", "expire", "during", "2011", "and", "are", "secured", "by", "investments", "of", "similar", "amounts.", "<tag2>", "We", "and", "our", "contract", "manufacturers", "are", "required", "in", "certain", "cases", "to", "maintain", "compliance", "with", "current", "good", "manufacturing", "practices", "(cGMP),", "including", "cGMP", "guidelines", "applicable", "to", "active", "pharmaceutical", "ingredients,", "and", "are", "subject", "to", "inspections", "by", "the", "FDA", "or", "comparable", "agencies", "in", "other", "jurisdictions", "to", "confirm", "such", "compliance.", "<tag3>"], "wordsA": ["These", "letters", "of", "credit", "will", "expire", "during", "2011", "and", "are", "secured", "by", "investments", "of", "similar", "amounts."], "wordsB": ["We", "and", "our", "contract", "manufacturers", "are", "required", "in", "certain", "cases", "to", "maintain", "compliance", "with", "current", "good", "manufacturing", "practices", "(cGMP),", "including", "cGMP", "guidelines", "applicable", "to", "active", "pharmaceutical", "ingredients,", "and", "are", "subject", "to", "inspections", "by", "the", "FDA", "or", "comparable", "agencies", "in", "other", "jurisdictions", "to", "confirm", "such", "compliance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p19_s1", "idA": "906709_11_item1a_p12_s0", "sentA": "We will likely not have sufficient capital to fund the development of the drug candidates in our current research and development pipeline, fund late stage clinical development of NKTR-102 and repay the $215.0 million convertible notes when they become due in September 2012.", "sentB": "If a third party obtains injunctive or other equitable relief against us or our partners, they could effectively prevent us, or our partners, from developing or commercializing, or deriving revenue from, certain drugs or drug candidates in the U.S. and abroad.", "type": 1, "words": ["<tag1>", "We", "will", "likely", "not", "have", "sufficient", "capital", "to", "fund", "the", "development", "of", "the", "drug", "candidates", "in", "our", "current", "research", "and", "development", "pipeline,", "fund", "late", "stage", "clinical", "development", "of", "NKTR-102", "and", "repay", "the", "$215.0", "million", "convertible", "notes", "when", "they", "become", "due", "in", "September", "2012.", "<tag2>", "If", "a", "third", "party", "obtains", "injunctive", "or", "other", "equitable", "relief", "against", "us", "or", "our", "partners,", "they", "could", "effectively", "prevent", "us,", "or", "our", "partners,", "from", "developing", "or", "commercializing,", "or", "deriving", "revenue", "from,", "certain", "drugs", "or", "drug", "candidates", "in", "the", "U.S.", "and", "abroad.", "<tag3>"], "wordsA": ["We", "will", "likely", "not", "have", "sufficient", "capital", "to", "fund", "the", "development", "of", "the", "drug", "candidates", "in", "our", "current", "research", "and", "development", "pipeline,", "fund", "late", "stage", "clinical", "development", "of", "NKTR-102", "and", "repay", "the", "$215.0", "million", "convertible", "notes", "when", "they", "become", "due", "in", "September", "2012."], "wordsB": ["If", "a", "third", "party", "obtains", "injunctive", "or", "other", "equitable", "relief", "against", "us", "or", "our", "partners,", "they", "could", "effectively", "prevent", "us,", "or", "our", "partners,", "from", "developing", "or", "commercializing,", "or", "deriving", "revenue", "from,", "certain", "drugs", "or", "drug", "candidates", "in", "the", "U.S.", "and", "abroad."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s10", "idA": "906709_11_item1a_p12_s0", "sentA": "We will likely not have sufficient capital to fund the development of the drug candidates in our current research and development pipeline, fund late stage clinical development of NKTR-102 and repay the $215.0 million convertible notes when they become due in September 2012.", "sentB": "A number of companies have suffered significant unforeseen failures in late stage clinical studies due to factors such as inconclusive efficacy results and adverse medical events, even after achieving positive results in earlier clinical studies that were satisfactory both to them and to reviewing government health authorities.", "type": 1, "words": ["<tag1>", "We", "will", "likely", "not", "have", "sufficient", "capital", "to", "fund", "the", "development", "of", "the", "drug", "candidates", "in", "our", "current", "research", "and", "development", "pipeline,", "fund", "late", "stage", "clinical", "development", "of", "NKTR-102", "and", "repay", "the", "$215.0", "million", "convertible", "notes", "when", "they", "become", "due", "in", "September", "2012.", "<tag2>", "A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "late", "stage", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "results", "and", "adverse", "medical", "events,", "even", "after", "achieving", "positive", "results", "in", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "government", "health", "authorities.", "<tag3>"], "wordsA": ["We", "will", "likely", "not", "have", "sufficient", "capital", "to", "fund", "the", "development", "of", "the", "drug", "candidates", "in", "our", "current", "research", "and", "development", "pipeline,", "fund", "late", "stage", "clinical", "development", "of", "NKTR-102", "and", "repay", "the", "$215.0", "million", "convertible", "notes", "when", "they", "become", "due", "in", "September", "2012."], "wordsB": ["A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "late", "stage", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "results", "and", "adverse", "medical", "events,", "even", "after", "achieving", "positive", "results", "in", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "government", "health", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s6", "idA": "906709_11_item1a_p12_s0", "sentA": "We will likely not have sufficient capital to fund the development of the drug candidates in our current research and development pipeline, fund late stage clinical development of NKTR-102 and repay the $215.0 million convertible notes when they become due in September 2012.", "sentB": "Typically, there is a high rate of attrition for drug candidates in preclinical and clinical trials due to scientific feasibility, safety, efficacy, changing standards of medical care and other variables.", "type": 1, "words": ["<tag1>", "We", "will", "likely", "not", "have", "sufficient", "capital", "to", "fund", "the", "development", "of", "the", "drug", "candidates", "in", "our", "current", "research", "and", "development", "pipeline,", "fund", "late", "stage", "clinical", "development", "of", "NKTR-102", "and", "repay", "the", "$215.0", "million", "convertible", "notes", "when", "they", "become", "due", "in", "September", "2012.", "<tag2>", "Typically,", "there", "is", "a", "high", "rate", "of", "attrition", "for", "drug", "candidates", "in", "preclinical", "and", "clinical", "trials", "due", "to", "scientific", "feasibility,", "safety,", "efficacy,", "changing", "standards", "of", "medical", "care", "and", "other", "variables.", "<tag3>"], "wordsA": ["We", "will", "likely", "not", "have", "sufficient", "capital", "to", "fund", "the", "development", "of", "the", "drug", "candidates", "in", "our", "current", "research", "and", "development", "pipeline,", "fund", "late", "stage", "clinical", "development", "of", "NKTR-102", "and", "repay", "the", "$215.0", "million", "convertible", "notes", "when", "they", "become", "due", "in", "September", "2012."], "wordsB": ["Typically,", "there", "is", "a", "high", "rate", "of", "attrition", "for", "drug", "candidates", "in", "preclinical", "and", "clinical", "trials", "due", "to", "scientific", "feasibility,", "safety,", "efficacy,", "changing", "standards", "of", "medical", "care", "and", "other", "variables."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p5_s1", "idA": "906709_11_item1a_p12_s0", "sentA": "We will likely not have sufficient capital to fund the development of the drug candidates in our current research and development pipeline, fund late stage clinical development of NKTR-102 and repay the $215.0 million convertible notes when they become due in September 2012.", "sentB": "If we do not receive substantial milestone payments from our existing collaboration agreements, execute new high value collaborations or other arrangements, or are unable to raise additional capital in one or more financing transactions, we would be unable to continue our current level of investment in research and development.", "type": 1, "words": ["<tag1>", "We", "will", "likely", "not", "have", "sufficient", "capital", "to", "fund", "the", "development", "of", "the", "drug", "candidates", "in", "our", "current", "research", "and", "development", "pipeline,", "fund", "late", "stage", "clinical", "development", "of", "NKTR-102", "and", "repay", "the", "$215.0", "million", "convertible", "notes", "when", "they", "become", "due", "in", "September", "2012.", "<tag2>", "If", "we", "do", "not", "receive", "substantial", "milestone", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high", "value", "collaborations", "or", "other", "arrangements,", "or", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development.", "<tag3>"], "wordsA": ["We", "will", "likely", "not", "have", "sufficient", "capital", "to", "fund", "the", "development", "of", "the", "drug", "candidates", "in", "our", "current", "research", "and", "development", "pipeline,", "fund", "late", "stage", "clinical", "development", "of", "NKTR-102", "and", "repay", "the", "$215.0", "million", "convertible", "notes", "when", "they", "become", "due", "in", "September", "2012."], "wordsB": ["If", "we", "do", "not", "receive", "substantial", "milestone", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high", "value", "collaborations", "or", "other", "arrangements,", "or", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p20_s4", "idA": "906709_11_item1a_p12_s1", "sentA": "We have no material credit facility or other material committed sources of capital.", "sentB": "Third-party claims involving proprietary rights or other matters could also result in substantial settlement payments or substantial damages to be paid by us.", "type": 1, "words": ["<tag1>", "We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital.", "<tag2>", "Third-party", "claims", "involving", "proprietary", "rights", "or", "other", "matters", "could", "also", "result", "in", "substantial", "settlement", "payments", "or", "substantial", "damages", "to", "be", "paid", "by", "us.", "<tag3>"], "wordsA": ["We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital."], "wordsB": ["Third-party", "claims", "involving", "proprietary", "rights", "or", "other", "matters", "could", "also", "result", "in", "substantial", "settlement", "payments", "or", "substantial", "damages", "to", "be", "paid", "by", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p20_s5", "idA": "906709_11_item1a_p12_s1", "sentA": "We have no material credit facility or other material committed sources of capital.", "sentB": "For instance, a settlement might require us to enter a license agreement under which we would pay substantial royalties or other compensation to a third party, diminishing our future economic returns from the related drug.", "type": 1, "words": ["<tag1>", "We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital.", "<tag2>", "For", "instance,", "a", "settlement", "might", "require", "us", "to", "enter", "a", "license", "agreement", "under", "which", "we", "would", "pay", "substantial", "royalties", "or", "other", "compensation", "to", "a", "third", "party,", "diminishing", "our", "future", "economic", "returns", "from", "the", "related", "drug.", "<tag3>"], "wordsA": ["We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital."], "wordsB": ["For", "instance,", "a", "settlement", "might", "require", "us", "to", "enter", "a", "license", "agreement", "under", "which", "we", "would", "pay", "substantial", "royalties", "or", "other", "compensation", "to", "a", "third", "party,", "diminishing", "our", "future", "economic", "returns", "from", "the", "related", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p28_s1", "idA": "906709_11_item1a_p12_s1", "sentA": "We have no material credit facility or other material committed sources of capital.", "sentB": "We have experienced repeated significant delays in starting the Phase 3 clinical development program for Amikacin Inhale as we seek to finalize and validate the device design with a demonstrated capability to be manufactured at commercial scale.", "type": 1, "words": ["<tag1>", "We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital.", "<tag2>", "We", "have", "experienced", "repeated", "significant", "delays", "in", "starting", "the", "Phase", "3", "clinical", "development", "program", "for", "Amikacin", "Inhale", "as", "we", "seek", "to", "finalize", "and", "validate", "the", "device", "design", "with", "a", "demonstrated", "capability", "to", "be", "manufactured", "at", "commercial", "scale.", "<tag3>"], "wordsA": ["We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital."], "wordsB": ["We", "have", "experienced", "repeated", "significant", "delays", "in", "starting", "the", "Phase", "3", "clinical", "development", "program", "for", "Amikacin", "Inhale", "as", "we", "seek", "to", "finalize", "and", "validate", "the", "device", "design", "with", "a", "demonstrated", "capability", "to", "be", "manufactured", "at", "commercial", "scale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s11", "idA": "906709_11_item1a_p12_s1", "sentA": "We have no material credit facility or other material committed sources of capital.", "sentB": "While the NKTR-118, NKTR-102, and Amikacin Inhale drug candidates have each demonstrated positive results from Phase 2 clinical studies, there is a substantial risk that Phase 3 clinical study outcomes from these drug candidates from larger patient populations will not demonstrate positive efficacy, safety or other clinical outcomes sufficient to support regulatory filings and achieve regulatory approval.", "type": 1, "words": ["<tag1>", "We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital.", "<tag2>", "While", "the", "NKTR-118,", "NKTR-102,", "and", "Amikacin", "Inhale", "drug", "candidates", "have", "each", "demonstrated", "positive", "results", "from", "Phase", "2", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "from", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval.", "<tag3>"], "wordsA": ["We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital."], "wordsB": ["While", "the", "NKTR-118,", "NKTR-102,", "and", "Amikacin", "Inhale", "drug", "candidates", "have", "each", "demonstrated", "positive", "results", "from", "Phase", "2", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "from", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s19", "idA": "906709_11_item1a_p12_s1", "sentA": "We have no material credit facility or other material committed sources of capital.", "sentB": "We have implemented certain anti-takeover measures, which make it more difficult to acquire us, even though such acquisitions may be beneficial to our stockholders.", "type": 1, "words": ["<tag1>", "We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital.", "<tag2>", "We", "have", "implemented", "certain", "anti-takeover", "measures,", "which", "make", "it", "more", "difficult", "to", "acquire", "us,", "even", "though", "such", "acquisitions", "may", "be", "beneficial", "to", "our", "stockholders.", "<tag3>"], "wordsA": ["We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital."], "wordsB": ["We", "have", "implemented", "certain", "anti-takeover", "measures,", "which", "make", "it", "more", "difficult", "to", "acquire", "us,", "even", "though", "such", "acquisitions", "may", "be", "beneficial", "to", "our", "stockholders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p25_s0", "idA": "906709_11_item1a_p13_s0", "sentA": "resources because we anticipate bearing a majority or all of the development costs for that drug candidate.", "sentB": "Pharmaceutical manufacturing involves significant risks and uncertainties related to the demonstration of adequate stability, sufficient purification of the drug substance and drug product, the identification and elimination of impurities, optimal formulations, process validation, and challenges in controlling for all of these variables.", "type": 1, "words": ["<tag1>", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate.", "<tag2>", "Pharmaceutical", "manufacturing", "involves", "significant", "risks", "and", "uncertainties", "related", "to", "the", "demonstration", "of", "adequate", "stability,", "sufficient", "purification", "of", "the", "drug", "substance", "and", "drug", "product,", "the", "identification", "and", "elimination", "of", "impurities,", "optimal", "formulations,", "process", "validation,", "and", "challenges", "in", "controlling", "for", "all", "of", "these", "variables.", "<tag3>"], "wordsA": ["resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate."], "wordsB": ["Pharmaceutical", "manufacturing", "involves", "significant", "risks", "and", "uncertainties", "related", "to", "the", "demonstration", "of", "adequate", "stability,", "sufficient", "purification", "of", "the", "drug", "substance", "and", "drug", "product,", "the", "identification", "and", "elimination", "of", "impurities,", "optimal", "formulations,", "process", "validation,", "and", "challenges", "in", "controlling", "for", "all", "of", "these", "variables."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s9", "idA": "906709_11_item1a_p13_s0", "sentA": "resources because we anticipate bearing a majority or all of the development costs for that drug candidate.", "sentB": "Even with success in preclinical testing and previously completed clinical trials, the risk of clinical failure for any drug candidate remains high prior to regulatory approval.", "type": 1, "words": ["<tag1>", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate.", "<tag2>", "Even", "with", "success", "in", "preclinical", "testing", "and", "previously", "completed", "clinical", "trials,", "the", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval.", "<tag3>"], "wordsA": ["resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate."], "wordsB": ["Even", "with", "success", "in", "preclinical", "testing", "and", "previously", "completed", "clinical", "trials,", "the", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p21_s1", "idA": "906709_11_item1a_p14_s0", "sentA": "Prior to the maturity of the convertible notes, we plan to explore a number of alternatives to provide for the repayment of the convertible notes, including restructuring the convertible notes.", "sentB": "We own greater than 120 U.S. and 420 foreign patents and a number of pending patent applications that cover various aspects of our technologies.", "type": 1, "words": ["<tag1>", "Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes.", "<tag2>", "We", "own", "greater", "than", "120", "U.S.", "and", "420", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies.", "<tag3>"], "wordsA": ["Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes."], "wordsB": ["We", "own", "greater", "than", "120", "U.S.", "and", "420", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p30_s3", "idA": "906709_11_item1a_p14_s0", "sentA": "Prior to the maturity of the convertible notes, we plan to explore a number of alternatives to provide for the repayment of the convertible notes, including restructuring the convertible notes.", "sentB": "The amount of our revenue derived from collaboration agreements in any given period will depend on a number of unpredictable factors, including our ability to find and maintain suitable collaboration partners, the timing of the negotiation and conclusion of collaboration agreements with such partners, whether and when we or our collaboration partners achieve clinical, regulatory and sales milestones, the timing of regulatory approvals in one or more major markets, reimbursement levels by private and government payers, and the market introduction of new drugs or generic versions of the approved drug, as well as other factors.", "type": 1, "words": ["<tag1>", "Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes.", "<tag2>", "The", "amount", "of", "our", "revenue", "derived", "from", "collaboration", "agreements", "in", "any", "given", "period", "will", "depend", "on", "a", "number", "of", "unpredictable", "factors,", "including", "our", "ability", "to", "find", "and", "maintain", "suitable", "collaboration", "partners,", "the", "timing", "of", "the", "negotiation", "and", "conclusion", "of", "collaboration", "agreements", "with", "such", "partners,", "whether", "and", "when", "we", "or", "our", "collaboration", "partners", "achieve", "clinical,", "regulatory", "and", "sales", "milestones,", "the", "timing", "of", "regulatory", "approvals", "in", "one", "or", "more", "major", "markets,", "reimbursement", "levels", "by", "private", "and", "government", "payers,", "and", "the", "market", "introduction", "of", "new", "drugs", "or", "generic", "versions", "of", "the", "approved", "drug,", "as", "well", "as", "other", "factors.", "<tag3>"], "wordsA": ["Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes."], "wordsB": ["The", "amount", "of", "our", "revenue", "derived", "from", "collaboration", "agreements", "in", "any", "given", "period", "will", "depend", "on", "a", "number", "of", "unpredictable", "factors,", "including", "our", "ability", "to", "find", "and", "maintain", "suitable", "collaboration", "partners,", "the", "timing", "of", "the", "negotiation", "and", "conclusion", "of", "collaboration", "agreements", "with", "such", "partners,", "whether", "and", "when", "we", "or", "our", "collaboration", "partners", "achieve", "clinical,", "regulatory", "and", "sales", "milestones,", "the", "timing", "of", "regulatory", "approvals", "in", "one", "or", "more", "major", "markets,", "reimbursement", "levels", "by", "private", "and", "government", "payers,", "and", "the", "market", "introduction", "of", "new", "drugs", "or", "generic", "versions", "of", "the", "approved", "drug,", "as", "well", "as", "other", "factors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p37_s7", "idA": "906709_11_item1a_p14_s0", "sentA": "Prior to the maturity of the convertible notes, we plan to explore a number of alternatives to provide for the repayment of the convertible notes, including restructuring the convertible notes.", "sentB": "For example, there are only a limited number of qualified suppliers, and in some cases single source suppliers, for the raw materials included in our PEGylation and advanced polymer conjugate drug formulations, and any interruption in supply or failure to procure such raw materials on commercially feasible terms could harm our business by delaying our clinical trials, impeding commercialization of approved drugs or increasing our costs to the extent we cannot pass on increased costs to a manufacturing customer.", "type": 1, "words": ["<tag1>", "Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes.", "<tag2>", "For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "drug", "formulations,", "and", "any", "interruption", "in", "supply", "or", "failure", "to", "procure", "such", "raw", "materials", "on", "commercially", "feasible", "terms", "could", "harm", "our", "business", "by", "delaying", "our", "clinical", "trials,", "impeding", "commercialization", "of", "approved", "drugs", "or", "increasing", "our", "costs", "to", "the", "extent", "we", "cannot", "pass", "on", "increased", "costs", "to", "a", "manufacturing", "customer.", "<tag3>"], "wordsA": ["Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes."], "wordsB": ["For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "drug", "formulations,", "and", "any", "interruption", "in", "supply", "or", "failure", "to", "procure", "such", "raw", "materials", "on", "commercially", "feasible", "terms", "could", "harm", "our", "business", "by", "delaying", "our", "clinical", "trials,", "impeding", "commercialization", "of", "approved", "drugs", "or", "increasing", "our", "costs", "to", "the", "extent", "we", "cannot", "pass", "on", "increased", "costs", "to", "a", "manufacturing", "customer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p44_s2", "idA": "906709_11_item1a_p14_s0", "sentA": "Prior to the maturity of the convertible notes, we plan to explore a number of alternatives to provide for the repayment of the convertible notes, including restructuring the convertible notes.", "sentB": "In addition, there are a number of companies developing potential products which are in various stages of clinical development and are being evaluated for the treatment of OIC and OBD in different patient populations, including Adolor Corporation, Progenics Pharmaceuticals, Inc. in collaboration with Salix Pharmaceuticals, Ltd., Mundipharma Int.", "type": 1, "words": ["<tag1>", "Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes.", "<tag2>", "In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Adolor", "Corporation,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int.", "<tag3>"], "wordsA": ["Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes."], "wordsB": ["In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Adolor", "Corporation,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p45_s0", "idA": "906709_11_item1a_p14_s0", "sentA": "Prior to the maturity of the convertible notes, we plan to explore a number of alternatives to provide for the repayment of the convertible notes, including restructuring the convertible notes.", "sentB": "For NKTR-102, there are a number of chemotherapies and cancer therapies approved today and in various stages of clinical development for ovarian and breast cancers including but not limited to: Avastin (bevacizumab), Camptosar (irinotecan), Doxil (doxorubicin HCl), Ellence (epirubicin), Gemzar (gemcitabine), Herceptin (trastuzumab), Hycamtin (topotecan), Iniparib, Paraplatin (carboplatin), and Taxol (paclitaxel).", "type": 1, "words": ["<tag1>", "Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes.", "<tag2>", "For", "NKTR-102,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "ovarian", "and", "breast", "cancers", "including", "but", "not", "limited", "to:", "Avastin", "(bevacizumab),", "Camptosar", "(irinotecan),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Iniparib,", "Paraplatin", "(carboplatin),", "and", "Taxol", "(paclitaxel).", "<tag3>"], "wordsA": ["Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes."], "wordsB": ["For", "NKTR-102,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "ovarian", "and", "breast", "cancers", "including", "but", "not", "limited", "to:", "Avastin", "(bevacizumab),", "Camptosar", "(irinotecan),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Iniparib,", "Paraplatin", "(carboplatin),", "and", "Taxol", "(paclitaxel)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s1", "idA": "906709_11_item1a_p14_s0", "sentA": "Prior to the maturity of the convertible notes, we plan to explore a number of alternatives to provide for the repayment of the convertible notes, including restructuring the convertible notes.", "sentB": "Because our executive officers and key employees are not obligated to provide us with continued services, they could terminate their employment with us at any time without penalty.", "type": 1, "words": ["<tag1>", "Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes.", "<tag2>", "Because", "our", "executive", "officers", "and", "key", "employees", "are", "not", "obligated", "to", "provide", "us", "with", "continued", "services,", "they", "could", "terminate", "their", "employment", "with", "us", "at", "any", "time", "without", "penalty.", "<tag3>"], "wordsA": ["Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes."], "wordsB": ["Because", "our", "executive", "officers", "and", "key", "employees", "are", "not", "obligated", "to", "provide", "us", "with", "continued", "services,", "they", "could", "terminate", "their", "employment", "with", "us", "at", "any", "time", "without", "penalty."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p22_s1", "idA": "906709_11_item1a_p14_s1", "sentA": "Despite these efforts, we may be unable to find a commercially acceptable alternative or any alternative to repaying the notes by September 2012.", "sentB": "Further, an issued patent may undergo further proceedings to limit its scope so as not to provide meaningful protection and any claims that have issued, or that eventually issue, may be circumvented or otherwise invalidated.", "type": 1, "words": ["<tag1>", "Despite", "these", "efforts,", "we", "may", "be", "unable", "to", "find", "a", "commercially", "acceptable", "alternative", "or", "any", "alternative", "to", "repaying", "the", "notes", "by", "September", "2012.", "<tag2>", "Further,", "an", "issued", "patent", "may", "undergo", "further", "proceedings", "to", "limit", "its", "scope", "so", "as", "not", "to", "provide", "meaningful", "protection", "and", "any", "claims", "that", "have", "issued,", "or", "that", "eventually", "issue,", "may", "be", "circumvented", "or", "otherwise", "invalidated.", "<tag3>"], "wordsA": ["Despite", "these", "efforts,", "we", "may", "be", "unable", "to", "find", "a", "commercially", "acceptable", "alternative", "or", "any", "alternative", "to", "repaying", "the", "notes", "by", "September", "2012."], "wordsB": ["Further,", "an", "issued", "patent", "may", "undergo", "further", "proceedings", "to", "limit", "its", "scope", "so", "as", "not", "to", "provide", "meaningful", "protection", "and", "any", "claims", "that", "have", "issued,", "or", "that", "eventually", "issue,", "may", "be", "circumvented", "or", "otherwise", "invalidated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s2", "idA": "906709_11_item1a_p14_s1", "sentA": "Despite these efforts, we may be unable to find a commercially acceptable alternative or any alternative to repaying the notes by September 2012.", "sentB": "New laws, regulations and judicial decisions may be retroactive in effect, potentially reducing or eliminating our ability to implement our patent-related strategies.", "type": 1, "words": ["<tag1>", "Despite", "these", "efforts,", "we", "may", "be", "unable", "to", "find", "a", "commercially", "acceptable", "alternative", "or", "any", "alternative", "to", "repaying", "the", "notes", "by", "September", "2012.", "<tag2>", "New", "laws,", "regulations", "and", "judicial", "decisions", "may", "be", "retroactive", "in", "effect,", "potentially", "reducing", "or", "eliminating", "our", "ability", "to", "implement", "our", "patent-related", "strategies.", "<tag3>"], "wordsA": ["Despite", "these", "efforts,", "we", "may", "be", "unable", "to", "find", "a", "commercially", "acceptable", "alternative", "or", "any", "alternative", "to", "repaying", "the", "notes", "by", "September", "2012."], "wordsB": ["New", "laws,", "regulations", "and", "judicial", "decisions", "may", "be", "retroactive", "in", "effect,", "potentially", "reducing", "or", "eliminating", "our", "ability", "to", "implement", "our", "patent-related", "strategies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p36_s0", "idA": "906709_11_item1a_p14_s1", "sentA": "Despite these efforts, we may be unable to find a commercially acceptable alternative or any alternative to repaying the notes by September 2012.", "sentB": "If we are unable either to create sales, marketing and distribution capabilities or to enter into agreements with third parties to perform these functions, we will be unable to commercialize our products successfully.", "type": 1, "words": ["<tag1>", "Despite", "these", "efforts,", "we", "may", "be", "unable", "to", "find", "a", "commercially", "acceptable", "alternative", "or", "any", "alternative", "to", "repaying", "the", "notes", "by", "September", "2012.", "<tag2>", "If", "we", "are", "unable", "either", "to", "create", "sales,", "marketing", "and", "distribution", "capabilities", "or", "to", "enter", "into", "agreements", "with", "third", "parties", "to", "perform", "these", "functions,", "we", "will", "be", "unable", "to", "commercialize", "our", "products", "successfully.", "<tag3>"], "wordsA": ["Despite", "these", "efforts,", "we", "may", "be", "unable", "to", "find", "a", "commercially", "acceptable", "alternative", "or", "any", "alternative", "to", "repaying", "the", "notes", "by", "September", "2012."], "wordsB": ["If", "we", "are", "unable", "either", "to", "create", "sales,", "marketing", "and", "distribution", "capabilities", "or", "to", "enter", "into", "agreements", "with", "third", "parties", "to", "perform", "these", "functions,", "we", "will", "be", "unable", "to", "commercialize", "our", "products", "successfully."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s9", "idA": "906709_11_item1a_p14_s1", "sentA": "Despite these efforts, we may be unable to find a commercially acceptable alternative or any alternative to repaying the notes by September 2012.", "sentB": "If we are unable to effectively manage our expenses, we may find it necessary to reduce our personnel-related costs through reductions in our workforce, which could harm our operations, employee morale and impair our ability to retain and recruit talent.", "type": 1, "words": ["<tag1>", "Despite", "these", "efforts,", "we", "may", "be", "unable", "to", "find", "a", "commercially", "acceptable", "alternative", "or", "any", "alternative", "to", "repaying", "the", "notes", "by", "September", "2012.", "<tag2>", "If", "we", "are", "unable", "to", "effectively", "manage", "our", "expenses,", "we", "may", "find", "it", "necessary", "to", "reduce", "our", "personnel-related", "costs", "through", "reductions", "in", "our", "workforce,", "which", "could", "harm", "our", "operations,", "employee", "morale", "and", "impair", "our", "ability", "to", "retain", "and", "recruit", "talent.", "<tag3>"], "wordsA": ["Despite", "these", "efforts,", "we", "may", "be", "unable", "to", "find", "a", "commercially", "acceptable", "alternative", "or", "any", "alternative", "to", "repaying", "the", "notes", "by", "September", "2012."], "wordsB": ["If", "we", "are", "unable", "to", "effectively", "manage", "our", "expenses,", "we", "may", "find", "it", "necessary", "to", "reduce", "our", "personnel-related", "costs", "through", "reductions", "in", "our", "workforce,", "which", "could", "harm", "our", "operations,", "employee", "morale", "and", "impair", "our", "ability", "to", "retain", "and", "recruit", "talent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p12_s3", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "As a result, preliminary and interim data should be viewed with caution until the final data are available.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "As", "a", "result,", "preliminary", "and", "interim", "data", "should", "be", "viewed", "with", "caution", "until", "the", "final", "data", "are", "available.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["As", "a", "result,", "preliminary", "and", "interim", "data", "should", "be", "viewed", "with", "caution", "until", "the", "final", "data", "are", "available."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s0", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "There are many laws, regulations and judicial decisions that dictate and otherwise influence the manner in which patent applications are filed and prosecuted and in which patents are granted and enforced.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "There", "are", "many", "laws,", "regulations", "and", "judicial", "decisions", "that", "dictate", "and", "otherwise", "influence", "the", "manner", "in", "which", "patent", "applications", "are", "filed", "and", "prosecuted", "and", "in", "which", "patents", "are", "granted", "and", "enforced.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["There", "are", "many", "laws,", "regulations", "and", "judicial", "decisions", "that", "dictate", "and", "otherwise", "influence", "the", "manner", "in", "which", "patent", "applications", "are", "filed", "and", "prosecuted", "and", "in", "which", "patents", "are", "granted", "and", "enforced."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p26_s0", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "Failures in device manufacturing has similar effects.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "Failures", "in", "device", "manufacturing", "has", "similar", "effects.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["Failures", "in", "device", "manufacturing", "has", "similar", "effects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s0", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "Risks Related to Our Business Drug development is a long and inherently uncertain process with a high risk of failure at every stage of development.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "Risks", "Related", "to", "Our", "Business", "Drug", "development", "is", "a", "long", "and", "inherently", "uncertain", "process", "with", "a", "high", "risk", "of", "failure", "at", "every", "stage", "of", "development.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["Risks", "Related", "to", "Our", "Business", "Drug", "development", "is", "a", "long", "and", "inherently", "uncertain", "process", "with", "a", "high", "risk", "of", "failure", "at", "every", "stage", "of", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s2", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "Preclinical testing and clinical studies are long, expensive and highly uncertain processes.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "Preclinical", "testing", "and", "clinical", "studies", "are", "long,", "expensive", "and", "highly", "uncertain", "processes.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["Preclinical", "testing", "and", "clinical", "studies", "are", "long,", "expensive", "and", "highly", "uncertain", "processes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p40_s0", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "maintain sufficient funds to finance our activities.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "maintain", "sufficient", "funds", "to", "finance", "our", "activities.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["maintain", "sufficient", "funds", "to", "finance", "our", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p40_s3", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "Such third-party payers are increasingly challenging the price and cost effectiveness of medical products and services.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "Such", "third-party", "payers", "are", "increasingly", "challenging", "the", "price", "and", "cost", "effectiveness", "of", "medical", "products", "and", "services.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["Such", "third-party", "payers", "are", "increasingly", "challenging", "the", "price", "and", "cost", "effectiveness", "of", "medical", "products", "and", "services."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p44_s3", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "Limited, Sucampo Pharmaceuticals, Alkermes, Inc. and Takeda Pharmaceutical Company Limited.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "Limited,", "Sucampo", "Pharmaceuticals,", "Alkermes,", "Inc.", "and", "Takeda", "Pharmaceutical", "Company", "Limited.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["Limited,", "Sucampo", "Pharmaceuticals,", "Alkermes,", "Inc.", "and", "Takeda", "Pharmaceutical", "Company", "Limited."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p48_s4", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "These developments could make our products or technologies uncompetitive or obsolete.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "These", "developments", "could", "make", "our", "products", "or", "technologies", "uncompetitive", "or", "obsolete.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["These", "developments", "could", "make", "our", "products", "or", "technologies", "uncompetitive", "or", "obsolete."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s13", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "We may seek to repurchase our convertible notes through cash purchases in open market transactions, privately negotiated transactions and/or a tender offer, if we can do so on attractive terms.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "We", "may", "seek", "to", "repurchase", "our", "convertible", "notes", "through", "cash", "purchases", "in", "open", "market", "transactions,", "privately", "negotiated", "transactions", "and/or", "a", "tender", "offer,", "if", "we", "can", "do", "so", "on", "attractive", "terms.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["We", "may", "seek", "to", "repurchase", "our", "convertible", "notes", "through", "cash", "purchases", "in", "open", "market", "transactions,", "privately", "negotiated", "transactions", "and/or", "a", "tender", "offer,", "if", "we", "can", "do", "so", "on", "attractive", "terms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p51_s0", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "limitations on who may call a special meeting of stockholders.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "limitations", "on", "who", "may", "call", "a", "special", "meeting", "of", "stockholders.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["limitations", "on", "who", "may", "call", "a", "special", "meeting", "of", "stockholders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p51_s1", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "Further, provisions of Delaware law relating to business combinations with interested stockholders may discourage, delay or prevent a third party from acquiring us.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "Further,", "provisions", "of", "Delaware", "law", "relating", "to", "business", "combinations", "with", "interested", "stockholders", "may", "discourage,", "delay", "or", "prevent", "a", "third", "party", "from", "acquiring", "us.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["Further,", "provisions", "of", "Delaware", "law", "relating", "to", "business", "combinations", "with", "interested", "stockholders", "may", "discourage,", "delay", "or", "prevent", "a", "third", "party", "from", "acquiring", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p51_s4", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "This severance plan could discourage a third party from acquiring us.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "This", "severance", "plan", "could", "discourage", "a", "third", "party", "from", "acquiring", "us.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["This", "severance", "plan", "could", "discourage", "a", "third", "party", "from", "acquiring", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s18", "idA": "906709_11_item1a_p15_s0", "sentA": "Due to the potential for continued uncertainty in the credit markets in 2011, we may experience reduced liquidity with respect to some of our short-term investments.", "sentB": "These restrictive covenants may include limitations on additional borrowing and specific restrictions on the use of our assets, as well as prohibitions on our ability to create liens or make investments.", "type": 1, "words": ["<tag1>", "Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2011,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "short-term", "investments.", "<tag2>", "These", "restrictive", "covenants", "may", "include", "limitations", "on", "additional", "borrowing", "and", "specific", "restrictions", "on", "the", "use", "of", "our", "assets,", "as", "well", "as", "prohibitions", "on", "our", "ability", "to", "create", "liens", "or", "make", "investments.", "<tag3>"], "wordsA": ["Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2011,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "short-term", "investments."], "wordsB": ["These", "restrictive", "covenants", "may", "include", "limitations", "on", "additional", "borrowing", "and", "specific", "restrictions", "on", "the", "use", "of", "our", "assets,", "as", "well", "as", "prohibitions", "on", "our", "ability", "to", "create", "liens", "or", "make", "investments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p7_s1", "idA": "906709_11_item1a_p15_s0", "sentA": "Due to the potential for continued uncertainty in the credit markets in 2011, we may experience reduced liquidity with respect to some of our short-term investments.", "sentB": "We expanded the NKTR-102 Phase 2 study by 110 patients in women with platinum-resistant/refractory ovarian cancer that had received prior Doxil therapy with the potential for us to consider an early NDA submission after we evaluate these expanded study results.", "type": 1, "words": ["<tag1>", "Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2011,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "short-term", "investments.", "<tag2>", "We", "expanded", "the", "NKTR-102", "Phase", "2", "study", "by", "110", "patients", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "that", "had", "received", "prior", "Doxil", "therapy", "with", "the", "potential", "for", "us", "to", "consider", "an", "early", "NDA", "submission", "after", "we", "evaluate", "these", "expanded", "study", "results.", "<tag3>"], "wordsA": ["Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2011,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "short-term", "investments."], "wordsB": ["We", "expanded", "the", "NKTR-102", "Phase", "2", "study", "by", "110", "patients", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "that", "had", "received", "prior", "Doxil", "therapy", "with", "the", "potential", "for", "us", "to", "consider", "an", "early", "NDA", "submission", "after", "we", "evaluate", "these", "expanded", "study", "results."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p9_s2", "idA": "906709_11_item1a_p15_s0", "sentA": "Due to the potential for continued uncertainty in the credit markets in 2011, we may experience reduced liquidity with respect to some of our short-term investments.", "sentB": "An important objective of our NKTR-181 drug development program is to create a unique opioid molecule that does not rapidly enter a patient s central nervous system and therefore has the potential to be less susceptible to abuse than alternative opioid therapies.", "type": 1, "words": ["<tag1>", "Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2011,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "short-term", "investments.", "<tag2>", "An", "important", "objective", "of", "our", "NKTR-181", "drug", "development", "program", "is", "to", "create", "a", "unique", "opioid", "molecule", "that", "does", "not", "rapidly", "enter", "a", "patient", "s", "central", "nervous", "system", "and", "therefore", "has", "the", "potential", "to", "be", "less", "susceptible", "to", "abuse", "than", "alternative", "opioid", "therapies.", "<tag3>"], "wordsA": ["Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2011,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "short-term", "investments."], "wordsB": ["An", "important", "objective", "of", "our", "NKTR-181", "drug", "development", "program", "is", "to", "create", "a", "unique", "opioid", "molecule", "that", "does", "not", "rapidly", "enter", "a", "patient", "s", "central", "nervous", "system", "and", "therefore", "has", "the", "potential", "to", "be", "less", "susceptible", "to", "abuse", "than", "alternative", "opioid", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p22_s0", "idA": "906709_11_item1a_p15_s2", "sentA": "However, if the need arose to liquidate such securities before maturity, we may experience losses on liquidation.", "sentB": "substantial cost to us, even if the eventual outcome is favorable.", "type": 1, "words": ["<tag1>", "However,", "if", "the", "need", "arose", "to", "liquidate", "such", "securities", "before", "maturity,", "we", "may", "experience", "losses", "on", "liquidation.", "<tag2>", "substantial", "cost", "to", "us,", "even", "if", "the", "eventual", "outcome", "is", "favorable.", "<tag3>"], "wordsA": ["However,", "if", "the", "need", "arose", "to", "liquidate", "such", "securities", "before", "maturity,", "we", "may", "experience", "losses", "on", "liquidation."], "wordsB": ["substantial", "cost", "to", "us,", "even", "if", "the", "eventual", "outcome", "is", "favorable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p48_s5", "idA": "906709_11_item1a_p15_s2", "sentA": "However, if the need arose to liquidate such securities before maturity, we may experience losses on liquidation.", "sentB": "If product liability lawsuits are brought against us, we may incur substantial liabilities.", "type": 1, "words": ["<tag1>", "However,", "if", "the", "need", "arose", "to", "liquidate", "such", "securities", "before", "maturity,", "we", "may", "experience", "losses", "on", "liquidation.", "<tag2>", "If", "product", "liability", "lawsuits", "are", "brought", "against", "us,", "we", "may", "incur", "substantial", "liabilities.", "<tag3>"], "wordsA": ["However,", "if", "the", "need", "arose", "to", "liquidate", "such", "securities", "before", "maturity,", "we", "may", "experience", "losses", "on", "liquidation."], "wordsB": ["If", "product", "liability", "lawsuits", "are", "brought", "against", "us,", "we", "may", "incur", "substantial", "liabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p1_s2", "idA": "906709_11_item1a_p15_s4", "sentA": "Based on our available cash and our expected operating cash requirements, we do not intend to sell these securities and it is more likely than not that we will not be required to sell these securities before we recover the amortized cost basis.", "sentB": "You should understand that it is not possible to predict or identify all such factors.", "type": 1, "words": ["<tag1>", "Based", "on", "our", "available", "cash", "and", "our", "expected", "operating", "cash", "requirements,", "we", "do", "not", "intend", "to", "sell", "these", "securities", "and", "it", "is", "more", "likely", "than", "not", "that", "we", "will", "not", "be", "required", "to", "sell", "these", "securities", "before", "we", "recover", "the", "amortized", "cost", "basis.", "<tag2>", "You", "should", "understand", "that", "it", "is", "not", "possible", "to", "predict", "or", "identify", "all", "such", "factors.", "<tag3>"], "wordsA": ["Based", "on", "our", "available", "cash", "and", "our", "expected", "operating", "cash", "requirements,", "we", "do", "not", "intend", "to", "sell", "these", "securities", "and", "it", "is", "more", "likely", "than", "not", "that", "we", "will", "not", "be", "required", "to", "sell", "these", "securities", "before", "we", "recover", "the", "amortized", "cost", "basis."], "wordsB": ["You", "should", "understand", "that", "it", "is", "not", "possible", "to", "predict", "or", "identify", "all", "such", "factors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s12", "idA": "906709_11_item1a_p15_s4", "sentA": "Based on our available cash and our expected operating cash requirements, we do not intend to sell these securities and it is more likely than not that we will not be required to sell these securities before we recover the amortized cost basis.", "sentB": "Phase 3 clinical outcomes remain very unpredictable and it is possible that one or more of these Phase 3 clinical studies could fail at any time due to efficacy, safety or other important clinical findings or regulatory requirements.", "type": 1, "words": ["<tag1>", "Based", "on", "our", "available", "cash", "and", "our", "expected", "operating", "cash", "requirements,", "we", "do", "not", "intend", "to", "sell", "these", "securities", "and", "it", "is", "more", "likely", "than", "not", "that", "we", "will", "not", "be", "required", "to", "sell", "these", "securities", "before", "we", "recover", "the", "amortized", "cost", "basis.", "<tag2>", "Phase", "3", "clinical", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "these", "Phase", "3", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements.", "<tag3>"], "wordsA": ["Based", "on", "our", "available", "cash", "and", "our", "expected", "operating", "cash", "requirements,", "we", "do", "not", "intend", "to", "sell", "these", "securities", "and", "it", "is", "more", "likely", "than", "not", "that", "we", "will", "not", "be", "required", "to", "sell", "these", "securities", "before", "we", "recover", "the", "amortized", "cost", "basis."], "wordsB": ["Phase", "3", "clinical", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "these", "Phase", "3", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p38_s2", "idA": "906709_11_item1a_p15_s4", "sentA": "Based on our available cash and our expected operating cash requirements, we do not intend to sell these securities and it is more likely than not that we will not be required to sell these securities before we recover the amortized cost basis.", "sentB": "No assurance can be given that others will not independently develop substantially equivalent confidential and proprietary information or otherwise gain access to our trade secrets or disclose such technology, or that we can meaningfully protect our trade secrets.", "type": 1, "words": ["<tag1>", "Based", "on", "our", "available", "cash", "and", "our", "expected", "operating", "cash", "requirements,", "we", "do", "not", "intend", "to", "sell", "these", "securities", "and", "it", "is", "more", "likely", "than", "not", "that", "we", "will", "not", "be", "required", "to", "sell", "these", "securities", "before", "we", "recover", "the", "amortized", "cost", "basis.", "<tag2>", "No", "assurance", "can", "be", "given", "that", "others", "will", "not", "independently", "develop", "substantially", "equivalent", "confidential", "and", "proprietary", "information", "or", "otherwise", "gain", "access", "to", "our", "trade", "secrets", "or", "disclose", "such", "technology,", "or", "that", "we", "can", "meaningfully", "protect", "our", "trade", "secrets.", "<tag3>"], "wordsA": ["Based", "on", "our", "available", "cash", "and", "our", "expected", "operating", "cash", "requirements,", "we", "do", "not", "intend", "to", "sell", "these", "securities", "and", "it", "is", "more", "likely", "than", "not", "that", "we", "will", "not", "be", "required", "to", "sell", "these", "securities", "before", "we", "recover", "the", "amortized", "cost", "basis."], "wordsB": ["No", "assurance", "can", "be", "given", "that", "others", "will", "not", "independently", "develop", "substantially", "equivalent", "confidential", "and", "proprietary", "information", "or", "otherwise", "gain", "access", "to", "our", "trade", "secrets", "or", "disclose", "such", "technology,", "or", "that", "we", "can", "meaningfully", "protect", "our", "trade", "secrets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p48_s3", "idA": "906709_11_item1a_p15_s4", "sentA": "Based on our available cash and our expected operating cash requirements, we do not intend to sell these securities and it is more likely than not that we will not be required to sell these securities before we recover the amortized cost basis.", "sentB": "As a result, our competitors may succeed in developing competing technologies, obtaining regulatory approval or gaining market acceptance for products before we do.", "type": 1, "words": ["<tag1>", "Based", "on", "our", "available", "cash", "and", "our", "expected", "operating", "cash", "requirements,", "we", "do", "not", "intend", "to", "sell", "these", "securities", "and", "it", "is", "more", "likely", "than", "not", "that", "we", "will", "not", "be", "required", "to", "sell", "these", "securities", "before", "we", "recover", "the", "amortized", "cost", "basis.", "<tag2>", "As", "a", "result,", "our", "competitors", "may", "succeed", "in", "developing", "competing", "technologies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do.", "<tag3>"], "wordsA": ["Based", "on", "our", "available", "cash", "and", "our", "expected", "operating", "cash", "requirements,", "we", "do", "not", "intend", "to", "sell", "these", "securities", "and", "it", "is", "more", "likely", "than", "not", "that", "we", "will", "not", "be", "required", "to", "sell", "these", "securities", "before", "we", "recover", "the", "amortized", "cost", "basis."], "wordsB": ["As", "a", "result,", "our", "competitors", "may", "succeed", "in", "developing", "competing", "technologies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p14_s2", "idA": "906709_11_item1a_p15_s5", "sentA": "To date we have not experienced any liquidity issues with respect to these securities, but should such issues arise, we may be required to hold some, or all, of these securities until maturity.", "sentB": "In certain cases, we have existing licenses or cross-licenses with third parties, however the scope and adequacy of these licenses is very uncertain and can change substantially during long development and commercialization cycles for biotechnology and pharmaceutical products.", "type": 1, "words": ["<tag1>", "To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity.", "<tag2>", "In", "certain", "cases,", "we", "have", "existing", "licenses", "or", "cross-licenses", "with", "third", "parties,", "however", "the", "scope", "and", "adequacy", "of", "these", "licenses", "is", "very", "uncertain", "and", "can", "change", "substantially", "during", "long", "development", "and", "commercialization", "cycles", "for", "biotechnology", "and", "pharmaceutical", "products.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity."], "wordsB": ["In", "certain", "cases,", "we", "have", "existing", "licenses", "or", "cross-licenses", "with", "third", "parties,", "however", "the", "scope", "and", "adequacy", "of", "these", "licenses", "is", "very", "uncertain", "and", "can", "change", "substantially", "during", "long", "development", "and", "commercialization", "cycles", "for", "biotechnology", "and", "pharmaceutical", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s3", "idA": "906709_11_item1a_p15_s5", "sentA": "To date we have not experienced any liquidity issues with respect to these securities, but should such issues arise, we may be required to hold some, or all, of these securities until maturity.", "sentB": "Changes to laws, regulations and judicial decisions that affect our business are often difficult or impossible to foresee, which limits our ability to adequately adapt our patent strategies to these changes.", "type": 1, "words": ["<tag1>", "To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity.", "<tag2>", "Changes", "to", "laws,", "regulations", "and", "judicial", "decisions", "that", "affect", "our", "business", "are", "often", "difficult", "or", "impossible", "to", "foresee,", "which", "limits", "our", "ability", "to", "adequately", "adapt", "our", "patent", "strategies", "to", "these", "changes.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity."], "wordsB": ["Changes", "to", "laws,", "regulations", "and", "judicial", "decisions", "that", "affect", "our", "business", "are", "often", "difficult", "or", "impossible", "to", "foresee,", "which", "limits", "our", "ability", "to", "adequately", "adapt", "our", "patent", "strategies", "to", "these", "changes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s18", "idA": "906709_11_item1a_p15_s6", "sentA": "We believe that, even allowing for potential liquidity issues with respect to these securities, our remaining cash and cash equivalents and short-term investments will be sufficient to meet our anticipated cash needs for at least the next twelve months.", "sentB": "In addition, our insurance coverage may not be sufficient to compensate us for actual losses from any interruption of our business that may occur.", "type": 1, "words": ["<tag1>", "We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash", "and", "cash", "equivalents", "and", "short-term", "investments", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months.", "<tag2>", "In", "addition,", "our", "insurance", "coverage", "may", "not", "be", "sufficient", "to", "compensate", "us", "for", "actual", "losses", "from", "any", "interruption", "of", "our", "business", "that", "may", "occur.", "<tag3>"], "wordsA": ["We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash", "and", "cash", "equivalents", "and", "short-term", "investments", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months."], "wordsB": ["In", "addition,", "our", "insurance", "coverage", "may", "not", "be", "sufficient", "to", "compensate", "us", "for", "actual", "losses", "from", "any", "interruption", "of", "our", "business", "that", "may", "occur."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s13", "idA": "906709_11_item1a_p16_s0", "sentA": "During the year ended December 31, 2010, net cash used in operating activities totaled $55.9 million, which primarily consisted of spending on operating costs and expenses and includes $7.0 million for interest payments on our convertible subordinated notes, and was partially offset by a $50.0 million upfront payment received from Amgen under the supply, dedicated suite and manufacturing guarantee agreement that we entered into with Amgen in October 2010.", "sentB": "As a result, we could incur substantial costs and damages, and reduce or even eliminate product or royalty revenue.", "type": 1, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2010,", "net", "cash", "used", "in", "operating", "activities", "totaled", "$55.9", "million,", "which", "primarily", "consisted", "of", "spending", "on", "operating", "costs", "and", "expenses", "and", "includes", "$7.0", "million", "for", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "and", "was", "partially", "offset", "by", "a", "$50.0", "million", "upfront", "payment", "received", "from", "Amgen", "under", "the", "supply,", "dedicated", "suite", "and", "manufacturing", "guarantee", "agreement", "that", "we", "entered", "into", "with", "Amgen", "in", "October", "2010.", "<tag2>", "As", "a", "result,", "we", "could", "incur", "substantial", "costs", "and", "damages,", "and", "reduce", "or", "even", "eliminate", "product", "or", "royalty", "revenue.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2010,", "net", "cash", "used", "in", "operating", "activities", "totaled", "$55.9", "million,", "which", "primarily", "consisted", "of", "spending", "on", "operating", "costs", "and", "expenses", "and", "includes", "$7.0", "million", "for", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "and", "was", "partially", "offset", "by", "a", "$50.0", "million", "upfront", "payment", "received", "from", "Amgen", "under", "the", "supply,", "dedicated", "suite", "and", "manufacturing", "guarantee", "agreement", "that", "we", "entered", "into", "with", "Amgen", "in", "October", "2010."], "wordsB": ["As", "a", "result,", "we", "could", "incur", "substantial", "costs", "and", "damages,", "and", "reduce", "or", "even", "eliminate", "product", "or", "royalty", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p39_s2", "idA": "906709_11_item1a_p18_s0", "sentA": "During the year ended December 31, 2008, net cash used for our operating activities was $145.8 million, which included a number of significant items including a $10.0 million clinical development milestone received from Bayer Healthcare LLC under our collaboration agreement for Amikacin Inhale, payments by us to Bespak Europe Ltd. and Tech Group North America, Inc. of $40.2 million for amounts due under termination agreements with these Exubera inhaler device contract manufacturers, all of which was recorded as an expense in 2007, $6.8 million paid to maintain Exubera manufacturing capacity through April 2008, and $5.4 million for severance, and employee benefits in connection with our workforce reduction plans.", "sentB": "Other factors that will affect whether we achieve and sustain profitability include our ability, alone or together with our partners, to:", "type": 1, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2008,", "net", "cash", "used", "for", "our", "operating", "activities", "was", "$145.8", "million,", "which", "included", "a", "number", "of", "significant", "items", "including", "a", "$10.0", "million", "clinical", "development", "milestone", "received", "from", "Bayer", "Healthcare", "LLC", "under", "our", "collaboration", "agreement", "for", "Amikacin", "Inhale,", "payments", "by", "us", "to", "Bespak", "Europe", "Ltd.", "and", "Tech", "Group", "North", "America,", "Inc.", "of", "$40.2", "million", "for", "amounts", "due", "under", "termination", "agreements", "with", "these", "Exubera", "inhaler", "device", "contract", "manufacturers,", "all", "of", "which", "was", "recorded", "as", "an", "expense", "in", "2007,", "$6.8", "million", "paid", "to", "maintain", "Exubera", "manufacturing", "capacity", "through", "April", "2008,", "and", "$5.4", "million", "for", "severance,", "and", "employee", "benefits", "in", "connection", "with", "our", "workforce", "reduction", "plans.", "<tag2>", "Other", "factors", "that", "will", "affect", "whether", "we", "achieve", "and", "sustain", "profitability", "include", "our", "ability,", "alone", "or", "together", "with", "our", "partners,", "to:", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2008,", "net", "cash", "used", "for", "our", "operating", "activities", "was", "$145.8", "million,", "which", "included", "a", "number", "of", "significant", "items", "including", "a", "$10.0", "million", "clinical", "development", "milestone", "received", "from", "Bayer", "Healthcare", "LLC", "under", "our", "collaboration", "agreement", "for", "Amikacin", "Inhale,", "payments", "by", "us", "to", "Bespak", "Europe", "Ltd.", "and", "Tech", "Group", "North", "America,", "Inc.", "of", "$40.2", "million", "for", "amounts", "due", "under", "termination", "agreements", "with", "these", "Exubera", "inhaler", "device", "contract", "manufacturers,", "all", "of", "which", "was", "recorded", "as", "an", "expense", "in", "2007,", "$6.8", "million", "paid", "to", "maintain", "Exubera", "manufacturing", "capacity", "through", "April", "2008,", "and", "$5.4", "million", "for", "severance,", "and", "employee", "benefits", "in", "connection", "with", "our", "workforce", "reduction", "plans."], "wordsB": ["Other", "factors", "that", "will", "affect", "whether", "we", "achieve", "and", "sustain", "profitability", "include", "our", "ability,", "alone", "or", "together", "with", "our", "partners,", "to:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p37_s0", "idA": "906709_11_item1a_p1_s0", "sentA": "General and administrative expenses are associated with administrative staffing, business development, finance, marketing, and legal.", "sentB": "unforeseen costs and expenses associated with creating and sustaining an independent sales and marketing organization.", "type": 1, "words": ["<tag1>", "General", "and", "administrative", "expenses", "are", "associated", "with", "administrative", "staffing,", "business", "development,", "finance,", "marketing,", "and", "legal.", "<tag2>", "unforeseen", "costs", "and", "expenses", "associated", "with", "creating", "and", "sustaining", "an", "independent", "sales", "and", "marketing", "organization.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "are", "associated", "with", "administrative", "staffing,", "business", "development,", "finance,", "marketing,", "and", "legal."], "wordsB": ["unforeseen", "costs", "and", "expenses", "associated", "with", "creating", "and", "sustaining", "an", "independent", "sales", "and", "marketing", "organization."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s0", "idA": "906709_11_item1a_p20_s0", "sentA": "On December 31, 2008, we completed the sale of certain pulmonary assets to Novartis for a purchase price of $115.0 million.", "sentB": "The manufacture, clinical testing, marketing and sale of medical products involve inherent product liability risks.", "type": 1, "words": ["<tag1>", "On", "December", "31,", "2008,", "we", "completed", "the", "sale", "of", "certain", "pulmonary", "assets", "to", "Novartis", "for", "a", "purchase", "price", "of", "$115.0", "million.", "<tag2>", "The", "manufacture,", "clinical", "testing,", "marketing", "and", "sale", "of", "medical", "products", "involve", "inherent", "product", "liability", "risks.", "<tag3>"], "wordsA": ["On", "December", "31,", "2008,", "we", "completed", "the", "sale", "of", "certain", "pulmonary", "assets", "to", "Novartis", "for", "a", "purchase", "price", "of", "$115.0", "million."], "wordsB": ["The", "manufacture,", "clinical", "testing,", "marketing", "and", "sale", "of", "medical", "products", "involve", "inherent", "product", "liability", "risks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p38_s3", "idA": "906709_11_item1a_p20_s2", "sentA": "In addition, in July 2008, we invested $4.2 million in Pearl Therapeutics Inc. (Pearl).", "sentB": "In addition, unpatented proprietary rights, including trade secrets and know-how, can be difficult to protect and may lose their value if they are independently developed by a third party or if their secrecy is lost.", "type": 1, "words": ["<tag1>", "In", "addition,", "in", "July", "2008,", "we", "invested", "$4.2", "million", "in", "Pearl", "Therapeutics", "Inc.", "(Pearl).", "<tag2>", "In", "addition,", "unpatented", "proprietary", "rights,", "including", "trade", "secrets", "and", "know-how,", "can", "be", "difficult", "to", "protect", "and", "may", "lose", "their", "value", "if", "they", "are", "independently", "developed", "by", "a", "third", "party", "or", "if", "their", "secrecy", "is", "lost.", "<tag3>"], "wordsA": ["In", "addition,", "in", "July", "2008,", "we", "invested", "$4.2", "million", "in", "Pearl", "Therapeutics", "Inc.", "(Pearl)."], "wordsB": ["In", "addition,", "unpatented", "proprietary", "rights,", "including", "trade", "secrets", "and", "know-how,", "can", "be", "difficult", "to", "protect", "and", "may", "lose", "their", "value", "if", "they", "are", "independently", "developed", "by", "a", "third", "party", "or", "if", "their", "secrecy", "is", "lost."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p16_s0", "idA": "906709_11_item1a_p20_s3", "sentA": "In 2007, we granted Pearl a limited field intellectual property license to certain of our proprietary pulmonary delivery technology.", "sentB": "indemnity obligations for intellectual property infringement, product liability and certain other claims.", "type": 1, "words": ["<tag1>", "In", "2007,", "we", "granted", "Pearl", "a", "limited", "field", "intellectual", "property", "license", "to", "certain", "of", "our", "proprietary", "pulmonary", "delivery", "technology.", "<tag2>", "indemnity", "obligations", "for", "intellectual", "property", "infringement,", "product", "liability", "and", "certain", "other", "claims.", "<tag3>"], "wordsA": ["In", "2007,", "we", "granted", "Pearl", "a", "limited", "field", "intellectual", "property", "license", "to", "certain", "of", "our", "proprietary", "pulmonary", "delivery", "technology."], "wordsB": ["indemnity", "obligations", "for", "intellectual", "property", "infringement,", "product", "liability", "and", "certain", "other", "claims."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p19_s0", "idA": "906709_11_item1a_p20_s3", "sentA": "In 2007, we granted Pearl a limited field intellectual property license to certain of our proprietary pulmonary delivery technology.", "sentB": "In certain of our agreements with our partners, we are obligated to indemnify and hold harmless our collaboration partners from intellectual property infringement, product liability and certain other claims, which could cause us to incur substantial costs and liability if we are called upon to defend ourselves and our partners against any claims.", "type": 1, "words": ["<tag1>", "In", "2007,", "we", "granted", "Pearl", "a", "limited", "field", "intellectual", "property", "license", "to", "certain", "of", "our", "proprietary", "pulmonary", "delivery", "technology.", "<tag2>", "In", "certain", "of", "our", "agreements", "with", "our", "partners,", "we", "are", "obligated", "to", "indemnify", "and", "hold", "harmless", "our", "collaboration", "partners", "from", "intellectual", "property", "infringement,", "product", "liability", "and", "certain", "other", "claims,", "which", "could", "cause", "us", "to", "incur", "substantial", "costs", "and", "liability", "if", "we", "are", "called", "upon", "to", "defend", "ourselves", "and", "our", "partners", "against", "any", "claims.", "<tag3>"], "wordsA": ["In", "2007,", "we", "granted", "Pearl", "a", "limited", "field", "intellectual", "property", "license", "to", "certain", "of", "our", "proprietary", "pulmonary", "delivery", "technology."], "wordsB": ["In", "certain", "of", "our", "agreements", "with", "our", "partners,", "we", "are", "obligated", "to", "indemnify", "and", "hold", "harmless", "our", "collaboration", "partners", "from", "intellectual", "property", "infringement,", "product", "liability", "and", "certain", "other", "claims,", "which", "could", "cause", "us", "to", "incur", "substantial", "costs", "and", "liability", "if", "we", "are", "called", "upon", "to", "defend", "ourselves", "and", "our", "partners", "against", "any", "claims."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p19_s2", "idA": "906709_11_item1a_p20_s3", "sentA": "In 2007, we granted Pearl a limited field intellectual property license to certain of our proprietary pulmonary delivery technology.", "sentB": "For instance, F. Hoffmann-La Roche Ltd, to which we license our proprietary PEGylation reagent intellectual property for use in the MIRCERA product, was a party to a significant patent infringement lawsuit brought by Amgen Inc. related to Roche s proposed marketing and sale of MIRCERA to treat chemotherapy anemia in the U.S.", "type": 1, "words": ["<tag1>", "In", "2007,", "we", "granted", "Pearl", "a", "limited", "field", "intellectual", "property", "license", "to", "certain", "of", "our", "proprietary", "pulmonary", "delivery", "technology.", "<tag2>", "For", "instance,", "F.", "Hoffmann-La", "Roche", "Ltd,", "to", "which", "we", "license", "our", "proprietary", "PEGylation", "reagent", "intellectual", "property", "for", "use", "in", "the", "MIRCERA", "product,", "was", "a", "party", "to", "a", "significant", "patent", "infringement", "lawsuit", "brought", "by", "Amgen", "Inc.", "related", "to", "Roche", "s", "proposed", "marketing", "and", "sale", "of", "MIRCERA", "to", "treat", "chemotherapy", "anemia", "in", "the", "U.S.", "<tag3>"], "wordsA": ["In", "2007,", "we", "granted", "Pearl", "a", "limited", "field", "intellectual", "property", "license", "to", "certain", "of", "our", "proprietary", "pulmonary", "delivery", "technology."], "wordsB": ["For", "instance,", "F.", "Hoffmann-La", "Roche", "Ltd,", "to", "which", "we", "license", "our", "proprietary", "PEGylation", "reagent", "intellectual", "property", "for", "use", "in", "the", "MIRCERA", "product,", "was", "a", "party", "to", "a", "significant", "patent", "infringement", "lawsuit", "brought", "by", "Amgen", "Inc.", "related", "to", "Roche", "s", "proposed", "marketing", "and", "sale", "of", "MIRCERA", "to", "treat", "chemotherapy", "anemia", "in", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p21_s2", "idA": "906709_11_item1a_p20_s3", "sentA": "In 2007, we granted Pearl a limited field intellectual property license to certain of our proprietary pulmonary delivery technology.", "sentB": "We have filed patent applications, and plan to file additional patent applications, covering various aspects of our PEGylation and advanced polymer conjugate technologies and our proprietary product candidates.", "type": 1, "words": ["<tag1>", "In", "2007,", "we", "granted", "Pearl", "a", "limited", "field", "intellectual", "property", "license", "to", "certain", "of", "our", "proprietary", "pulmonary", "delivery", "technology.", "<tag2>", "We", "have", "filed", "patent", "applications,", "and", "plan", "to", "file", "additional", "patent", "applications,", "covering", "various", "aspects", "of", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technologies", "and", "our", "proprietary", "product", "candidates.", "<tag3>"], "wordsA": ["In", "2007,", "we", "granted", "Pearl", "a", "limited", "field", "intellectual", "property", "license", "to", "certain", "of", "our", "proprietary", "pulmonary", "delivery", "technology."], "wordsB": ["We", "have", "filed", "patent", "applications,", "and", "plan", "to", "file", "additional", "patent", "applications,", "covering", "various", "aspects", "of", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technologies", "and", "our", "proprietary", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p21_s0", "idA": "906709_11_item1a_p24_s1", "sentA": "Additionally, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "sentB": "The patent positions of pharmaceutical and biotechnology companies, such as ours, are uncertain and involve complex legal and factual issues.", "type": 1, "words": ["<tag1>", "Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag2>", "The", "patent", "positions", "of", "pharmaceutical", "and", "biotechnology", "companies,", "such", "as", "ours,", "are", "uncertain", "and", "involve", "complex", "legal", "and", "factual", "issues.", "<tag3>"], "wordsA": ["Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "wordsB": ["The", "patent", "positions", "of", "pharmaceutical", "and", "biotechnology", "companies,", "such", "as", "ours,", "are", "uncertain", "and", "involve", "complex", "legal", "and", "factual", "issues."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s5", "idA": "906709_11_item1a_p24_s1", "sentA": "Additionally, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "sentB": "Our partnered drugs that have obtained regulatory approval, and the manufacturing processes for these products, are subject to continued review and periodic inspections by the FDA and other regulatory authorities.", "type": 1, "words": ["<tag1>", "Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag2>", "Our", "partnered", "drugs", "that", "have", "obtained", "regulatory", "approval,", "and", "the", "manufacturing", "processes", "for", "these", "products,", "are", "subject", "to", "continued", "review", "and", "periodic", "inspections", "by", "the", "FDA", "and", "other", "regulatory", "authorities.", "<tag3>"], "wordsA": ["Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "wordsB": ["Our", "partnered", "drugs", "that", "have", "obtained", "regulatory", "approval,", "and", "the", "manufacturing", "processes", "for", "these", "products,", "are", "subject", "to", "continued", "review", "and", "periodic", "inspections", "by", "the", "FDA", "and", "other", "regulatory", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s11", "idA": "906709_11_item1a_p24_s1", "sentA": "Additionally, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "sentB": "If earthquakes and other catastrophic events strike, our business may be harmed.", "type": 1, "words": ["<tag1>", "Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag2>", "If", "earthquakes", "and", "other", "catastrophic", "events", "strike,", "our", "business", "may", "be", "harmed.", "<tag3>"], "wordsA": ["Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "wordsB": ["If", "earthquakes", "and", "other", "catastrophic", "events", "strike,", "our", "business", "may", "be", "harmed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p51_s3", "idA": "906709_11_item1a_p24_s1", "sentA": "Additionally, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "sentB": "We also have a change of control severance benefit plan which provides for certain cash severance, stock award acceleration and other benefits in the event our employees are terminated (or, in some cases, resign for specified reasons) following an acquisition.", "type": 1, "words": ["<tag1>", "Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag2>", "We", "also", "have", "a", "change", "of", "control", "severance", "benefit", "plan", "which", "provides", "for", "certain", "cash", "severance,", "stock", "award", "acceleration", "and", "other", "benefits", "in", "the", "event", "our", "employees", "are", "terminated", "(or,", "in", "some", "cases,", "resign", "for", "specified", "reasons)", "following", "an", "acquisition.", "<tag3>"], "wordsA": ["Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "wordsB": ["We", "also", "have", "a", "change", "of", "control", "severance", "benefit", "plan", "which", "provides", "for", "certain", "cash", "severance,", "stock", "award", "acceleration", "and", "other", "benefits", "in", "the", "event", "our", "employees", "are", "terminated", "(or,", "in", "some", "cases,", "resign", "for", "specified", "reasons)", "following", "an", "acquisition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p17_s5", "idA": "906709_11_item1a_p26_s1", "sentA": "As of November 29, 2010, we have ceased use of this space as a result of the relocation of all of our functions, including our corporate headquarters and an R D center, to our Mission Bay Facility.", "sentB": "From time to time, we have informal dispute resolution discussions with third parties regarding the appropriate interpretation of the complex commercial terms contained in our agreements.", "type": 1, "words": ["<tag1>", "As", "of", "November", "29,", "2010,", "we", "have", "ceased", "use", "of", "this", "space", "as", "a", "result", "of", "the", "relocation", "of", "all", "of", "our", "functions,", "including", "our", "corporate", "headquarters", "and", "an", "R", "D", "center,", "to", "our", "Mission", "Bay", "Facility.", "<tag2>", "From", "time", "to", "time,", "we", "have", "informal", "dispute", "resolution", "discussions", "with", "third", "parties", "regarding", "the", "appropriate", "interpretation", "of", "the", "complex", "commercial", "terms", "contained", "in", "our", "agreements.", "<tag3>"], "wordsA": ["As", "of", "November", "29,", "2010,", "we", "have", "ceased", "use", "of", "this", "space", "as", "a", "result", "of", "the", "relocation", "of", "all", "of", "our", "functions,", "including", "our", "corporate", "headquarters", "and", "an", "R", "D", "center,", "to", "our", "Mission", "Bay", "Facility."], "wordsB": ["From", "time", "to", "time,", "we", "have", "informal", "dispute", "resolution", "discussions", "with", "third", "parties", "regarding", "the", "appropriate", "interpretation", "of", "the", "complex", "commercial", "terms", "contained", "in", "our", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p20_s2", "idA": "906709_11_item1a_p26_s2", "sentA": "We currently intend to sublease the San Carlos space, but have not been relieved of any obligations of the terms of this lease, which is discussed in Note 6 of Item 8.", "sentB": "However, we cannot predict with certainty the eventual outcome of any pending or future litigation.", "type": 1, "words": ["<tag1>", "We", "currently", "intend", "to", "sublease", "the", "San", "Carlos", "space,", "but", "have", "not", "been", "relieved", "of", "any", "obligations", "of", "the", "terms", "of", "this", "lease,", "which", "is", "discussed", "in", "Note", "6", "of", "Item", "8.", "<tag2>", "However,", "we", "cannot", "predict", "with", "certainty", "the", "eventual", "outcome", "of", "any", "pending", "or", "future", "litigation.", "<tag3>"], "wordsA": ["We", "currently", "intend", "to", "sublease", "the", "San", "Carlos", "space,", "but", "have", "not", "been", "relieved", "of", "any", "obligations", "of", "the", "terms", "of", "this", "lease,", "which", "is", "discussed", "in", "Note", "6", "of", "Item", "8."], "wordsB": ["However,", "we", "cannot", "predict", "with", "certainty", "the", "eventual", "outcome", "of", "any", "pending", "or", "future", "litigation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p3_s1", "idA": "906709_11_item1a_p26_s2", "sentA": "We currently intend to sublease the San Carlos space, but have not been relieved of any obligations of the terms of this lease, which is discussed in Note 6 of Item 8.", "sentB": "We or our partners may not obtain regulatory approval for drug candidates on a timely basis, or at all, or the terms of any approval (which in some countries includes pricing approval) may impose significant restrictions or limitations on use.", "type": 1, "words": ["<tag1>", "We", "currently", "intend", "to", "sublease", "the", "San", "Carlos", "space,", "but", "have", "not", "been", "relieved", "of", "any", "obligations", "of", "the", "terms", "of", "this", "lease,", "which", "is", "discussed", "in", "Note", "6", "of", "Item", "8.", "<tag2>", "We", "or", "our", "partners", "may", "not", "obtain", "regulatory", "approval", "for", "drug", "candidates", "on", "a", "timely", "basis,", "or", "at", "all,", "or", "the", "terms", "of", "any", "approval", "(which", "in", "some", "countries", "includes", "pricing", "approval)", "may", "impose", "significant", "restrictions", "or", "limitations", "on", "use.", "<tag3>"], "wordsA": ["We", "currently", "intend", "to", "sublease", "the", "San", "Carlos", "space,", "but", "have", "not", "been", "relieved", "of", "any", "obligations", "of", "the", "terms", "of", "this", "lease,", "which", "is", "discussed", "in", "Note", "6", "of", "Item", "8."], "wordsB": ["We", "or", "our", "partners", "may", "not", "obtain", "regulatory", "approval", "for", "drug", "candidates", "on", "a", "timely", "basis,", "or", "at", "all,", "or", "the", "terms", "of", "any", "approval", "(which", "in", "some", "countries", "includes", "pricing", "approval)", "may", "impose", "significant", "restrictions", "or", "limitations", "on", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p9_s1", "idA": "906709_11_item1a_p26_s2", "sentA": "We currently intend to sublease the San Carlos space, but have not been relieved of any obligations of the terms of this lease, which is discussed in Note 6 of Item 8.", "sentB": "While we have conducted numerous experiments using laboratory and home-based chemistry techniques that have not been able to convert NKTR-181 into a rapid-acting and more abusable opioid, there is a risk that in the future a technique could be discovered to convert NKTR-181 into a rapid-acting and more abusable opioid which would significantly diminish the value of this drug candidate.", "type": 1, "words": ["<tag1>", "We", "currently", "intend", "to", "sublease", "the", "San", "Carlos", "space,", "but", "have", "not", "been", "relieved", "of", "any", "obligations", "of", "the", "terms", "of", "this", "lease,", "which", "is", "discussed", "in", "Note", "6", "of", "Item", "8.", "<tag2>", "While", "we", "have", "conducted", "numerous", "experiments", "using", "laboratory", "and", "home-based", "chemistry", "techniques", "that", "have", "not", "been", "able", "to", "convert", "NKTR-181", "into", "a", "rapid-acting", "and", "more", "abusable", "opioid,", "there", "is", "a", "risk", "that", "in", "the", "future", "a", "technique", "could", "be", "discovered", "to", "convert", "NKTR-181", "into", "a", "rapid-acting", "and", "more", "abusable", "opioid", "which", "would", "significantly", "diminish", "the", "value", "of", "this", "drug", "candidate.", "<tag3>"], "wordsA": ["We", "currently", "intend", "to", "sublease", "the", "San", "Carlos", "space,", "but", "have", "not", "been", "relieved", "of", "any", "obligations", "of", "the", "terms", "of", "this", "lease,", "which", "is", "discussed", "in", "Note", "6", "of", "Item", "8."], "wordsB": ["While", "we", "have", "conducted", "numerous", "experiments", "using", "laboratory", "and", "home-based", "chemistry", "techniques", "that", "have", "not", "been", "able", "to", "convert", "NKTR-181", "into", "a", "rapid-acting", "and", "more", "abusable", "opioid,", "there", "is", "a", "risk", "that", "in", "the", "future", "a", "technique", "could", "be", "discovered", "to", "convert", "NKTR-181", "into", "a", "rapid-acting", "and", "more", "abusable", "opioid", "which", "would", "significantly", "diminish", "the", "value", "of", "this", "drug", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s0", "idA": "906709_11_item1a_p27_s0", "sentA": "In November 2010, we moved into our Mission Bay Facility, which includes our corporate headquarters and an R D center at 455 Mission Bay Boulevard South in San Francisco, California.", "sentB": "Drug candidates must undergo rigorous animal and human testing and an extensive FDA mandated or equivalent foreign government health authority review process for safety and efficacy.", "type": 1, "words": ["<tag1>", "In", "November", "2010,", "we", "moved", "into", "our", "Mission", "Bay", "Facility,", "which", "includes", "our", "corporate", "headquarters", "and", "an", "R", "D", "center", "at", "455", "Mission", "Bay", "Boulevard", "South", "in", "San", "Francisco,", "California.", "<tag2>", "Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "FDA", "mandated", "or", "equivalent", "foreign", "government", "health", "authority", "review", "process", "for", "safety", "and", "efficacy.", "<tag3>"], "wordsA": ["In", "November", "2010,", "we", "moved", "into", "our", "Mission", "Bay", "Facility,", "which", "includes", "our", "corporate", "headquarters", "and", "an", "R", "D", "center", "at", "455", "Mission", "Bay", "Boulevard", "South", "in", "San", "Francisco,", "California."], "wordsB": ["Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "FDA", "mandated", "or", "equivalent", "foreign", "government", "health", "authority", "review", "process", "for", "safety", "and", "efficacy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p19_s3", "idA": "906709_11_item1a_p27_s1", "sentA": "Under the terms of the sublease we entered into with Pfizer Inc. on September 30, 2009 for the Mission Bay Facility, we will begin making non-cancelable lease payments in 2014.", "sentB": "In October 2008, a federal court ruled in favor of Amgen, issuing a permanent injunction preventing Roche from marketing or selling MIRCERA in the U.S. Roche and Amgen subsequently entered into a settlement and limited license agreement which allows Roche to begin selling MIRCERA in the U.S. in July 2014.", "type": 1, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014.", "<tag2>", "In", "October", "2008,", "a", "federal", "court", "ruled", "in", "favor", "of", "Amgen,", "issuing", "a", "permanent", "injunction", "preventing", "Roche", "from", "marketing", "or", "selling", "MIRCERA", "in", "the", "U.S.", "Roche", "and", "Amgen", "subsequently", "entered", "into", "a", "settlement", "and", "limited", "license", "agreement", "which", "allows", "Roche", "to", "begin", "selling", "MIRCERA", "in", "the", "U.S.", "in", "July", "2014.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014."], "wordsB": ["In", "October", "2008,", "a", "federal", "court", "ruled", "in", "favor", "of", "Amgen,", "issuing", "a", "permanent", "injunction", "preventing", "Roche", "from", "marketing", "or", "selling", "MIRCERA", "in", "the", "U.S.", "Roche", "and", "Amgen", "subsequently", "entered", "into", "a", "settlement", "and", "limited", "license", "agreement", "which", "allows", "Roche", "to", "begin", "selling", "MIRCERA", "in", "the", "U.S.", "in", "July", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p38_s1", "idA": "906709_11_item1a_p28_s1", "sentA": "This amount does not represent minimum contract termination liability for our existing contracts.", "sentB": "We rely on trade secret protection for our confidential and proprietary information.", "type": 1, "words": ["<tag1>", "This", "amount", "does", "not", "represent", "minimum", "contract", "termination", "liability", "for", "our", "existing", "contracts.", "<tag2>", "We", "rely", "on", "trade", "secret", "protection", "for", "our", "confidential", "and", "proprietary", "information.", "<tag3>"], "wordsA": ["This", "amount", "does", "not", "represent", "minimum", "contract", "termination", "liability", "for", "our", "existing", "contracts."], "wordsB": ["We", "rely", "on", "trade", "secret", "protection", "for", "our", "confidential", "and", "proprietary", "information."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p41_s1", "idA": "906709_11_item1a_p28_s1", "sentA": "This amount does not represent minimum contract termination liability for our existing contracts.", "sentB": "We depend on independent clinical investigators, contract research organizations and other third-party service providers to conduct clinical trials for our proprietary product candidates.", "type": 1, "words": ["<tag1>", "This", "amount", "does", "not", "represent", "minimum", "contract", "termination", "liability", "for", "our", "existing", "contracts.", "<tag2>", "We", "depend", "on", "independent", "clinical", "investigators,", "contract", "research", "organizations", "and", "other", "third-party", "service", "providers", "to", "conduct", "clinical", "trials", "for", "our", "proprietary", "product", "candidates.", "<tag3>"], "wordsA": ["This", "amount", "does", "not", "represent", "minimum", "contract", "termination", "liability", "for", "our", "existing", "contracts."], "wordsB": ["We", "depend", "on", "independent", "clinical", "investigators,", "contract", "research", "organizations", "and", "other", "third-party", "service", "providers", "to", "conduct", "clinical", "trials", "for", "our", "proprietary", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p43_s0", "idA": "906709_11_item1a_p28_s1", "sentA": "This amount does not represent minimum contract termination liability for our existing contracts.", "sentB": "There are several competitors for our proprietary product candidates currently in development.", "type": 1, "words": ["<tag1>", "This", "amount", "does", "not", "represent", "minimum", "contract", "termination", "liability", "for", "our", "existing", "contracts.", "<tag2>", "There", "are", "several", "competitors", "for", "our", "proprietary", "product", "candidates", "currently", "in", "development.", "<tag3>"], "wordsA": ["This", "amount", "does", "not", "represent", "minimum", "contract", "termination", "liability", "for", "our", "existing", "contracts."], "wordsB": ["There", "are", "several", "competitors", "for", "our", "proprietary", "product", "candidates", "currently", "in", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s14", "idA": "906709_11_item1a_p28_s1", "sentA": "This amount does not represent minimum contract termination liability for our existing contracts.", "sentB": "There are no backup facilities for our manufacturing operations located in Huntsville, Alabama.", "type": 1, "words": ["<tag1>", "This", "amount", "does", "not", "represent", "minimum", "contract", "termination", "liability", "for", "our", "existing", "contracts.", "<tag2>", "There", "are", "no", "backup", "facilities", "for", "our", "manufacturing", "operations", "located", "in", "Huntsville,", "Alabama.", "<tag3>"], "wordsA": ["This", "amount", "does", "not", "represent", "minimum", "contract", "termination", "liability", "for", "our", "existing", "contracts."], "wordsB": ["There", "are", "no", "backup", "facilities", "for", "our", "manufacturing", "operations", "located", "in", "Huntsville,", "Alabama."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s9", "idA": "906709_11_item1a_p29_s1", "sentA": "We plan to continue to invest in our growth and our future cash requirements will depend upon the timing and results of these investments.", "sentB": "The results of these inspections could result in costly manufacturing changes or facility or capital equipment upgrades to satisfy the FDA that our manufacturing and quality control procedures are in substantial compliance with cGMP.", "type": 1, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments.", "<tag2>", "The", "results", "of", "these", "inspections", "could", "result", "in", "costly", "manufacturing", "changes", "or", "facility", "or", "capital", "equipment", "upgrades", "to", "satisfy", "the", "FDA", "that", "our", "manufacturing", "and", "quality", "control", "procedures", "are", "in", "substantial", "compliance", "with", "cGMP.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments."], "wordsB": ["The", "results", "of", "these", "inspections", "could", "result", "in", "costly", "manufacturing", "changes", "or", "facility", "or", "capital", "equipment", "upgrades", "to", "satisfy", "the", "FDA", "that", "our", "manufacturing", "and", "quality", "control", "procedures", "are", "in", "substantial", "compliance", "with", "cGMP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p39_s0", "idA": "906709_11_item1a_p29_s1", "sentA": "We plan to continue to invest in our growth and our future cash requirements will depend upon the timing and results of these investments.", "sentB": "If and when we achieve profitability depends upon a number of factors, including the timing and recognition of milestone payments and royalties received, the timing of revenue under our collaboration agreements, the amount of investments we make in our proprietary product candidates and the regulatory approval and market success of our product candidates.", "type": 1, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments.", "<tag2>", "If", "and", "when", "we", "achieve", "profitability", "depends", "upon", "a", "number", "of", "factors,", "including", "the", "timing", "and", "recognition", "of", "milestone", "payments", "and", "royalties", "received,", "the", "timing", "of", "revenue", "under", "our", "collaboration", "agreements,", "the", "amount", "of", "investments", "we", "make", "in", "our", "proprietary", "product", "candidates", "and", "the", "regulatory", "approval", "and", "market", "success", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments."], "wordsB": ["If", "and", "when", "we", "achieve", "profitability", "depends", "upon", "a", "number", "of", "factors,", "including", "the", "timing", "and", "recognition", "of", "milestone", "payments", "and", "royalties", "received,", "the", "timing", "of", "revenue", "under", "our", "collaboration", "agreements,", "the", "amount", "of", "investments", "we", "make", "in", "our", "proprietary", "product", "candidates", "and", "the", "regulatory", "approval", "and", "market", "success", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p41_s7", "idA": "906709_11_item1a_p29_s1", "sentA": "We plan to continue to invest in our growth and our future cash requirements will depend upon the timing and results of these investments.", "sentB": "Significant competition for our polymer conjugate chemistry technology platforms and our partnered and proprietary products and product candidates could make our technologies, products or product candidates obsolete or uncompetitive, which would negatively impact our business, results of operations and financial condition.", "type": 1, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments.", "<tag2>", "Significant", "competition", "for", "our", "polymer", "conjugate", "chemistry", "technology", "platforms", "and", "our", "partnered", "and", "proprietary", "products", "and", "product", "candidates", "could", "make", "our", "technologies,", "products", "or", "product", "candidates", "obsolete", "or", "uncompetitive,", "which", "would", "negatively", "impact", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments."], "wordsB": ["Significant", "competition", "for", "our", "polymer", "conjugate", "chemistry", "technology", "platforms", "and", "our", "partnered", "and", "proprietary", "products", "and", "product", "candidates", "could", "make", "our", "technologies,", "products", "or", "product", "candidates", "obsolete", "or", "uncompetitive,", "which", "would", "negatively", "impact", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p42_s0", "idA": "906709_11_item1a_p29_s1", "sentA": "We plan to continue to invest in our growth and our future cash requirements will depend upon the timing and results of these investments.", "sentB": "Our PEGylation and advanced polymer conjugate chemistry platforms and our partnered and proprietary products and product candidates compete with various pharmaceutical and biotechnology companies.", "type": 1, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments.", "<tag2>", "Our", "PEGylation", "and", "advanced", "polymer", "conjugate", "chemistry", "platforms", "and", "our", "partnered", "and", "proprietary", "products", "and", "product", "candidates", "compete", "with", "various", "pharmaceutical", "and", "biotechnology", "companies.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments."], "wordsB": ["Our", "PEGylation", "and", "advanced", "polymer", "conjugate", "chemistry", "platforms", "and", "our", "partnered", "and", "proprietary", "products", "and", "product", "candidates", "compete", "with", "various", "pharmaceutical", "and", "biotechnology", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s7", "idA": "906709_11_item1a_p29_s1", "sentA": "We plan to continue to invest in our growth and our future cash requirements will depend upon the timing and results of these investments.", "sentB": "Because competition for skilled personnel in our industry is intense, companies such as ours sometimes experience high attrition rates with regard to their skilled employees.", "type": 1, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments.", "<tag2>", "Because", "competition", "for", "skilled", "personnel", "in", "our", "industry", "is", "intense,", "companies", "such", "as", "ours", "sometimes", "experience", "high", "attrition", "rates", "with", "regard", "to", "their", "skilled", "employees.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments."], "wordsB": ["Because", "competition", "for", "skilled", "personnel", "in", "our", "industry", "is", "intense,", "companies", "such", "as", "ours", "sometimes", "experience", "high", "attrition", "rates", "with", "regard", "to", "their", "skilled", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p14_s4", "idA": "906709_11_item1a_p2_s0", "sentA": "General and administrative expenses for the year ended December 31, 2010 remained at a consistent level compared to the year ended December 31, 2009.", "sentB": "If we are required to enter into a license with a third party, our potential economic benefit for the products subject to the license will be diminished.", "type": 1, "words": ["<tag1>", "General", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2010", "remained", "at", "a", "consistent", "level", "compared", "to", "the", "year", "ended", "December", "31,", "2009.", "<tag2>", "If", "we", "are", "required", "to", "enter", "into", "a", "license", "with", "a", "third", "party,", "our", "potential", "economic", "benefit", "for", "the", "products", "subject", "to", "the", "license", "will", "be", "diminished.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2010", "remained", "at", "a", "consistent", "level", "compared", "to", "the", "year", "ended", "December", "31,", "2009."], "wordsB": ["If", "we", "are", "required", "to", "enter", "into", "a", "license", "with", "a", "third", "party,", "our", "potential", "economic", "benefit", "for", "the", "products", "subject", "to", "the", "license", "will", "be", "diminished."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p13_s2", "idA": "906709_11_item1a_p30_s0", "sentA": "filing, prosecuting, maintaining and enforcing patent claims, the need to acquire licenses to new technologies and the status of competitive products.", "sentB": "It is very difficult to estimate the commercial potential of product candidates due to important factors such as safety and efficacy compared to other available treatments, including potential generic drug alternatives with similar efficacy profiles, changing standards of care, third party payer reimbursement standards, patient and physician preferences, the availability of competitive alternatives that may emerge either during the long drug development process or after commercial introduction, and the availability of generic versions of our successful product candidates following approval by government health authorities based on the expiration of regulatory exclusivity or our inability to prevent generic versions from coming to market by asserting our patents.", "type": 1, "words": ["<tag1>", "filing,", "prosecuting,", "maintaining", "and", "enforcing", "patent", "claims,", "the", "need", "to", "acquire", "licenses", "to", "new", "technologies", "and", "the", "status", "of", "competitive", "products.", "<tag2>", "It", "is", "very", "difficult", "to", "estimate", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payer", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "successful", "product", "candidates", "following", "approval", "by", "government", "health", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents.", "<tag3>"], "wordsA": ["filing,", "prosecuting,", "maintaining", "and", "enforcing", "patent", "claims,", "the", "need", "to", "acquire", "licenses", "to", "new", "technologies", "and", "the", "status", "of", "competitive", "products."], "wordsB": ["It", "is", "very", "difficult", "to", "estimate", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payer", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "successful", "product", "candidates", "following", "approval", "by", "government", "health", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p23_s0", "idA": "906709_11_item1a_p30_s0", "sentA": "filing, prosecuting, maintaining and enforcing patent claims, the need to acquire licenses to new technologies and the status of competitive products.", "sentB": "Even if a patent is issued and enforceable, because development and commercialization of pharmaceutical products can be subject to substantial delays, patents may expire early and provide only a short period of protection, if any, following commercialization of related products.", "type": 1, "words": ["<tag1>", "filing,", "prosecuting,", "maintaining", "and", "enforcing", "patent", "claims,", "the", "need", "to", "acquire", "licenses", "to", "new", "technologies", "and", "the", "status", "of", "competitive", "products.", "<tag2>", "Even", "if", "a", "patent", "is", "issued", "and", "enforceable,", "because", "development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays,", "patents", "may", "expire", "early", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "commercialization", "of", "related", "products.", "<tag3>"], "wordsA": ["filing,", "prosecuting,", "maintaining", "and", "enforcing", "patent", "claims,", "the", "need", "to", "acquire", "licenses", "to", "new", "technologies", "and", "the", "status", "of", "competitive", "products."], "wordsB": ["Even", "if", "a", "patent", "is", "issued", "and", "enforceable,", "because", "development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays,", "patents", "may", "expire", "early", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "commercialization", "of", "related", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p40_s6", "idA": "906709_11_item1a_p30_s0", "sentA": "filing, prosecuting, maintaining and enforcing patent claims, the need to acquire licenses to new technologies and the status of competitive products.", "sentB": "A government or third-party payer decision not to approve pricing for, or provide adequate coverage and reimbursements of, our products would limit market acceptance of such products.", "type": 1, "words": ["<tag1>", "filing,", "prosecuting,", "maintaining", "and", "enforcing", "patent", "claims,", "the", "need", "to", "acquire", "licenses", "to", "new", "technologies", "and", "the", "status", "of", "competitive", "products.", "<tag2>", "A", "government", "or", "third-party", "payer", "decision", "not", "to", "approve", "pricing", "for,", "or", "provide", "adequate", "coverage", "and", "reimbursements", "of,", "our", "products", "would", "limit", "market", "acceptance", "of", "such", "products.", "<tag3>"], "wordsA": ["filing,", "prosecuting,", "maintaining", "and", "enforcing", "patent", "claims,", "the", "need", "to", "acquire", "licenses", "to", "new", "technologies", "and", "the", "status", "of", "competitive", "products."], "wordsB": ["A", "government", "or", "third-party", "payer", "decision", "not", "to", "approve", "pricing", "for,", "or", "provide", "adequate", "coverage", "and", "reimbursements", "of,", "our", "products", "would", "limit", "market", "acceptance", "of", "such", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s0", "idA": "906709_11_item1a_p30_s0", "sentA": "filing, prosecuting, maintaining and enforcing patent claims, the need to acquire licenses to new technologies and the status of competitive products.", "sentB": "products and the regulatory approval process.", "type": 1, "words": ["<tag1>", "filing,", "prosecuting,", "maintaining", "and", "enforcing", "patent", "claims,", "the", "need", "to", "acquire", "licenses", "to", "new", "technologies", "and", "the", "status", "of", "competitive", "products.", "<tag2>", "products", "and", "the", "regulatory", "approval", "process.", "<tag3>"], "wordsA": ["filing,", "prosecuting,", "maintaining", "and", "enforcing", "patent", "claims,", "the", "need", "to", "acquire", "licenses", "to", "new", "technologies", "and", "the", "status", "of", "competitive", "products."], "wordsB": ["products", "and", "the", "regulatory", "approval", "process."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s7", "idA": "906709_11_item1a_p31_s0", "sentA": "To date we have incurred substantial debt as a result of our issuances of subordinated notes that are convertible into our common stock.", "sentB": "The risk of failure is increased for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to small molecules, including NKTR-118, NKTR-119, NKTR-102, NKTR-181, NKTR-192 and other drug candidates currently in discovery research or preclinical development.", "type": 1, "words": ["<tag1>", "To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock.", "<tag2>", "The", "risk", "of", "failure", "is", "increased", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "small", "molecules,", "including", "NKTR-118,", "NKTR-119,", "NKTR-102,", "NKTR-181,", "NKTR-192", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock."], "wordsB": ["The", "risk", "of", "failure", "is", "increased", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "small", "molecules,", "including", "NKTR-118,", "NKTR-119,", "NKTR-102,", "NKTR-181,", "NKTR-192", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s6", "idA": "906709_11_item1a_p31_s1", "sentA": "Our substantial debt, the market price of our securities, and the general economic climate, among other factors, could have material consequences for our financial condition and could affect our sources of short-term and long-term funding.", "sentB": "We anticipate periodic regulatory inspections of our drug manufacturing facilities and the manufacturing facilities of our contract manufacturers for compliance with applicable regulatory requirements.", "type": 1, "words": ["<tag1>", "Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding.", "<tag2>", "We", "anticipate", "periodic", "regulatory", "inspections", "of", "our", "drug", "manufacturing", "facilities", "and", "the", "manufacturing", "facilities", "of", "our", "contract", "manufacturers", "for", "compliance", "with", "applicable", "regulatory", "requirements.", "<tag3>"], "wordsA": ["Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding."], "wordsB": ["We", "anticipate", "periodic", "regulatory", "inspections", "of", "our", "drug", "manufacturing", "facilities", "and", "the", "manufacturing", "facilities", "of", "our", "contract", "manufacturers", "for", "compliance", "with", "applicable", "regulatory", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p40_s2", "idA": "906709_11_item1a_p31_s1", "sentA": "Our substantial debt, the market price of our securities, and the general economic climate, among other factors, could have material consequences for our financial condition and could affect our sources of short-term and long-term funding.", "sentB": "In both domestic and foreign markets, sales of our partnered and proprietary products that have received regulatory approval will depend in part on market acceptance among physicians and patients, pricing approvals by government authorities and the availability of payment or reimbursement from third-party payers, such as government health administration authorities, managed care providers, private health insurers and other organizations.", "type": 1, "words": ["<tag1>", "Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding.", "<tag2>", "In", "both", "domestic", "and", "foreign", "markets,", "sales", "of", "our", "partnered", "and", "proprietary", "products", "that", "have", "received", "regulatory", "approval", "will", "depend", "in", "part", "on", "market", "acceptance", "among", "physicians", "and", "patients,", "pricing", "approvals", "by", "government", "authorities", "and", "the", "availability", "of", "payment", "or", "reimbursement", "from", "third-party", "payers,", "such", "as", "government", "health", "administration", "authorities,", "managed", "care", "providers,", "private", "health", "insurers", "and", "other", "organizations.", "<tag3>"], "wordsA": ["Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding."], "wordsB": ["In", "both", "domestic", "and", "foreign", "markets,", "sales", "of", "our", "partnered", "and", "proprietary", "products", "that", "have", "received", "regulatory", "approval", "will", "depend", "in", "part", "on", "market", "acceptance", "among", "physicians", "and", "patients,", "pricing", "approvals", "by", "government", "authorities", "and", "the", "availability", "of", "payment", "or", "reimbursement", "from", "third-party", "payers,", "such", "as", "government", "health", "administration", "authorities,", "managed", "care", "providers,", "private", "health", "insurers", "and", "other", "organizations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p40_s5", "idA": "906709_11_item1a_p31_s1", "sentA": "Our substantial debt, the market price of our securities, and the general economic climate, among other factors, could have material consequences for our financial condition and could affect our sources of short-term and long-term funding.", "sentB": "Moreover, legislation and regulations affecting the pricing of pharmaceuticals may change before regulatory agencies approve our proposed products for marketing and could further limit pricing approvals for, and reimbursement of, our products from government authorities and third-party payers.", "type": 1, "words": ["<tag1>", "Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding.", "<tag2>", "Moreover,", "legislation", "and", "regulations", "affecting", "the", "pricing", "of", "pharmaceuticals", "may", "change", "before", "regulatory", "agencies", "approve", "our", "proposed", "products", "for", "marketing", "and", "could", "further", "limit", "pricing", "approvals", "for,", "and", "reimbursement", "of,", "our", "products", "from", "government", "authorities", "and", "third-party", "payers.", "<tag3>"], "wordsA": ["Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding."], "wordsB": ["Moreover,", "legislation", "and", "regulations", "affecting", "the", "pricing", "of", "pharmaceuticals", "may", "change", "before", "regulatory", "agencies", "approve", "our", "proposed", "products", "for", "marketing", "and", "could", "further", "limit", "pricing", "approvals", "for,", "and", "reimbursement", "of,", "our", "products", "from", "government", "authorities", "and", "third-party", "payers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s11", "idA": "906709_11_item1a_p31_s1", "sentA": "Our substantial debt, the market price of our securities, and the general economic climate, among other factors, could have material consequences for our financial condition and could affect our sources of short-term and long-term funding.", "sentB": "We are dependent on our management team and key technical personnel, and the loss of any key manager or employee may impair our ability to develop our products effectively and may harm our business, operating results and financial condition.", "type": 1, "words": ["<tag1>", "Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding.", "<tag2>", "We", "are", "dependent", "on", "our", "management", "team", "and", "key", "technical", "personnel,", "and", "the", "loss", "of", "any", "key", "manager", "or", "employee", "may", "impair", "our", "ability", "to", "develop", "our", "products", "effectively", "and", "may", "harm", "our", "business,", "operating", "results", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding."], "wordsB": ["We", "are", "dependent", "on", "our", "management", "team", "and", "key", "technical", "personnel,", "and", "the", "loss", "of", "any", "key", "manager", "or", "employee", "may", "impair", "our", "ability", "to", "develop", "our", "products", "effectively", "and", "may", "harm", "our", "business,", "operating", "results", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s9", "idA": "906709_11_item1a_p31_s1", "sentA": "Our substantial debt, the market price of our securities, and the general economic climate, among other factors, could have material consequences for our financial condition and could affect our sources of short-term and long-term funding.", "sentB": "Our equity incentive plan and employee benefit plans may not be effective in motivating or retaining our employees or attracting new employees, and significant volatility in the price of our stock may adversely affect our ability to attract or retain qualified personnel.", "type": 1, "words": ["<tag1>", "Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding.", "<tag2>", "Our", "equity", "incentive", "plan", "and", "employee", "benefit", "plans", "may", "not", "be", "effective", "in", "motivating", "or", "retaining", "our", "employees", "or", "attracting", "new", "employees,", "and", "significant", "volatility", "in", "the", "price", "of", "our", "stock", "may", "adversely", "affect", "our", "ability", "to", "attract", "or", "retain", "qualified", "personnel.", "<tag3>"], "wordsA": ["Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding."], "wordsB": ["Our", "equity", "incentive", "plan", "and", "employee", "benefit", "plans", "may", "not", "be", "effective", "in", "motivating", "or", "retaining", "our", "employees", "or", "attracting", "new", "employees,", "and", "significant", "volatility", "in", "the", "price", "of", "our", "stock", "may", "adversely", "affect", "our", "ability", "to", "attract", "or", "retain", "qualified", "personnel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p27_s0", "idA": "906709_11_item1a_p31_s2", "sentA": "Our ability to meet our ongoing operating expenses and repay our outstanding indebtedness is dependent upon our and our partners ability to successfully complete clinical development of, obtain regulatory approvals for and successfully commercialize new drugs.", "sentB": "Building and validating large scale clinical or commercial-scale manufacturing facilities and processes, recruiting and training qualified personnel and obtaining necessary regulatory approvals is complex, expensive and time consuming.", "type": 1, "words": ["<tag1>", "Our", "ability", "to", "meet", "our", "ongoing", "operating", "expenses", "and", "repay", "our", "outstanding", "indebtedness", "is", "dependent", "upon", "our", "and", "our", "partners", "ability", "to", "successfully", "complete", "clinical", "development", "of,", "obtain", "regulatory", "approvals", "for", "and", "successfully", "commercialize", "new", "drugs.", "<tag2>", "Building", "and", "validating", "large", "scale", "clinical", "or", "commercial-scale", "manufacturing", "facilities", "and", "processes,", "recruiting", "and", "training", "qualified", "personnel", "and", "obtaining", "necessary", "regulatory", "approvals", "is", "complex,", "expensive", "and", "time", "consuming.", "<tag3>"], "wordsA": ["Our", "ability", "to", "meet", "our", "ongoing", "operating", "expenses", "and", "repay", "our", "outstanding", "indebtedness", "is", "dependent", "upon", "our", "and", "our", "partners", "ability", "to", "successfully", "complete", "clinical", "development", "of,", "obtain", "regulatory", "approvals", "for", "and", "successfully", "commercialize", "new", "drugs."], "wordsB": ["Building", "and", "validating", "large", "scale", "clinical", "or", "commercial-scale", "manufacturing", "facilities", "and", "processes,", "recruiting", "and", "training", "qualified", "personnel", "and", "obtaining", "necessary", "regulatory", "approvals", "is", "complex,", "expensive", "and", "time", "consuming."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p35_s3", "idA": "906709_11_item1a_p31_s2", "sentA": "Our ability to meet our ongoing operating expenses and repay our outstanding indebtedness is dependent upon our and our partners ability to successfully complete clinical development of, obtain regulatory approvals for and successfully commercialize new drugs.", "sentB": "If other collaborations are suspended or terminated, our ability to commercialize certain other proposed product candidates could also be negatively impacted.", "type": 1, "words": ["<tag1>", "Our", "ability", "to", "meet", "our", "ongoing", "operating", "expenses", "and", "repay", "our", "outstanding", "indebtedness", "is", "dependent", "upon", "our", "and", "our", "partners", "ability", "to", "successfully", "complete", "clinical", "development", "of,", "obtain", "regulatory", "approvals", "for", "and", "successfully", "commercialize", "new", "drugs.", "<tag2>", "If", "other", "collaborations", "are", "suspended", "or", "terminated,", "our", "ability", "to", "commercialize", "certain", "other", "proposed", "product", "candidates", "could", "also", "be", "negatively", "impacted.", "<tag3>"], "wordsA": ["Our", "ability", "to", "meet", "our", "ongoing", "operating", "expenses", "and", "repay", "our", "outstanding", "indebtedness", "is", "dependent", "upon", "our", "and", "our", "partners", "ability", "to", "successfully", "complete", "clinical", "development", "of,", "obtain", "regulatory", "approvals", "for", "and", "successfully", "commercialize", "new", "drugs."], "wordsB": ["If", "other", "collaborations", "are", "suspended", "or", "terminated,", "our", "ability", "to", "commercialize", "certain", "other", "proposed", "product", "candidates", "could", "also", "be", "negatively", "impacted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s14", "idA": "906709_11_item1a_p31_s2", "sentA": "Our ability to meet our ongoing operating expenses and repay our outstanding indebtedness is dependent upon our and our partners ability to successfully complete clinical development of, obtain regulatory approvals for and successfully commercialize new drugs.", "sentB": "The relationships that our key managers have cultivated within our industry make us particularly dependent upon their continued employment with us.", "type": 1, "words": ["<tag1>", "Our", "ability", "to", "meet", "our", "ongoing", "operating", "expenses", "and", "repay", "our", "outstanding", "indebtedness", "is", "dependent", "upon", "our", "and", "our", "partners", "ability", "to", "successfully", "complete", "clinical", "development", "of,", "obtain", "regulatory", "approvals", "for", "and", "successfully", "commercialize", "new", "drugs.", "<tag2>", "The", "relationships", "that", "our", "key", "managers", "have", "cultivated", "within", "our", "industry", "make", "us", "particularly", "dependent", "upon", "their", "continued", "employment", "with", "us.", "<tag3>"], "wordsA": ["Our", "ability", "to", "meet", "our", "ongoing", "operating", "expenses", "and", "repay", "our", "outstanding", "indebtedness", "is", "dependent", "upon", "our", "and", "our", "partners", "ability", "to", "successfully", "complete", "clinical", "development", "of,", "obtain", "regulatory", "approvals", "for", "and", "successfully", "commercialize", "new", "drugs."], "wordsB": ["The", "relationships", "that", "our", "key", "managers", "have", "cultivated", "within", "our", "industry", "make", "us", "particularly", "dependent", "upon", "their", "continued", "employment", "with", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p8_s4", "idA": "906709_11_item1a_p31_s2", "sentA": "Our ability to meet our ongoing operating expenses and repay our outstanding indebtedness is dependent upon our and our partners ability to successfully complete clinical development of, obtain regulatory approvals for and successfully commercialize new drugs.", "sentB": "One or more of such judgments and determinations by the FDA could impair our ability to submit an accelerated NDA for platinum resistant/refractory ovarian cancer patients, and even if submitted, whether the FDA would accept it for review and/or approve the NDA.", "type": 1, "words": ["<tag1>", "Our", "ability", "to", "meet", "our", "ongoing", "operating", "expenses", "and", "repay", "our", "outstanding", "indebtedness", "is", "dependent", "upon", "our", "and", "our", "partners", "ability", "to", "successfully", "complete", "clinical", "development", "of,", "obtain", "regulatory", "approvals", "for", "and", "successfully", "commercialize", "new", "drugs.", "<tag2>", "One", "or", "more", "of", "such", "judgments", "and", "determinations", "by", "the", "FDA", "could", "impair", "our", "ability", "to", "submit", "an", "accelerated", "NDA", "for", "platinum", "resistant/refractory", "ovarian", "cancer", "patients,", "and", "even", "if", "submitted,", "whether", "the", "FDA", "would", "accept", "it", "for", "review", "and/or", "approve", "the", "NDA.", "<tag3>"], "wordsA": ["Our", "ability", "to", "meet", "our", "ongoing", "operating", "expenses", "and", "repay", "our", "outstanding", "indebtedness", "is", "dependent", "upon", "our", "and", "our", "partners", "ability", "to", "successfully", "complete", "clinical", "development", "of,", "obtain", "regulatory", "approvals", "for", "and", "successfully", "commercialize", "new", "drugs."], "wordsB": ["One", "or", "more", "of", "such", "judgments", "and", "determinations", "by", "the", "FDA", "could", "impair", "our", "ability", "to", "submit", "an", "accelerated", "NDA", "for", "platinum", "resistant/refractory", "ovarian", "cancer", "patients,", "and", "even", "if", "submitted,", "whether", "the", "FDA", "would", "accept", "it", "for", "review", "and/or", "approve", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s3", "idA": "906709_11_item1a_p31_s3", "sentA": "Even if we or our partners are successful, we may require additional capital to continue to fund our operations and repay our debt obligations as they become due.", "sentB": "It will take us, or our collaborative partners, several years to complete clinical studies.", "type": 1, "words": ["<tag1>", "Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due.", "<tag2>", "It", "will", "take", "us,", "or", "our", "collaborative", "partners,", "several", "years", "to", "complete", "clinical", "studies.", "<tag3>"], "wordsA": ["Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due."], "wordsB": ["It", "will", "take", "us,", "or", "our", "collaborative", "partners,", "several", "years", "to", "complete", "clinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p36_s4", "idA": "906709_11_item1a_p31_s3", "sentA": "Even if we or our partners are successful, we may require additional capital to continue to fund our operations and repay our debt obligations as they become due.", "sentB": "Factors that may inhibit our efforts to commercialize our products directly or indirectly with our partners include:", "type": 1, "words": ["<tag1>", "Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due.", "<tag2>", "Factors", "that", "may", "inhibit", "our", "efforts", "to", "commercialize", "our", "products", "directly", "or", "indirectly", "with", "our", "partners", "include:", "<tag3>"], "wordsA": ["Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due."], "wordsB": ["Factors", "that", "may", "inhibit", "our", "efforts", "to", "commercialize", "our", "products", "directly", "or", "indirectly", "with", "our", "partners", "include:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p21_s6", "idA": "906709_11_item1a_p33_s0", "sentA": "The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "sentB": "Since publication of discoveries in scientific or patent literature often lags behind the date of such discoveries, we cannot be certain that we were the first inventor of inventions covered by our patents or patent applications.", "type": 1, "words": ["<tag1>", "The", "preparation", "of", "financial", "statements", "in", "conformity", "with", "U.S.", "Generally", "Accepted", "Accounting", "Principles", "(GAAP)", "requires", "management", "to", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag2>", "Since", "publication", "of", "discoveries", "in", "scientific", "or", "patent", "literature", "often", "lags", "behind", "the", "date", "of", "such", "discoveries,", "we", "cannot", "be", "certain", "that", "we", "were", "the", "first", "inventor", "of", "inventions", "covered", "by", "our", "patents", "or", "patent", "applications.", "<tag3>"], "wordsA": ["The", "preparation", "of", "financial", "statements", "in", "conformity", "with", "U.S.", "Generally", "Accepted", "Accounting", "Principles", "(GAAP)", "requires", "management", "to", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "wordsB": ["Since", "publication", "of", "discoveries", "in", "scientific", "or", "patent", "literature", "often", "lags", "behind", "the", "date", "of", "such", "discoveries,", "we", "cannot", "be", "certain", "that", "we", "were", "the", "first", "inventor", "of", "inventions", "covered", "by", "our", "patents", "or", "patent", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s2", "idA": "906709_11_item1a_p33_s0", "sentA": "The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "sentB": "The time required for completing testing and obtaining approvals is uncertain, and the FDA and other U.S. and foreign regulatory agencies have substantial discretion, at any phase of development, to terminate clinical studies, require additional clinical development or other testing, delay or withhold registration and marketing approval and mandate product withdrawals, including recalls.", "type": 1, "words": ["<tag1>", "The", "preparation", "of", "financial", "statements", "in", "conformity", "with", "U.S.", "Generally", "Accepted", "Accounting", "Principles", "(GAAP)", "requires", "management", "to", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag2>", "The", "time", "required", "for", "completing", "testing", "and", "obtaining", "approvals", "is", "uncertain,", "and", "the", "FDA", "and", "other", "U.S.", "and", "foreign", "regulatory", "agencies", "have", "substantial", "discretion,", "at", "any", "phase", "of", "development,", "to", "terminate", "clinical", "studies,", "require", "additional", "clinical", "development", "or", "other", "testing,", "delay", "or", "withhold", "registration", "and", "marketing", "approval", "and", "mandate", "product", "withdrawals,", "including", "recalls.", "<tag3>"], "wordsA": ["The", "preparation", "of", "financial", "statements", "in", "conformity", "with", "U.S.", "Generally", "Accepted", "Accounting", "Principles", "(GAAP)", "requires", "management", "to", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "wordsB": ["The", "time", "required", "for", "completing", "testing", "and", "obtaining", "approvals", "is", "uncertain,", "and", "the", "FDA", "and", "other", "U.S.", "and", "foreign", "regulatory", "agencies", "have", "substantial", "discretion,", "at", "any", "phase", "of", "development,", "to", "terminate", "clinical", "studies,", "require", "additional", "clinical", "development", "or", "other", "testing,", "delay", "or", "withhold", "registration", "and", "marketing", "approval", "and", "mandate", "product", "withdrawals,", "including", "recalls."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p0_s0", "idA": "906709_11_item1a_p34_s0", "sentA": "We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form our basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources, and evaluate our estimates on an ongoing basis.", "sentB": "We are providing the following cautionary discussion of risk factors, uncertainties and assumptions that we believe are relevant to our business.", "type": 1, "words": ["<tag1>", "We", "base", "our", "estimates", "on", "historical", "experience", "and", "on", "various", "other", "assumptions", "that", "we", "believe", "to", "be", "reasonable", "under", "the", "circumstances,", "the", "results", "of", "which", "form", "our", "basis", "for", "making", "judgments", "about", "the", "carrying", "value", "of", "assets", "and", "liabilities", "that", "are", "not", "readily", "apparent", "from", "other", "sources,", "and", "evaluate", "our", "estimates", "on", "an", "ongoing", "basis.", "<tag2>", "We", "are", "providing", "the", "following", "cautionary", "discussion", "of", "risk", "factors,", "uncertainties", "and", "assumptions", "that", "we", "believe", "are", "relevant", "to", "our", "business.", "<tag3>"], "wordsA": ["We", "base", "our", "estimates", "on", "historical", "experience", "and", "on", "various", "other", "assumptions", "that", "we", "believe", "to", "be", "reasonable", "under", "the", "circumstances,", "the", "results", "of", "which", "form", "our", "basis", "for", "making", "judgments", "about", "the", "carrying", "value", "of", "assets", "and", "liabilities", "that", "are", "not", "readily", "apparent", "from", "other", "sources,", "and", "evaluate", "our", "estimates", "on", "an", "ongoing", "basis."], "wordsB": ["We", "are", "providing", "the", "following", "cautionary", "discussion", "of", "risk", "factors,", "uncertainties", "and", "assumptions", "that", "we", "believe", "are", "relevant", "to", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p17_s4", "idA": "906709_11_item1a_p34_s2", "sentA": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "sentB": "Our agreements with AstraZeneca and Novartis contain complex representations and warranties, covenants and indemnification obligations that could result in substantial future liability and harm our financial condition if we breach any of our agreements with AstraZeneca or Novartis or any third party agreements impacted by these complex transactions.", "type": 1, "words": ["<tag1>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag2>", "Our", "agreements", "with", "AstraZeneca", "and", "Novartis", "contain", "complex", "representations", "and", "warranties,", "covenants", "and", "indemnification", "obligations", "that", "could", "result", "in", "substantial", "future", "liability", "and", "harm", "our", "financial", "condition", "if", "we", "breach", "any", "of", "our", "agreements", "with", "AstraZeneca", "or", "Novartis", "or", "any", "third", "party", "agreements", "impacted", "by", "these", "complex", "transactions.", "<tag3>"], "wordsA": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "wordsB": ["Our", "agreements", "with", "AstraZeneca", "and", "Novartis", "contain", "complex", "representations", "and", "warranties,", "covenants", "and", "indemnification", "obligations", "that", "could", "result", "in", "substantial", "future", "liability", "and", "harm", "our", "financial", "condition", "if", "we", "breach", "any", "of", "our", "agreements", "with", "AstraZeneca", "or", "Novartis", "or", "any", "third", "party", "agreements", "impacted", "by", "these", "complex", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p41_s3", "idA": "906709_11_item1a_p34_s2", "sentA": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "sentB": "Though we are ultimately responsible for the results of their activities, many aspects of their activities are beyond our control.", "type": 1, "words": ["<tag1>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag2>", "Though", "we", "are", "ultimately", "responsible", "for", "the", "results", "of", "their", "activities,", "many", "aspects", "of", "their", "activities", "are", "beyond", "our", "control.", "<tag3>"], "wordsA": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "wordsB": ["Though", "we", "are", "ultimately", "responsible", "for", "the", "results", "of", "their", "activities,", "many", "aspects", "of", "their", "activities", "are", "beyond", "our", "control."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s13", "idA": "906709_11_item1a_p34_s2", "sentA": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "sentB": "The loss of one or more members of our management team or other key employees could seriously harm our business, operating results and financial condition.", "type": 1, "words": ["<tag1>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag2>", "The", "loss", "of", "one", "or", "more", "members", "of", "our", "management", "team", "or", "other", "key", "employees", "could", "seriously", "harm", "our", "business,", "operating", "results", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "wordsB": ["The", "loss", "of", "one", "or", "more", "members", "of", "our", "management", "team", "or", "other", "key", "employees", "could", "seriously", "harm", "our", "business,", "operating", "results", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s2", "idA": "906709_11_item1a_p34_s2", "sentA": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "sentB": "Whether or not we are ultimately successful in any product liability litigation, such litigation would consume substantial amounts of our financial and managerial resources and might result in adverse publicity, all of which would impair our business.", "type": 1, "words": ["<tag1>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag2>", "Whether", "or", "not", "we", "are", "ultimately", "successful", "in", "any", "product", "liability", "litigation,", "such", "litigation", "would", "consume", "substantial", "amounts", "of", "our", "financial", "and", "managerial", "resources", "and", "might", "result", "in", "adverse", "publicity,", "all", "of", "which", "would", "impair", "our", "business.", "<tag3>"], "wordsA": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "wordsB": ["Whether", "or", "not", "we", "are", "ultimately", "successful", "in", "any", "product", "liability", "litigation,", "such", "litigation", "would", "consume", "substantial", "amounts", "of", "our", "financial", "and", "managerial", "resources", "and", "might", "result", "in", "adverse", "publicity,", "all", "of", "which", "would", "impair", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p8_s5", "idA": "906709_11_item1a_p34_s2", "sentA": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "sentB": "Further, this expansion of our Phase 2 study in platinum resistant/refractory ovarian cancer will necessarily change the final efficacy (e.g., overall response rates, progression-free survival, overall survival) and safety (i.e., frequency and severity of serious adverse events) results, and, accordingly, the final results in this study remain subject to substantial change and could be materially and adversely different from previously announced results.", "type": 1, "words": ["<tag1>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag2>", "Further,", "this", "expansion", "of", "our", "Phase", "2", "study", "in", "platinum", "resistant/refractory", "ovarian", "cancer", "will", "necessarily", "change", "the", "final", "efficacy", "(e.g.,", "overall", "response", "rates,", "progression-free", "survival,", "overall", "survival)", "and", "safety", "(i.e.,", "frequency", "and", "severity", "of", "serious", "adverse", "events)", "results,", "and,", "accordingly,", "the", "final", "results", "in", "this", "study", "remain", "subject", "to", "substantial", "change", "and", "could", "be", "materially", "and", "adversely", "different", "from", "previously", "announced", "results.", "<tag3>"], "wordsA": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "wordsB": ["Further,", "this", "expansion", "of", "our", "Phase", "2", "study", "in", "platinum", "resistant/refractory", "ovarian", "cancer", "will", "necessarily", "change", "the", "final", "efficacy", "(e.g.,", "overall", "response", "rates,", "progression-free", "survival,", "overall", "survival)", "and", "safety", "(i.e.,", "frequency", "and", "severity", "of", "serious", "adverse", "events)", "results,", "and,", "accordingly,", "the", "final", "results", "in", "this", "study", "remain", "subject", "to", "substantial", "change", "and", "could", "be", "materially", "and", "adversely", "different", "from", "previously", "announced", "results."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p30_s1", "idA": "906709_11_item1a_p35_s0", "sentA": "License, collaboration and other research revenue is recognized based on the facts and circumstances of each contractual agreement and includes amortization of upfront fees.", "sentB": "Our revenue is derived from our collaboration agreements from which we receive contract research payments, milestone payments based on clinical progress, regulatory progress or net sales achievements, royalties and manufacturing revenue.", "type": 1, "words": ["<tag1>", "License,", "collaboration", "and", "other", "research", "revenue", "is", "recognized", "based", "on", "the", "facts", "and", "circumstances", "of", "each", "contractual", "agreement", "and", "includes", "amortization", "of", "upfront", "fees.", "<tag2>", "Our", "revenue", "is", "derived", "from", "our", "collaboration", "agreements", "from", "which", "we", "receive", "contract", "research", "payments,", "milestone", "payments", "based", "on", "clinical", "progress,", "regulatory", "progress", "or", "net", "sales", "achievements,", "royalties", "and", "manufacturing", "revenue.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "research", "revenue", "is", "recognized", "based", "on", "the", "facts", "and", "circumstances", "of", "each", "contractual", "agreement", "and", "includes", "amortization", "of", "upfront", "fees."], "wordsB": ["Our", "revenue", "is", "derived", "from", "our", "collaboration", "agreements", "from", "which", "we", "receive", "contract", "research", "payments,", "milestone", "payments", "based", "on", "clinical", "progress,", "regulatory", "progress", "or", "net", "sales", "achievements,", "royalties", "and", "manufacturing", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p28_s2", "idA": "906709_11_item1a_p36_s0", "sentA": "We defer income under contractual agreements when we have further obligations that indicate that a separate earnings process has not been completed.", "sentB": "This work is ongoing and there remains significant risk in finalizing, validating, and producing the device at sufficient quantities meeting applicable quality requirements until this work is completed.", "type": 1, "words": ["<tag1>", "We", "defer", "income", "under", "contractual", "agreements", "when", "we", "have", "further", "obligations", "that", "indicate", "that", "a", "separate", "earnings", "process", "has", "not", "been", "completed.", "<tag2>", "This", "work", "is", "ongoing", "and", "there", "remains", "significant", "risk", "in", "finalizing,", "validating,", "and", "producing", "the", "device", "at", "sufficient", "quantities", "meeting", "applicable", "quality", "requirements", "until", "this", "work", "is", "completed.", "<tag3>"], "wordsA": ["We", "defer", "income", "under", "contractual", "agreements", "when", "we", "have", "further", "obligations", "that", "indicate", "that", "a", "separate", "earnings", "process", "has", "not", "been", "completed."], "wordsB": ["This", "work", "is", "ongoing", "and", "there", "remains", "significant", "risk", "in", "finalizing,", "validating,", "and", "producing", "the", "device", "at", "sufficient", "quantities", "meeting", "applicable", "quality", "requirements", "until", "this", "work", "is", "completed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p9_s3", "idA": "906709_11_item1a_p36_s0", "sentA": "We defer income under contractual agreements when we have further obligations that indicate that a separate earnings process has not been completed.", "sentB": "To date, we have conducted numerous experiments using laboratory and home-based chemistry techniques that have been unable to convert NKTR-181 into a rapidly-acting, more abusable form of opioid.", "type": 1, "words": ["<tag1>", "We", "defer", "income", "under", "contractual", "agreements", "when", "we", "have", "further", "obligations", "that", "indicate", "that", "a", "separate", "earnings", "process", "has", "not", "been", "completed.", "<tag2>", "To", "date,", "we", "have", "conducted", "numerous", "experiments", "using", "laboratory", "and", "home-based", "chemistry", "techniques", "that", "have", "been", "unable", "to", "convert", "NKTR-181", "into", "a", "rapidly-acting,", "more", "abusable", "form", "of", "opioid.", "<tag3>"], "wordsA": ["We", "defer", "income", "under", "contractual", "agreements", "when", "we", "have", "further", "obligations", "that", "indicate", "that", "a", "separate", "earnings", "process", "has", "not", "been", "completed."], "wordsB": ["To", "date,", "we", "have", "conducted", "numerous", "experiments", "using", "laboratory", "and", "home-based", "chemistry", "techniques", "that", "have", "been", "unable", "to", "convert", "NKTR-181", "into", "a", "rapidly-acting,", "more", "abusable", "form", "of", "opioid."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s6", "idA": "906709_11_item1a_p37_s1", "sentA": "Management makes its best estimate of the period over which we expect to fulfill our performance obligations, which may include technology transfer assistance, clinical development activities, or manufacturing activities through the commercial life of the product.", "sentB": "Many of the organizations with which we compete for qualified personnel have greater resources than we have.", "type": 1, "words": ["<tag1>", "Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations,", "which", "may", "include", "technology", "transfer", "assistance,", "clinical", "development", "activities,", "or", "manufacturing", "activities", "through", "the", "commercial", "life", "of", "the", "product.", "<tag2>", "Many", "of", "the", "organizations", "with", "which", "we", "compete", "for", "qualified", "personnel", "have", "greater", "resources", "than", "we", "have.", "<tag3>"], "wordsA": ["Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations,", "which", "may", "include", "technology", "transfer", "assistance,", "clinical", "development", "activities,", "or", "manufacturing", "activities", "through", "the", "commercial", "life", "of", "the", "product."], "wordsB": ["Many", "of", "the", "organizations", "with", "which", "we", "compete", "for", "qualified", "personnel", "have", "greater", "resources", "than", "we", "have."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p1_s1", "idA": "906709_11_item1a_p39_s0", "sentA": "For our research and collaboration agreements, our performance obligations may span the life of the agreement.", "sentB": "We note these factors for investors as permitted by Section 21E of the Exchange Act and Section 27A of the Securities Act.", "type": 1, "words": ["<tag1>", "For", "our", "research", "and", "collaboration", "agreements,", "our", "performance", "obligations", "may", "span", "the", "life", "of", "the", "agreement.", "<tag2>", "We", "note", "these", "factors", "for", "investors", "as", "permitted", "by", "Section", "21E", "of", "the", "Exchange", "Act", "and", "Section", "27A", "of", "the", "Securities", "Act.", "<tag3>"], "wordsA": ["For", "our", "research", "and", "collaboration", "agreements,", "our", "performance", "obligations", "may", "span", "the", "life", "of", "the", "agreement."], "wordsB": ["We", "note", "these", "factors", "for", "investors", "as", "permitted", "by", "Section", "21E", "of", "the", "Exchange", "Act", "and", "Section", "27A", "of", "the", "Securities", "Act."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p20_s0", "idA": "906709_11_item1a_p39_s0", "sentA": "For our research and collaboration agreements, our performance obligations may span the life of the agreement.", "sentB": "Currently, the Research Foundation of the State University of New York (SUNY) seeks to recover amounts it alleges it is owed pursuant to a technology licensing contract between SUNY and us.", "type": 1, "words": ["<tag1>", "For", "our", "research", "and", "collaboration", "agreements,", "our", "performance", "obligations", "may", "span", "the", "life", "of", "the", "agreement.", "<tag2>", "Currently,", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "seeks", "to", "recover", "amounts", "it", "alleges", "it", "is", "owed", "pursuant", "to", "a", "technology", "licensing", "contract", "between", "SUNY", "and", "us.", "<tag3>"], "wordsA": ["For", "our", "research", "and", "collaboration", "agreements,", "our", "performance", "obligations", "may", "span", "the", "life", "of", "the", "agreement."], "wordsB": ["Currently,", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "seeks", "to", "recover", "amounts", "it", "alleges", "it", "is", "owed", "pursuant", "to", "a", "technology", "licensing", "contract", "between", "SUNY", "and", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p8_s3", "idA": "906709_11_item1a_p39_s1", "sentA": "For these, the shortest reasonable period is the end of the development period (estimated to be 4 to 6 years) and the longest period is the contractual life of the agreement, which is generally 10-12 years from the first commercial sale.", "sentB": "The FDA has significant discretion to determine what constitutes a high unmet medical need, what therapies should be considered available to patients regardless of which therapies are approved or typically prescribed in a particular setting, the relevance of certain efficacy end points (e.g. overall response rate, progression free survival, overall survival), and the number of patients required to be studied to demonstrate sufficient therapeutic benefit and safety profile.", "type": 1, "words": ["<tag1>", "For", "these,", "the", "shortest", "reasonable", "period", "is", "the", "end", "of", "the", "development", "period", "(estimated", "to", "be", "4", "to", "6", "years)", "and", "the", "longest", "period", "is", "the", "contractual", "life", "of", "the", "agreement,", "which", "is", "generally", "10-12", "years", "from", "the", "first", "commercial", "sale.", "<tag2>", "The", "FDA", "has", "significant", "discretion", "to", "determine", "what", "constitutes", "a", "high", "unmet", "medical", "need,", "what", "therapies", "should", "be", "considered", "available", "to", "patients", "regardless", "of", "which", "therapies", "are", "approved", "or", "typically", "prescribed", "in", "a", "particular", "setting,", "the", "relevance", "of", "certain", "efficacy", "end", "points", "(e.g.", "overall", "response", "rate,", "progression", "free", "survival,", "overall", "survival),", "and", "the", "number", "of", "patients", "required", "to", "be", "studied", "to", "demonstrate", "sufficient", "therapeutic", "benefit", "and", "safety", "profile.", "<tag3>"], "wordsA": ["For", "these,", "the", "shortest", "reasonable", "period", "is", "the", "end", "of", "the", "development", "period", "(estimated", "to", "be", "4", "to", "6", "years)", "and", "the", "longest", "period", "is", "the", "contractual", "life", "of", "the", "agreement,", "which", "is", "generally", "10-12", "years", "from", "the", "first", "commercial", "sale."], "wordsB": ["The", "FDA", "has", "significant", "discretion", "to", "determine", "what", "constitutes", "a", "high", "unmet", "medical", "need,", "what", "therapies", "should", "be", "considered", "available", "to", "patients", "regardless", "of", "which", "therapies", "are", "approved", "or", "typically", "prescribed", "in", "a", "particular", "setting,", "the", "relevance", "of", "certain", "efficacy", "end", "points", "(e.g.", "overall", "response", "rate,", "progression", "free", "survival,", "overall", "survival),", "and", "the", "number", "of", "patients", "required", "to", "be", "studied", "to", "demonstrate", "sufficient", "therapeutic", "benefit", "and", "safety", "profile."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p17_s2", "idA": "906709_11_item1a_p3_s0", "sentA": "The decrease in general and administrative expenses for the year ended December 31, 2009 compared to the year ended December 31, 2008 is primarily attributable to decreased employee compensation costs of $4.1 million, decreased professional fees of $4.3 million, and decreased marketing costs of $1.5 million due to our election to terminate our co-promotion rights and obligations under the collaboration agreement with Bayer for Amikacin Inhale.", "sentB": "As part of the Novartis Pulmonary Asset Sale, we entered an exclusive license agreement with Novartis Pharma pursuant to which Novartis Pharma grants back to us an exclusive, irrevocable, perpetual, royalty-free and worldwide license under certain specific patent rights and other related intellectual property rights necessary for us to satisfy certain continuing contractual obligations to third parties, including in connection with development, manufacture, sale and commercialization activities related to our partnered program for Amikacin Inhale with Bayer.", "type": 1, "words": ["<tag1>", "The", "decrease", "in", "general", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008", "is", "primarily", "attributable", "to", "decreased", "employee", "compensation", "costs", "of", "$4.1", "million,", "decreased", "professional", "fees", "of", "$4.3", "million,", "and", "decreased", "marketing", "costs", "of", "$1.5", "million", "due", "to", "our", "election", "to", "terminate", "our", "co-promotion", "rights", "and", "obligations", "under", "the", "collaboration", "agreement", "with", "Bayer", "for", "Amikacin", "Inhale.", "<tag2>", "As", "part", "of", "the", "Novartis", "Pulmonary", "Asset", "Sale,", "we", "entered", "an", "exclusive", "license", "agreement", "with", "Novartis", "Pharma", "pursuant", "to", "which", "Novartis", "Pharma", "grants", "back", "to", "us", "an", "exclusive,", "irrevocable,", "perpetual,", "royalty-free", "and", "worldwide", "license", "under", "certain", "specific", "patent", "rights", "and", "other", "related", "intellectual", "property", "rights", "necessary", "for", "us", "to", "satisfy", "certain", "continuing", "contractual", "obligations", "to", "third", "parties,", "including", "in", "connection", "with", "development,", "manufacture,", "sale", "and", "commercialization", "activities", "related", "to", "our", "partnered", "program", "for", "Amikacin", "Inhale", "with", "Bayer.", "<tag3>"], "wordsA": ["The", "decrease", "in", "general", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008", "is", "primarily", "attributable", "to", "decreased", "employee", "compensation", "costs", "of", "$4.1", "million,", "decreased", "professional", "fees", "of", "$4.3", "million,", "and", "decreased", "marketing", "costs", "of", "$1.5", "million", "due", "to", "our", "election", "to", "terminate", "our", "co-promotion", "rights", "and", "obligations", "under", "the", "collaboration", "agreement", "with", "Bayer", "for", "Amikacin", "Inhale."], "wordsB": ["As", "part", "of", "the", "Novartis", "Pulmonary", "Asset", "Sale,", "we", "entered", "an", "exclusive", "license", "agreement", "with", "Novartis", "Pharma", "pursuant", "to", "which", "Novartis", "Pharma", "grants", "back", "to", "us", "an", "exclusive,", "irrevocable,", "perpetual,", "royalty-free", "and", "worldwide", "license", "under", "certain", "specific", "patent", "rights", "and", "other", "related", "intellectual", "property", "rights", "necessary", "for", "us", "to", "satisfy", "certain", "continuing", "contractual", "obligations", "to", "third", "parties,", "including", "in", "connection", "with", "development,", "manufacture,", "sale", "and", "commercialization", "activities", "related", "to", "our", "partnered", "program", "for", "Amikacin", "Inhale", "with", "Bayer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p22_s2", "idA": "906709_11_item1a_p41_s0", "sentA": "If we had determined a longer or shorter amortization period was appropriate, our annual upfront fee amortization for these agreements could be as low as $4.0 million or as high as $17.0 million.", "sentB": "Any attempt to enforce our patents or patent application rights could be time consuming and costly.", "type": 1, "words": ["<tag1>", "If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$4.0", "million", "or", "as", "high", "as", "$17.0", "million.", "<tag2>", "Any", "attempt", "to", "enforce", "our", "patents", "or", "patent", "application", "rights", "could", "be", "time", "consuming", "and", "costly.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$4.0", "million", "or", "as", "high", "as", "$17.0", "million."], "wordsB": ["Any", "attempt", "to", "enforce", "our", "patents", "or", "patent", "application", "rights", "could", "be", "time", "consuming", "and", "costly."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p36_s3", "idA": "906709_11_item1a_p41_s0", "sentA": "If we had determined a longer or shorter amortization period was appropriate, our annual upfront fee amortization for these agreements could be as low as $4.0 million or as high as $17.0 million.", "sentB": "If we decide to market our products directly, we must commit significant financial and managerial resources to develop a marketing and sales force with technical expertise and with supporting distribution, administration and compliance capabilities.", "type": 1, "words": ["<tag1>", "If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$4.0", "million", "or", "as", "high", "as", "$17.0", "million.", "<tag2>", "If", "we", "decide", "to", "market", "our", "products", "directly,", "we", "must", "commit", "significant", "financial", "and", "managerial", "resources", "to", "develop", "a", "marketing", "and", "sales", "force", "with", "technical", "expertise", "and", "with", "supporting", "distribution,", "administration", "and", "compliance", "capabilities.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$4.0", "million", "or", "as", "high", "as", "$17.0", "million."], "wordsB": ["If", "we", "decide", "to", "market", "our", "products", "directly,", "we", "must", "commit", "significant", "financial", "and", "managerial", "resources", "to", "develop", "a", "marketing", "and", "sales", "force", "with", "technical", "expertise", "and", "with", "supporting", "distribution,", "administration", "and", "compliance", "capabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p45_s1", "idA": "906709_11_item1a_p41_s0", "sentA": "If we had determined a longer or shorter amortization period was appropriate, our annual upfront fee amortization for these agreements could be as low as $4.0 million or as high as $17.0 million.", "sentB": "Major pharmaceutical or biotechnology companies with approved drugs or drugs in development for these cancers include Bristol-Meyers Squibb, Eli Lilly Co., Roche, GlaxoSmithKline plc, Johnson and Johnson, Pfizer, Inc., Sanofi Aventis, and many others.", "type": 1, "words": ["<tag1>", "If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$4.0", "million", "or", "as", "high", "as", "$17.0", "million.", "<tag2>", "Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include", "Bristol-Meyers", "Squibb,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc.,", "Sanofi", "Aventis,", "and", "many", "others.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$4.0", "million", "or", "as", "high", "as", "$17.0", "million."], "wordsB": ["Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include", "Bristol-Meyers", "Squibb,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc.,", "Sanofi", "Aventis,", "and", "many", "others."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s10", "idA": "906709_11_item1a_p41_s0", "sentA": "If we had determined a longer or shorter amortization period was appropriate, our annual upfront fee amortization for these agreements could be as low as $4.0 million or as high as $17.0 million.", "sentB": "If we fail to attract new personnel or to retain and motivate our current personnel, our business and future growth prospects could be severely harmed.", "type": 1, "words": ["<tag1>", "If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$4.0", "million", "or", "as", "high", "as", "$17.0", "million.", "<tag2>", "If", "we", "fail", "to", "attract", "new", "personnel", "or", "to", "retain", "and", "motivate", "our", "current", "personnel,", "our", "business", "and", "future", "growth", "prospects", "could", "be", "severely", "harmed.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$4.0", "million", "or", "as", "high", "as", "$17.0", "million."], "wordsB": ["If", "we", "fail", "to", "attract", "new", "personnel", "or", "to", "retain", "and", "motivate", "our", "current", "personnel,", "our", "business", "and", "future", "growth", "prospects", "could", "be", "severely", "harmed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p29_s1", "idA": "906709_11_item1a_p42_s0", "sentA": "As of December 31, 2010, we also had $95.2 million of deferred upfront fees related to five license and supply agreements that are being amortized over periods from 2 and 10 years.", "sentB": "There continues to be substantial and unpredictable risk and uncertainty related to manufacturing and supply until such time as the commercial supply chain is validated and proven.", "type": 1, "words": ["<tag1>", "As", "of", "December", "31,", "2010,", "we", "also", "had", "$95.2", "million", "of", "deferred", "upfront", "fees", "related", "to", "five", "license", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "2", "and", "10", "years.", "<tag2>", "There", "continues", "to", "be", "substantial", "and", "unpredictable", "risk", "and", "uncertainty", "related", "to", "manufacturing", "and", "supply", "until", "such", "time", "as", "the", "commercial", "supply", "chain", "is", "validated", "and", "proven.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2010,", "we", "also", "had", "$95.2", "million", "of", "deferred", "upfront", "fees", "related", "to", "five", "license", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "2", "and", "10", "years."], "wordsB": ["There", "continues", "to", "be", "substantial", "and", "unpredictable", "risk", "and", "uncertainty", "related", "to", "manufacturing", "and", "supply", "until", "such", "time", "as", "the", "commercial", "supply", "chain", "is", "validated", "and", "proven."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p48_s1", "idA": "906709_11_item1a_p43_s0", "sentA": "either specified or is much shorter than research and collaboration agreements.", "sentB": "Many of our competitors have greater financial, research and development, marketing and sales, manufacturing and managerial capabilities.", "type": 1, "words": ["<tag1>", "either", "specified", "or", "is", "much", "shorter", "than", "research", "and", "collaboration", "agreements.", "<tag2>", "Many", "of", "our", "competitors", "have", "greater", "financial,", "research", "and", "development,", "marketing", "and", "sales,", "manufacturing", "and", "managerial", "capabilities.", "<tag3>"], "wordsA": ["either", "specified", "or", "is", "much", "shorter", "than", "research", "and", "collaboration", "agreements."], "wordsB": ["Many", "of", "our", "competitors", "have", "greater", "financial,", "research", "and", "development,", "marketing", "and", "sales,", "manufacturing", "and", "managerial", "capabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s5", "idA": "906709_11_item1a_p43_s0", "sentA": "either specified or is much shorter than research and collaboration agreements.", "sentB": "We face intense competition from other biopharmaceutical companies, research and academic institutions and other organizations for qualified personnel.", "type": 1, "words": ["<tag1>", "either", "specified", "or", "is", "much", "shorter", "than", "research", "and", "collaboration", "agreements.", "<tag2>", "We", "face", "intense", "competition", "from", "other", "biopharmaceutical", "companies,", "research", "and", "academic", "institutions", "and", "other", "organizations", "for", "qualified", "personnel.", "<tag3>"], "wordsA": ["either", "specified", "or", "is", "much", "shorter", "than", "research", "and", "collaboration", "agreements."], "wordsB": ["We", "face", "intense", "competition", "from", "other", "biopharmaceutical", "companies,", "research", "and", "academic", "institutions", "and", "other", "organizations", "for", "qualified", "personnel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p6_s0", "idA": "906709_11_item1a_p43_s0", "sentA": "either specified or is much shorter than research and collaboration agreements.", "sentB": "disputes concerning patents, proprietary rights, or license and collaboration agreements that negatively impact our receipt of milestone payments or royalties or require us to make significant payments arising from licenses, settlements, adverse judgments or ongoing royalties.", "type": 1, "words": ["<tag1>", "either", "specified", "or", "is", "much", "shorter", "than", "research", "and", "collaboration", "agreements.", "<tag2>", "disputes", "concerning", "patents,", "proprietary", "rights,", "or", "license", "and", "collaboration", "agreements", "that", "negatively", "impact", "our", "receipt", "of", "milestone", "payments", "or", "royalties", "or", "require", "us", "to", "make", "significant", "payments", "arising", "from", "licenses,", "settlements,", "adverse", "judgments", "or", "ongoing", "royalties.", "<tag3>"], "wordsA": ["either", "specified", "or", "is", "much", "shorter", "than", "research", "and", "collaboration", "agreements."], "wordsB": ["disputes", "concerning", "patents,", "proprietary", "rights,", "or", "license", "and", "collaboration", "agreements", "that", "negatively", "impact", "our", "receipt", "of", "milestone", "payments", "or", "royalties", "or", "require", "us", "to", "make", "significant", "payments", "arising", "from", "licenses,", "settlements,", "adverse", "judgments", "or", "ongoing", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p1_s4", "idA": "906709_11_item1a_p43_s1", "sentA": "We may experience delays in the execution of technology transfer plans, which may result in a longer amortization period for applicable agreements.", "sentB": "Moreover, we operate in a competitive and rapidly changing environment.", "type": 1, "words": ["<tag1>", "We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements.", "<tag2>", "Moreover,", "we", "operate", "in", "a", "competitive", "and", "rapidly", "changing", "environment.", "<tag3>"], "wordsA": ["We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements."], "wordsB": ["Moreover,", "we", "operate", "in", "a", "competitive", "and", "rapidly", "changing", "environment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s7", "idA": "906709_11_item1a_p43_s1", "sentA": "We may experience delays in the execution of technology transfer plans, which may result in a longer amortization period for applicable agreements.", "sentB": "Any failure to follow and document our or our contract manufacturers adherence to such cGMP regulations or satisfy other manufacturing and product release regulatory requirements may disrupt our ability to meet our manufacturing obligations to our customers, lead to significant delays in the availability of products for commercial use or clinical study, result in the termination or hold on a clinical study or delay or prevent filing or approval of marketing applications for our products.", "type": 1, "words": ["<tag1>", "We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements.", "<tag2>", "Any", "failure", "to", "follow", "and", "document", "our", "or", "our", "contract", "manufacturers", "adherence", "to", "such", "cGMP", "regulations", "or", "satisfy", "other", "manufacturing", "and", "product", "release", "regulatory", "requirements", "may", "disrupt", "our", "ability", "to", "meet", "our", "manufacturing", "obligations", "to", "our", "customers,", "lead", "to", "significant", "delays", "in", "the", "availability", "of", "products", "for", "commercial", "use", "or", "clinical", "study,", "result", "in", "the", "termination", "or", "hold", "on", "a", "clinical", "study", "or", "delay", "or", "prevent", "filing", "or", "approval", "of", "marketing", "applications", "for", "our", "products.", "<tag3>"], "wordsA": ["We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements."], "wordsB": ["Any", "failure", "to", "follow", "and", "document", "our", "or", "our", "contract", "manufacturers", "adherence", "to", "such", "cGMP", "regulations", "or", "satisfy", "other", "manufacturing", "and", "product", "release", "regulatory", "requirements", "may", "disrupt", "our", "ability", "to", "meet", "our", "manufacturing", "obligations", "to", "our", "customers,", "lead", "to", "significant", "delays", "in", "the", "availability", "of", "products", "for", "commercial", "use", "or", "clinical", "study,", "result", "in", "the", "termination", "or", "hold", "on", "a", "clinical", "study", "or", "delay", "or", "prevent", "filing", "or", "approval", "of", "marketing", "applications", "for", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p28_s0", "idA": "906709_11_item1a_p43_s1", "sentA": "We may experience delays in the execution of technology transfer plans, which may result in a longer amortization period for applicable agreements.", "sentB": "In the past we have encountered challenges in scaling up manufacturing to meet the requirements of large scale clinical trials without making modifications to the drug formulation, which may cause significant delays in clinical development.", "type": 1, "words": ["<tag1>", "We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements.", "<tag2>", "In", "the", "past", "we", "have", "encountered", "challenges", "in", "scaling", "up", "manufacturing", "to", "meet", "the", "requirements", "of", "large", "scale", "clinical", "trials", "without", "making", "modifications", "to", "the", "drug", "formulation,", "which", "may", "cause", "significant", "delays", "in", "clinical", "development.", "<tag3>"], "wordsA": ["We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements."], "wordsB": ["In", "the", "past", "we", "have", "encountered", "challenges", "in", "scaling", "up", "manufacturing", "to", "meet", "the", "requirements", "of", "large", "scale", "clinical", "trials", "without", "making", "modifications", "to", "the", "drug", "formulation,", "which", "may", "cause", "significant", "delays", "in", "clinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p39_s1", "idA": "906709_11_item1a_p43_s1", "sentA": "We may experience delays in the execution of technology transfer plans, which may result in a longer amortization period for applicable agreements.", "sentB": "We may not be able to achieve and sustain profitability.", "type": 1, "words": ["<tag1>", "We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements.", "<tag2>", "We", "may", "not", "be", "able", "to", "achieve", "and", "sustain", "profitability.", "<tag3>"], "wordsA": ["We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements."], "wordsB": ["We", "may", "not", "be", "able", "to", "achieve", "and", "sustain", "profitability."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s3", "idA": "906709_11_item1a_p43_s1", "sentA": "We may experience delays in the execution of technology transfer plans, which may result in a longer amortization period for applicable agreements.", "sentB": "In addition, undesirable side effects caused by our drug candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restricted label or the delay or denial of regulatory approval by regulatory authorities.", "type": 1, "words": ["<tag1>", "We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements.", "<tag2>", "In", "addition,", "undesirable", "side", "effects", "caused", "by", "our", "drug", "candidates", "could", "cause", "us", "or", "regulatory", "authorities", "to", "interrupt,", "delay", "or", "halt", "clinical", "trials", "and", "could", "result", "in", "a", "more", "restricted", "label", "or", "the", "delay", "or", "denial", "of", "regulatory", "approval", "by", "regulatory", "authorities.", "<tag3>"], "wordsA": ["We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements."], "wordsB": ["In", "addition,", "undesirable", "side", "effects", "caused", "by", "our", "drug", "candidates", "could", "cause", "us", "or", "regulatory", "authorities", "to", "interrupt,", "delay", "or", "halt", "clinical", "trials", "and", "could", "result", "in", "a", "more", "restricted", "label", "or", "the", "delay", "or", "denial", "of", "regulatory", "approval", "by", "regulatory", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s6", "idA": "906709_11_item1a_p43_s1", "sentA": "We may experience delays in the execution of technology transfer plans, which may result in a longer amortization period for applicable agreements.", "sentB": "Discovery from such review and inspection of previously unknown problems may result in restrictions on marketed products or on us, including withdrawal or recall of such products from the market, suspension of related manufacturing operations or a more restricted label.", "type": 1, "words": ["<tag1>", "We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements.", "<tag2>", "Discovery", "from", "such", "review", "and", "inspection", "of", "previously", "unknown", "problems", "may", "result", "in", "restrictions", "on", "marketed", "products", "or", "on", "us,", "including", "withdrawal", "or", "recall", "of", "such", "products", "from", "the", "market,", "suspension", "of", "related", "manufacturing", "operations", "or", "a", "more", "restricted", "label.", "<tag3>"], "wordsA": ["We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements."], "wordsB": ["Discovery", "from", "such", "review", "and", "inspection", "of", "previously", "unknown", "problems", "may", "result", "in", "restrictions", "on", "marketed", "products", "or", "on", "us,", "including", "withdrawal", "or", "recall", "of", "such", "products", "from", "the", "market,", "suspension", "of", "related", "manufacturing", "operations", "or", "a", "more", "restricted", "label."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p7_s0", "idA": "906709_11_item1a_p43_s1", "sentA": "We may experience delays in the execution of technology transfer plans, which may result in a longer amortization period for applicable agreements.", "sentB": "The results from the expanded Phase 2 clinical study for NKTR-102 in women with platinum-resistant/refractory ovarian cancer are unlikely to result in a review or an approval of a new drug application (NDA) by the United States Food and Drug Administration (FDA), and the future results from this trial are difficult to predict.", "type": 1, "words": ["<tag1>", "We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements.", "<tag2>", "The", "results", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "are", "unlikely", "to", "result", "in", "a", "review", "or", "an", "approval", "of", "a", "new", "drug", "application", "(NDA)", "by", "the", "United", "States", "Food", "and", "Drug", "Administration", "(FDA),", "and", "the", "future", "results", "from", "this", "trial", "are", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements."], "wordsB": ["The", "results", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "are", "unlikely", "to", "result", "in", "a", "review", "or", "an", "approval", "of", "a", "new", "drug", "application", "(NDA)", "by", "the", "United", "States", "Food", "and", "Drug", "Administration", "(FDA),", "and", "the", "future", "results", "from", "this", "trial", "are", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p33_s0", "idA": "906709_11_item1a_p44_s0", "sentA": "Our original estimates are periodically evaluated to determine if circumstances have caused the estimates to change and if so, amortization of revenue is adjusted prospectively.", "sentB": "market and sell the drugs when and if they are approved.", "type": 1, "words": ["<tag1>", "Our", "original", "estimates", "are", "periodically", "evaluated", "to", "determine", "if", "circumstances", "have", "caused", "the", "estimates", "to", "change", "and", "if", "so,", "amortization", "of", "revenue", "is", "adjusted", "prospectively.", "<tag2>", "market", "and", "sell", "the", "drugs", "when", "and", "if", "they", "are", "approved.", "<tag3>"], "wordsA": ["Our", "original", "estimates", "are", "periodically", "evaluated", "to", "determine", "if", "circumstances", "have", "caused", "the", "estimates", "to", "change", "and", "if", "so,", "amortization", "of", "revenue", "is", "adjusted", "prospectively."], "wordsB": ["market", "and", "sell", "the", "drugs", "when", "and", "if", "they", "are", "approved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p8_s0", "idA": "906709_11_item1a_p46_s0", "sentA": "The Black-Scholes option pricing model requires the input of highly subjective assumptions.", "sentB": "Acceptance and approval of an NDA by the FDA almost always requires the sponsor to conduct comparative Phase 3 clinical studies prior to acceptance for review or approval of an NDA.", "type": 1, "words": ["<tag1>", "The", "Black-Scholes", "option", "pricing", "model", "requires", "the", "input", "of", "highly", "subjective", "assumptions.", "<tag2>", "Acceptance", "and", "approval", "of", "an", "NDA", "by", "the", "FDA", "almost", "always", "requires", "the", "sponsor", "to", "conduct", "comparative", "Phase", "3", "clinical", "studies", "prior", "to", "acceptance", "for", "review", "or", "approval", "of", "an", "NDA.", "<tag3>"], "wordsA": ["The", "Black-Scholes", "option", "pricing", "model", "requires", "the", "input", "of", "highly", "subjective", "assumptions."], "wordsB": ["Acceptance", "and", "approval", "of", "an", "NDA", "by", "the", "FDA", "almost", "always", "requires", "the", "sponsor", "to", "conduct", "comparative", "Phase", "3", "clinical", "studies", "prior", "to", "acceptance", "for", "review", "or", "approval", "of", "an", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p44_s1", "idA": "906709_11_item1a_p46_s2", "sentA": "In addition, management continually assesses the assumptions and methodologies used to calculate the estimated fair value of stock-based compensation.", "sentB": "For NKTR-118, there are currently several alternative therapies used to address opioid-induced constipation (OIC) and opioid-induced bowel dysfunction (OBD), including subcutaneous Relistor (methylnaltrexone bromide) and oral and rectal over-the-counter laxatives and stool softeners such as docusate sodium, senna and milk of magnesia.", "type": 1, "words": ["<tag1>", "In", "addition,", "management", "continually", "assesses", "the", "assumptions", "and", "methodologies", "used", "to", "calculate", "the", "estimated", "fair", "value", "of", "stock-based", "compensation.", "<tag2>", "For", "NKTR-118,", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "subcutaneous", "Relistor", "(methylnaltrexone", "bromide)", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia.", "<tag3>"], "wordsA": ["In", "addition,", "management", "continually", "assesses", "the", "assumptions", "and", "methodologies", "used", "to", "calculate", "the", "estimated", "fair", "value", "of", "stock-based", "compensation."], "wordsB": ["For", "NKTR-118,", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "subcutaneous", "Relistor", "(methylnaltrexone", "bromide)", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p11_s2", "idA": "906709_11_item1a_p46_s3", "sentA": "Circumstances may change and additional data may become available over time, which could result in changes to the assumptions and methodologies, and which could materially impact our fair value determination, as well as our stock-based compensation expense.", "sentB": "Preliminary and interim data from our clinical studies that we announce or publish from time to time is subject to audit and verification procedures that could result in material changes in the final data and may change as more patient data becomes available.", "type": 1, "words": ["<tag1>", "Circumstances", "may", "change", "and", "additional", "data", "may", "become", "available", "over", "time,", "which", "could", "result", "in", "changes", "to", "the", "assumptions", "and", "methodologies,", "and", "which", "could", "materially", "impact", "our", "fair", "value", "determination,", "as", "well", "as", "our", "stock-based", "compensation", "expense.", "<tag2>", "Preliminary", "and", "interim", "data", "from", "our", "clinical", "studies", "that", "we", "announce", "or", "publish", "from", "time", "to", "time", "is", "subject", "to", "audit", "and", "verification", "procedures", "that", "could", "result", "in", "material", "changes", "in", "the", "final", "data", "and", "may", "change", "as", "more", "patient", "data", "becomes", "available.", "<tag3>"], "wordsA": ["Circumstances", "may", "change", "and", "additional", "data", "may", "become", "available", "over", "time,", "which", "could", "result", "in", "changes", "to", "the", "assumptions", "and", "methodologies,", "and", "which", "could", "materially", "impact", "our", "fair", "value", "determination,", "as", "well", "as", "our", "stock-based", "compensation", "expense."], "wordsB": ["Preliminary", "and", "interim", "data", "from", "our", "clinical", "studies", "that", "we", "announce", "or", "publish", "from", "time", "to", "time", "is", "subject", "to", "audit", "and", "verification", "procedures", "that", "could", "result", "in", "material", "changes", "in", "the", "final", "data", "and", "may", "change", "as", "more", "patient", "data", "becomes", "available."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s8", "idA": "906709_11_item1a_p46_s3", "sentA": "Circumstances may change and additional data may become available over time, which could result in changes to the assumptions and methodologies, and which could materially impact our fair value determination, as well as our stock-based compensation expense.", "sentB": "Failure to comply with applicable regulations may also result in sanctions being imposed on us, including fines, injunctions, civil penalties, failure of regulatory authorities to grant marketing approval of our products, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of products, operating restrictions and criminal prosecutions, any of which could harm our business.", "type": 1, "words": ["<tag1>", "Circumstances", "may", "change", "and", "additional", "data", "may", "become", "available", "over", "time,", "which", "could", "result", "in", "changes", "to", "the", "assumptions", "and", "methodologies,", "and", "which", "could", "materially", "impact", "our", "fair", "value", "determination,", "as", "well", "as", "our", "stock-based", "compensation", "expense.", "<tag2>", "Failure", "to", "comply", "with", "applicable", "regulations", "may", "also", "result", "in", "sanctions", "being", "imposed", "on", "us,", "including", "fines,", "injunctions,", "civil", "penalties,", "failure", "of", "regulatory", "authorities", "to", "grant", "marketing", "approval", "of", "our", "products,", "delays,", "suspension", "or", "withdrawal", "of", "approvals,", "license", "revocation,", "seizures", "or", "recalls", "of", "products,", "operating", "restrictions", "and", "criminal", "prosecutions,", "any", "of", "which", "could", "harm", "our", "business.", "<tag3>"], "wordsA": ["Circumstances", "may", "change", "and", "additional", "data", "may", "become", "available", "over", "time,", "which", "could", "result", "in", "changes", "to", "the", "assumptions", "and", "methodologies,", "and", "which", "could", "materially", "impact", "our", "fair", "value", "determination,", "as", "well", "as", "our", "stock-based", "compensation", "expense."], "wordsB": ["Failure", "to", "comply", "with", "applicable", "regulations", "may", "also", "result", "in", "sanctions", "being", "imposed", "on", "us,", "including", "fines,", "injunctions,", "civil", "penalties,", "failure", "of", "regulatory", "authorities", "to", "grant", "marketing", "approval", "of", "our", "products,", "delays,", "suspension", "or", "withdrawal", "of", "approvals,", "license", "revocation,", "seizures", "or", "recalls", "of", "products,", "operating", "restrictions", "and", "criminal", "prosecutions,", "any", "of", "which", "could", "harm", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p12_s0", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "From time to time, we publish preliminary or interim data from our clinical studies.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "From", "time", "to", "time,", "we", "publish", "preliminary", "or", "interim", "data", "from", "our", "clinical", "studies.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["From", "time", "to", "time,", "we", "publish", "preliminary", "or", "interim", "data", "from", "our", "clinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p14_s0", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "Numerous pending and issued U.S. and foreign patent rights and other proprietary rights owned by third parties relate to pharmaceutical compositions, methods of preparation and manufacturing, and methods of use and administration.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "Numerous", "pending", "and", "issued", "U.S.", "and", "foreign", "patent", "rights", "and", "other", "proprietary", "rights", "owned", "by", "third", "parties", "relate", "to", "pharmaceutical", "compositions,", "methods", "of", "preparation", "and", "manufacturing,", "and", "methods", "of", "use", "and", "administration.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["Numerous", "pending", "and", "issued", "U.S.", "and", "foreign", "patent", "rights", "and", "other", "proprietary", "rights", "owned", "by", "third", "parties", "relate", "to", "pharmaceutical", "compositions,", "methods", "of", "preparation", "and", "manufacturing,", "and", "methods", "of", "use", "and", "administration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p14_s1", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "We cannot predict with any certainty which, if any, patent references will be considered relevant to our or our collaboration partners technology or drug candidates by authorities in the various jurisdictions where such rights exist, nor can we predict with certainty which, if any, of these rights will or may be asserted against us by third parties.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "We", "cannot", "predict", "with", "any", "certainty", "which,", "if", "any,", "patent", "references", "will", "be", "considered", "relevant", "to", "our", "or", "our", "collaboration", "partners", "technology", "or", "drug", "candidates", "by", "authorities", "in", "the", "various", "jurisdictions", "where", "such", "rights", "exist,", "nor", "can", "we", "predict", "with", "certainty", "which,", "if", "any,", "of", "these", "rights", "will", "or", "may", "be", "asserted", "against", "us", "by", "third", "parties.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["We", "cannot", "predict", "with", "any", "certainty", "which,", "if", "any,", "patent", "references", "will", "be", "considered", "relevant", "to", "our", "or", "our", "collaboration", "partners", "technology", "or", "drug", "candidates", "by", "authorities", "in", "the", "various", "jurisdictions", "where", "such", "rights", "exist,", "nor", "can", "we", "predict", "with", "certainty", "which,", "if", "any,", "of", "these", "rights", "will", "or", "may", "be", "asserted", "against", "us", "by", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p20_s1", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "SUNY has filed an action in the United States District Court for the Northern District of New York.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "SUNY", "has", "filed", "an", "action", "in", "the", "United", "States", "District", "Court", "for", "the", "Northern", "District", "of", "New", "York.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["SUNY", "has", "filed", "an", "action", "in", "the", "United", "States", "District", "Court", "for", "the", "Northern", "District", "of", "New", "York."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p22_s3", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "An adverse outcome could subject us to significant liabilities to third parties, require disputed rights to be licensed from or to third parties or require us to cease using the technology in dispute.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "An", "adverse", "outcome", "could", "subject", "us", "to", "significant", "liabilities", "to", "third", "parties,", "require", "disputed", "rights", "to", "be", "licensed", "from", "or", "to", "third", "parties", "or", "require", "us", "to", "cease", "using", "the", "technology", "in", "dispute.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["An", "adverse", "outcome", "could", "subject", "us", "to", "significant", "liabilities", "to", "third", "parties,", "require", "disputed", "rights", "to", "be", "licensed", "from", "or", "to", "third", "parties", "or", "require", "us", "to", "cease", "using", "the", "technology", "in", "dispute."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s12", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "If we or our contract manufacturers are not able to manufacture and supply sufficient drug quantities meeting applicable quality standards required to support large clinical studies or commercial manufacturing in a timely manner, we risk delaying our clinical studies or those of our collaboration partners, reducing drug sales by our collaboration partners or breaching contractual obligations.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "If", "we", "or", "our", "contract", "manufacturers", "are", "not", "able", "to", "manufacture", "and", "supply", "sufficient", "drug", "quantities", "meeting", "applicable", "quality", "standards", "required", "to", "support", "large", "clinical", "studies", "or", "commercial", "manufacturing", "in", "a", "timely", "manner,", "we", "risk", "delaying", "our", "clinical", "studies", "or", "those", "of", "our", "collaboration", "partners,", "reducing", "drug", "sales", "by", "our", "collaboration", "partners", "or", "breaching", "contractual", "obligations.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["If", "we", "or", "our", "contract", "manufacturers", "are", "not", "able", "to", "manufacture", "and", "supply", "sufficient", "drug", "quantities", "meeting", "applicable", "quality", "standards", "required", "to", "support", "large", "clinical", "studies", "or", "commercial", "manufacturing", "in", "a", "timely", "manner,", "we", "risk", "delaying", "our", "clinical", "studies", "or", "those", "of", "our", "collaboration", "partners,", "reducing", "drug", "sales", "by", "our", "collaboration", "partners", "or", "breaching", "contractual", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p25_s1", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "We have faced and may in the future face significant difficulties, delays and unexpected expenses as we validate third party contract manufacturers required for drug supply to support our clinical studies and the clinical studies and products of our collaboration partners.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "We", "have", "faced", "and", "may", "in", "the", "future", "face", "significant", "difficulties,", "delays", "and", "unexpected", "expenses", "as", "we", "validate", "third", "party", "contract", "manufacturers", "required", "for", "drug", "supply", "to", "support", "our", "clinical", "studies", "and", "the", "clinical", "studies", "and", "products", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["We", "have", "faced", "and", "may", "in", "the", "future", "face", "significant", "difficulties,", "delays", "and", "unexpected", "expenses", "as", "we", "validate", "third", "party", "contract", "manufacturers", "required", "for", "drug", "supply", "to", "support", "our", "clinical", "studies", "and", "the", "clinical", "studies", "and", "products", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p25_s2", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "Failure by us or our contract manufacturers to supply drug product in sufficient quantities that meet all applicable quality requirements could result in supply shortages for our clinical studies or the clinical studies and commercial activities of our collaboration partners.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "studies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "studies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s4", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "The start or end of a clinical study is often delayed or halted due to changing regulatory requirements, manufacturing challenges, required clinical trial administrative actions, slower than anticipated patient enrollment, changing standards of care, availability or prevalence of use of a comparator drug or required prior therapy, clinical outcomes, or our own financial constraints.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "The", "start", "or", "end", "of", "a", "clinical", "study", "is", "often", "delayed", "or", "halted", "due", "to", "changing", "regulatory", "requirements,", "manufacturing", "challenges,", "required", "clinical", "trial", "administrative", "actions,", "slower", "than", "anticipated", "patient", "enrollment,", "changing", "standards", "of", "care,", "availability", "or", "prevalence", "of", "use", "of", "a", "comparator", "drug", "or", "required", "prior", "therapy,", "clinical", "outcomes,", "or", "our", "own", "financial", "constraints.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["The", "start", "or", "end", "of", "a", "clinical", "study", "is", "often", "delayed", "or", "halted", "due", "to", "changing", "regulatory", "requirements,", "manufacturing", "challenges,", "required", "clinical", "trial", "administrative", "actions,", "slower", "than", "anticipated", "patient", "enrollment,", "changing", "standards", "of", "care,", "availability", "or", "prevalence", "of", "use", "of", "a", "comparator", "drug", "or", "required", "prior", "therapy,", "clinical", "outcomes,", "or", "our", "own", "financial", "constraints."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p36_s2", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "To commercialize any of our drugs that receive regulatory approval for commercialization, we must either develop internal sales, marketing and distribution capabilities, which would be expensive and time consuming, or enter into collaboration arrangements with third parties to perform these services.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "To", "commercialize", "any", "of", "our", "drugs", "that", "receive", "regulatory", "approval", "for", "commercialization,", "we", "must", "either", "develop", "internal", "sales,", "marketing", "and", "distribution", "capabilities,", "which", "would", "be", "expensive", "and", "time", "consuming,", "or", "enter", "into", "collaboration", "arrangements", "with", "third", "parties", "to", "perform", "these", "services.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["To", "commercialize", "any", "of", "our", "drugs", "that", "receive", "regulatory", "approval", "for", "commercialization,", "we", "must", "either", "develop", "internal", "sales,", "marketing", "and", "distribution", "capabilities,", "which", "would", "be", "expensive", "and", "time", "consuming,", "or", "enter", "into", "collaboration", "arrangements", "with", "third", "parties", "to", "perform", "these", "services."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p41_s5", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "Third parties may not complete activities on schedule or may not conduct our clinical trials in accordance with regulatory requirements or our stated protocols.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "Third", "parties", "may", "not", "complete", "activities", "on", "schedule", "or", "may", "not", "conduct", "our", "clinical", "trials", "in", "accordance", "with", "regulatory", "requirements", "or", "our", "stated", "protocols.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["Third", "parties", "may", "not", "complete", "activities", "on", "schedule", "or", "may", "not", "conduct", "our", "clinical", "trials", "in", "accordance", "with", "regulatory", "requirements", "or", "our", "stated", "protocols."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p42_s1", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "Competitors of our PEGylation and polymer conjugate chemistry technologies include Dr. Reddy s Laboratories Ltd., Enzon Pharmaceuticals, Inc., SunBio Corporation, Mountain View Pharmaceuticals, Inc., Novo Nordisk A/S (formerly assets held by Neose Technologies, Inc.), and NOF Corporation.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "Competitors", "of", "our", "PEGylation", "and", "polymer", "conjugate", "chemistry", "technologies", "include", "Dr.", "Reddy", "s", "Laboratories", "Ltd.,", "Enzon", "Pharmaceuticals,", "Inc.,", "SunBio", "Corporation,", "Mountain", "View", "Pharmaceuticals,", "Inc.,", "Novo", "Nordisk", "A/S", "(formerly", "assets", "held", "by", "Neose", "Technologies,", "Inc.),", "and", "NOF", "Corporation.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["Competitors", "of", "our", "PEGylation", "and", "polymer", "conjugate", "chemistry", "technologies", "include", "Dr.", "Reddy", "s", "Laboratories", "Ltd.,", "Enzon", "Pharmaceuticals,", "Inc.,", "SunBio", "Corporation,", "Mountain", "View", "Pharmaceuticals,", "Inc.,", "Novo", "Nordisk", "A/S", "(formerly", "assets", "held", "by", "Neose", "Technologies,", "Inc.),", "and", "NOF", "Corporation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p44_s0", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "For Amikacin Inhale, the current standard of care includes several approved intravenous antibiotics for the treatment of either hospital-acquired pneumonia or ventilator-associated pneumonia in patients on mechanical ventilators.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "For", "Amikacin", "Inhale,", "the", "current", "standard", "of", "care", "includes", "several", "approved", "intravenous", "antibiotics", "for", "the", "treatment", "of", "either", "hospital-acquired", "pneumonia", "or", "ventilator-associated", "pneumonia", "in", "patients", "on", "mechanical", "ventilators.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["For", "Amikacin", "Inhale,", "the", "current", "standard", "of", "care", "includes", "several", "approved", "intravenous", "antibiotics", "for", "the", "treatment", "of", "either", "hospital-acquired", "pneumonia", "or", "ventilator-associated", "pneumonia", "in", "patients", "on", "mechanical", "ventilators."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p46_s0", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "There are approved therapies for the treatment of colorectal cancer, including Eloxatin (oxaliplatin), Camptosar (irinotecan), Avastin (bevacizumab), Erbitux (cetuximab), Vectibix (panitumumab), Xeloda (capecitabine), Adrucil (fluorouracil), and Wellcovorin (leucovorin).", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "There", "are", "approved", "therapies", "for", "the", "treatment", "of", "colorectal", "cancer,", "including", "Eloxatin", "(oxaliplatin),", "Camptosar", "(irinotecan),", "Avastin", "(bevacizumab),", "Erbitux", "(cetuximab),", "Vectibix", "(panitumumab),", "Xeloda", "(capecitabine),", "Adrucil", "(fluorouracil),", "and", "Wellcovorin", "(leucovorin).", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["There", "are", "approved", "therapies", "for", "the", "treatment", "of", "colorectal", "cancer,", "including", "Eloxatin", "(oxaliplatin),", "Camptosar", "(irinotecan),", "Avastin", "(bevacizumab),", "Erbitux", "(cetuximab),", "Vectibix", "(panitumumab),", "Xeloda", "(capecitabine),", "Adrucil", "(fluorouracil),", "and", "Wellcovorin", "(leucovorin)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s3", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "Additionally, we may not be able to maintain our clinical trial insurance or product liability insurance at an acceptable cost, if at all, and this insurance may not provide adequate coverage against potential claims or losses.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "Additionally,", "we", "may", "not", "be", "able", "to", "maintain", "our", "clinical", "trial", "insurance", "or", "product", "liability", "insurance", "at", "an", "acceptable", "cost,", "if", "at", "all,", "and", "this", "insurance", "may", "not", "provide", "adequate", "coverage", "against", "potential", "claims", "or", "losses.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["Additionally,", "we", "may", "not", "be", "able", "to", "maintain", "our", "clinical", "trial", "insurance", "or", "product", "liability", "insurance", "at", "an", "acceptable", "cost,", "if", "at", "all,", "and", "this", "insurance", "may", "not", "provide", "adequate", "coverage", "against", "potential", "claims", "or", "losses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s4", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "Our future depends on the proper management of our current and future business operations and their associated expenses.", "type": 1, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "Our", "future", "depends", "on", "the", "proper", "management", "of", "our", "current", "and", "future", "business", "operations", "and", "their", "associated", "expenses.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["Our", "future", "depends", "on", "the", "proper", "management", "of", "our", "current", "and", "future", "business", "operations", "and", "their", "associated", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p35_s0", "idA": "906709_11_item1a_p47_s1", "sentA": "We accrue costs associated with the start-up and reporting phases of the clinical trials ratably over the estimated duration of the start-up and reporting phases.", "sentB": "partners may terminate their agreements with us unilaterally for any or no reason, in some cases with the payment of a termination fee penalty and in other cases with no termination fee penalty.", "type": 1, "words": ["<tag1>", "We", "accrue", "costs", "associated", "with", "the", "start-up", "and", "reporting", "phases", "of", "the", "clinical", "trials", "ratably", "over", "the", "estimated", "duration", "of", "the", "start-up", "and", "reporting", "phases.", "<tag2>", "partners", "may", "terminate", "their", "agreements", "with", "us", "unilaterally", "for", "any", "or", "no", "reason,", "in", "some", "cases", "with", "the", "payment", "of", "a", "termination", "fee", "penalty", "and", "in", "other", "cases", "with", "no", "termination", "fee", "penalty.", "<tag3>"], "wordsA": ["We", "accrue", "costs", "associated", "with", "the", "start-up", "and", "reporting", "phases", "of", "the", "clinical", "trials", "ratably", "over", "the", "estimated", "duration", "of", "the", "start-up", "and", "reporting", "phases."], "wordsB": ["partners", "may", "terminate", "their", "agreements", "with", "us", "unilaterally", "for", "any", "or", "no", "reason,", "in", "some", "cases", "with", "the", "payment", "of", "a", "termination", "fee", "penalty", "and", "in", "other", "cases", "with", "no", "termination", "fee", "penalty."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p41_s0", "idA": "906709_11_item1a_p47_s1", "sentA": "We accrue costs associated with the start-up and reporting phases of the clinical trials ratably over the estimated duration of the start-up and reporting phases.", "sentB": "We depend on third parties to conduct the clinical trials for our proprietary product candidates and any failure of those parties to fulfill their obligations could harm our development and commercialization plans.", "type": 1, "words": ["<tag1>", "We", "accrue", "costs", "associated", "with", "the", "start-up", "and", "reporting", "phases", "of", "the", "clinical", "trials", "ratably", "over", "the", "estimated", "duration", "of", "the", "start-up", "and", "reporting", "phases.", "<tag2>", "We", "depend", "on", "third", "parties", "to", "conduct", "the", "clinical", "trials", "for", "our", "proprietary", "product", "candidates", "and", "any", "failure", "of", "those", "parties", "to", "fulfill", "their", "obligations", "could", "harm", "our", "development", "and", "commercialization", "plans.", "<tag3>"], "wordsA": ["We", "accrue", "costs", "associated", "with", "the", "start-up", "and", "reporting", "phases", "of", "the", "clinical", "trials", "ratably", "over", "the", "estimated", "duration", "of", "the", "start-up", "and", "reporting", "phases."], "wordsB": ["We", "depend", "on", "third", "parties", "to", "conduct", "the", "clinical", "trials", "for", "our", "proprietary", "product", "candidates", "and", "any", "failure", "of", "those", "parties", "to", "fulfill", "their", "obligations", "could", "harm", "our", "development", "and", "commercialization", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p42_s3", "idA": "906709_11_item1a_p47_s2", "sentA": "If the actual timing of these phases varies from the estimate, we will adjust the accrual prospectively.", "sentB": "Some of these companies license or provide the technology to other companies, while others are developing the technology for internal use.", "type": 1, "words": ["<tag1>", "If", "the", "actual", "timing", "of", "these", "phases", "varies", "from", "the", "estimate,", "we", "will", "adjust", "the", "accrual", "prospectively.", "<tag2>", "Some", "of", "these", "companies", "license", "or", "provide", "the", "technology", "to", "other", "companies,", "while", "others", "are", "developing", "the", "technology", "for", "internal", "use.", "<tag3>"], "wordsA": ["If", "the", "actual", "timing", "of", "these", "phases", "varies", "from", "the", "estimate,", "we", "will", "adjust", "the", "accrual", "prospectively."], "wordsB": ["Some", "of", "these", "companies", "license", "or", "provide", "the", "technology", "to", "other", "companies,", "while", "others", "are", "developing", "the", "technology", "for", "internal", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p7_s4", "idA": "906709_11_item1a_p47_s2", "sentA": "If the actual timing of these phases varies from the estimate, we will adjust the accrual prospectively.", "sentB": "We are currently in the process of compiling and performing verification procedures on preliminary interim results from the patients.", "type": 1, "words": ["<tag1>", "If", "the", "actual", "timing", "of", "these", "phases", "varies", "from", "the", "estimate,", "we", "will", "adjust", "the", "accrual", "prospectively.", "<tag2>", "We", "are", "currently", "in", "the", "process", "of", "compiling", "and", "performing", "verification", "procedures", "on", "preliminary", "interim", "results", "from", "the", "patients.", "<tag3>"], "wordsA": ["If", "the", "actual", "timing", "of", "these", "phases", "varies", "from", "the", "estimate,", "we", "will", "adjust", "the", "accrual", "prospectively."], "wordsB": ["We", "are", "currently", "in", "the", "process", "of", "compiling", "and", "performing", "verification", "procedures", "on", "preliminary", "interim", "results", "from", "the", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p29_s0", "idA": "906709_11_item1a_p48_s0", "sentA": "We accrue costs associated with treatment phase of clinical trials based on the total estimated cost of the clinical trials and are expensed ratably based on patient enrollment in the trials.", "sentB": "Drug/device combination products are particularly complex, expensive and time-consuming to develop due to the number of variables involved in the final product design, including ease of patient/doctor use, maintenance of clinical efficacy, reliability and cost of manufacturing, regulatory approval requirements and standards and other important factors.", "type": 1, "words": ["<tag1>", "We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials.", "<tag2>", "Drug/device", "combination", "products", "are", "particularly", "complex,", "expensive", "and", "time-consuming", "to", "develop", "due", "to", "the", "number", "of", "variables", "involved", "in", "the", "final", "product", "design,", "including", "ease", "of", "patient/doctor", "use,", "maintenance", "of", "clinical", "efficacy,", "reliability", "and", "cost", "of", "manufacturing,", "regulatory", "approval", "requirements", "and", "standards", "and", "other", "important", "factors.", "<tag3>"], "wordsA": ["We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials."], "wordsB": ["Drug/device", "combination", "products", "are", "particularly", "complex,", "expensive", "and", "time-consuming", "to", "develop", "due", "to", "the", "number", "of", "variables", "involved", "in", "the", "final", "product", "design,", "including", "ease", "of", "patient/doctor", "use,", "maintenance", "of", "clinical", "efficacy,", "reliability", "and", "cost", "of", "manufacturing,", "regulatory", "approval", "requirements", "and", "standards", "and", "other", "important", "factors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s5", "idA": "906709_11_item1a_p48_s0", "sentA": "We accrue costs associated with treatment phase of clinical trials based on the total estimated cost of the clinical trials and are expensed ratably based on patient enrollment in the trials.", "sentB": "Drug development is a highly uncertain scientific and medical endeavor, and failure can unexpectedly occur at any stage of clinical development.", "type": 1, "words": ["<tag1>", "We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials.", "<tag2>", "Drug", "development", "is", "a", "highly", "uncertain", "scientific", "and", "medical", "endeavor,", "and", "failure", "can", "unexpectedly", "occur", "at", "any", "stage", "of", "clinical", "development.", "<tag3>"], "wordsA": ["We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials."], "wordsB": ["Drug", "development", "is", "a", "highly", "uncertain", "scientific", "and", "medical", "endeavor,", "and", "failure", "can", "unexpectedly", "occur", "at", "any", "stage", "of", "clinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p48_s2", "idA": "906709_11_item1a_p48_s0", "sentA": "We accrue costs associated with treatment phase of clinical trials based on the total estimated cost of the clinical trials and are expensed ratably based on patient enrollment in the trials.", "sentB": "We face competition from these companies not just in product development but also in areas such as recruiting employees, acquiring technologies that might enhance our ability to commercialize products, establishing relationships with certain research and academic institutions, enrolling patients in clinical trials and seeking program partnerships and collaborations with larger pharmaceutical companies.", "type": 1, "words": ["<tag1>", "We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials.", "<tag2>", "We", "face", "competition", "from", "these", "companies", "not", "just", "in", "product", "development", "but", "also", "in", "areas", "such", "as", "recruiting", "employees,", "acquiring", "technologies", "that", "might", "enhance", "our", "ability", "to", "commercialize", "products,", "establishing", "relationships", "with", "certain", "research", "and", "academic", "institutions,", "enrolling", "patients", "in", "clinical", "trials", "and", "seeking", "program", "partnerships", "and", "collaborations", "with", "larger", "pharmaceutical", "companies.", "<tag3>"], "wordsA": ["We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials."], "wordsB": ["We", "face", "competition", "from", "these", "companies", "not", "just", "in", "product", "development", "but", "also", "in", "areas", "such", "as", "recruiting", "employees,", "acquiring", "technologies", "that", "might", "enhance", "our", "ability", "to", "commercialize", "products,", "establishing", "relationships", "with", "certain", "research", "and", "academic", "institutions,", "enrolling", "patients", "in", "clinical", "trials", "and", "seeking", "program", "partnerships", "and", "collaborations", "with", "larger", "pharmaceutical", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s4", "idA": "906709_11_item1a_p48_s0", "sentA": "We accrue costs associated with treatment phase of clinical trials based on the total estimated cost of the clinical trials and are expensed ratably based on patient enrollment in the trials.", "sentB": "We must attract and retain experts in the areas of clinical testing, manufacturing, regulatory, finance, marketing and distribution and develop additional expertise in our existing personnel.", "type": 1, "words": ["<tag1>", "We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials.", "<tag2>", "We", "must", "attract", "and", "retain", "experts", "in", "the", "areas", "of", "clinical", "testing,", "manufacturing,", "regulatory,", "finance,", "marketing", "and", "distribution", "and", "develop", "additional", "expertise", "in", "our", "existing", "personnel.", "<tag3>"], "wordsA": ["We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials."], "wordsB": ["We", "must", "attract", "and", "retain", "experts", "in", "the", "areas", "of", "clinical", "testing,", "manufacturing,", "regulatory,", "finance,", "marketing", "and", "distribution", "and", "develop", "additional", "expertise", "in", "our", "existing", "personnel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p7_s2", "idA": "906709_11_item1a_p48_s0", "sentA": "We accrue costs associated with treatment phase of clinical trials based on the total estimated cost of the clinical trials and are expensed ratably based on patient enrollment in the trials.", "sentB": "As of February 2012, approximately 94 of the planned 110 patients had been enrolled in the study.", "type": 1, "words": ["<tag1>", "We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials.", "<tag2>", "As", "of", "February", "2012,", "approximately", "94", "of", "the", "planned", "110", "patients", "had", "been", "enrolled", "in", "the", "study.", "<tag3>"], "wordsA": ["We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials."], "wordsB": ["As", "of", "February", "2012,", "approximately", "94", "of", "the", "planned", "110", "patients", "had", "been", "enrolled", "in", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p21_s5", "idA": "906709_11_item1a_p4_s0", "sentA": "During the year ended December 31, 2010, we relocated all of our operations previously located in San Carlos, California, including our corporate headquarters, to our Mission Bay Facility in San Francisco, California.", "sentB": "The scope of our patent claim coverage can be critical to our right to receive royalties from our collaboration partnerships.", "type": 1, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2010,", "we", "relocated", "all", "of", "our", "operations", "previously", "located", "in", "San", "Carlos,", "California,", "including", "our", "corporate", "headquarters,", "to", "our", "Mission", "Bay", "Facility", "in", "San", "Francisco,", "California.", "<tag2>", "The", "scope", "of", "our", "patent", "claim", "coverage", "can", "be", "critical", "to", "our", "right", "to", "receive", "royalties", "from", "our", "collaboration", "partnerships.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2010,", "we", "relocated", "all", "of", "our", "operations", "previously", "located", "in", "San", "Carlos,", "California,", "including", "our", "corporate", "headquarters,", "to", "our", "Mission", "Bay", "Facility", "in", "San", "Francisco,", "California."], "wordsB": ["The", "scope", "of", "our", "patent", "claim", "coverage", "can", "be", "critical", "to", "our", "right", "to", "receive", "royalties", "from", "our", "collaboration", "partnerships."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s1", "idA": "906709_11_item1a_p4_s0", "sentA": "During the year ended December 31, 2010, we relocated all of our operations previously located in San Carlos, California, including our corporate headquarters, to our Mission Bay Facility in San Francisco, California.", "sentB": "Changes to these laws, regulations and judicial decisions are subject to influences outside of our control and may negatively affect our business, including our ability to obtain meaningful patent coverage or enforcement rights to any of our issued patents.", "type": 1, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2010,", "we", "relocated", "all", "of", "our", "operations", "previously", "located", "in", "San", "Carlos,", "California,", "including", "our", "corporate", "headquarters,", "to", "our", "Mission", "Bay", "Facility", "in", "San", "Francisco,", "California.", "<tag2>", "Changes", "to", "these", "laws,", "regulations", "and", "judicial", "decisions", "are", "subject", "to", "influences", "outside", "of", "our", "control", "and", "may", "negatively", "affect", "our", "business,", "including", "our", "ability", "to", "obtain", "meaningful", "patent", "coverage", "or", "enforcement", "rights", "to", "any", "of", "our", "issued", "patents.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2010,", "we", "relocated", "all", "of", "our", "operations", "previously", "located", "in", "San", "Carlos,", "California,", "including", "our", "corporate", "headquarters,", "to", "our", "Mission", "Bay", "Facility", "in", "San", "Francisco,", "California."], "wordsB": ["Changes", "to", "these", "laws,", "regulations", "and", "judicial", "decisions", "are", "subject", "to", "influences", "outside", "of", "our", "control", "and", "may", "negatively", "affect", "our", "business,", "including", "our", "ability", "to", "obtain", "meaningful", "patent", "coverage", "or", "enforcement", "rights", "to", "any", "of", "our", "issued", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p26_s2", "idA": "906709_11_item1a_p4_s0", "sentA": "During the year ended December 31, 2010, we relocated all of our operations previously located in San Carlos, California, including our corporate headquarters, to our Mission Bay Facility in San Francisco, California.", "sentB": "If our subcontractors do not dedicate adequate resources to our programs, we risk breach of our obligations to our partners.", "type": 1, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2010,", "we", "relocated", "all", "of", "our", "operations", "previously", "located", "in", "San", "Carlos,", "California,", "including", "our", "corporate", "headquarters,", "to", "our", "Mission", "Bay", "Facility", "in", "San", "Francisco,", "California.", "<tag2>", "If", "our", "subcontractors", "do", "not", "dedicate", "adequate", "resources", "to", "our", "programs,", "we", "risk", "breach", "of", "our", "obligations", "to", "our", "partners.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2010,", "we", "relocated", "all", "of", "our", "operations", "previously", "located", "in", "San", "Carlos,", "California,", "including", "our", "corporate", "headquarters,", "to", "our", "Mission", "Bay", "Facility", "in", "San", "Francisco,", "California."], "wordsB": ["If", "our", "subcontractors", "do", "not", "dedicate", "adequate", "resources", "to", "our", "programs,", "we", "risk", "breach", "of", "our", "obligations", "to", "our", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p1_s3", "idA": "906709_11_item1a_p4_s1", "sentA": "This event triggered an impairment test to be performed for the remaining assets located in San Carlos and an impairment charge of $12.6 million was recognized as a result.", "sentB": "Consequently, you should not consider this section to be a complete discussion of all potential risks or uncertainties that may substantially impact our business.", "type": 1, "words": ["<tag1>", "This", "event", "triggered", "an", "impairment", "test", "to", "be", "performed", "for", "the", "remaining", "assets", "located", "in", "San", "Carlos", "and", "an", "impairment", "charge", "of", "$12.6", "million", "was", "recognized", "as", "a", "result.", "<tag2>", "Consequently,", "you", "should", "not", "consider", "this", "section", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "substantially", "impact", "our", "business.", "<tag3>"], "wordsA": ["This", "event", "triggered", "an", "impairment", "test", "to", "be", "performed", "for", "the", "remaining", "assets", "located", "in", "San", "Carlos", "and", "an", "impairment", "charge", "of", "$12.6", "million", "was", "recognized", "as", "a", "result."], "wordsB": ["Consequently,", "you", "should", "not", "consider", "this", "section", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "substantially", "impact", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p10_s0", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "If we are unable to establish and maintain collaboration partnerships on attractive commercial terms, our business, results of operations and financial condition could suffer.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "If", "we", "are", "unable", "to", "establish", "and", "maintain", "collaboration", "partnerships", "on", "attractive", "commercial", "terms,", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "could", "suffer.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["If", "we", "are", "unable", "to", "establish", "and", "maintain", "collaboration", "partnerships", "on", "attractive", "commercial", "terms,", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "could", "suffer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p13_s1", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "If the market size for a new drug is significantly smaller than we anticipate, it could significantly and negatively impact our revenue, results of operations and financial condition.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "If", "the", "market", "size", "for", "a", "new", "drug", "is", "significantly", "smaller", "than", "we", "anticipate,", "it", "could", "significantly", "and", "negatively", "impact", "our", "revenue,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["If", "the", "market", "size", "for", "a", "new", "drug", "is", "significantly", "smaller", "than", "we", "anticipate,", "it", "could", "significantly", "and", "negatively", "impact", "our", "revenue,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p15_s0", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "We are a party to numerous collaboration agreements and other significant agreements which contain complex commercial terms that could result in disputes, litigation or indemnification liability that could adversely affect our business, results of operations and financial condition.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "We", "are", "a", "party", "to", "numerous", "collaboration", "agreements", "and", "other", "significant", "agreements", "which", "contain", "complex", "commercial", "terms", "that", "could", "result", "in", "disputes,", "litigation", "or", "indemnification", "liability", "that", "could", "adversely", "affect", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["We", "are", "a", "party", "to", "numerous", "collaboration", "agreements", "and", "other", "significant", "agreements", "which", "contain", "complex", "commercial", "terms", "that", "could", "result", "in", "disputes,", "litigation", "or", "indemnification", "liability", "that", "could", "adversely", "affect", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p25_s3", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "Such failures could significantly and materially delay clinical trials and regulatory submissions or result in reduced sales, any of which could significantly harm our business prospects, results of operations and financial condition.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "Such", "failures", "could", "significantly", "and", "materially", "delay", "clinical", "trials", "and", "regulatory", "submissions", "or", "result", "in", "reduced", "sales,", "any", "of", "which", "could", "significantly", "harm", "our", "business", "prospects,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["Such", "failures", "could", "significantly", "and", "materially", "delay", "clinical", "trials", "and", "regulatory", "submissions", "or", "result", "in", "reduced", "sales,", "any", "of", "which", "could", "significantly", "harm", "our", "business", "prospects,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p35_s4", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "If our collaborations fail, our product development or commercialization of product candidates could be delayed or cancelled, which would negatively impact our business, results of operations and financial condition.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "If", "our", "collaborations", "fail,", "our", "product", "development", "or", "commercialization", "of", "product", "candidates", "could", "be", "delayed", "or", "cancelled,", "which", "would", "negatively", "impact", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["If", "our", "collaborations", "fail,", "our", "product", "development", "or", "commercialization", "of", "product", "candidates", "could", "be", "delayed", "or", "cancelled,", "which", "would", "negatively", "impact", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p37_s1", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "If we, or our partners through our collaborations, are not successful in recruiting sales and marketing personnel or in building a sales and marketing infrastructure, we will have difficulty commercializing our products, which would adversely affect our business, results of operations and financial condition.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "If", "we,", "or", "our", "partners", "through", "our", "collaborations,", "are", "not", "successful", "in", "recruiting", "sales", "and", "marketing", "personnel", "or", "in", "building", "a", "sales", "and", "marketing", "infrastructure,", "we", "will", "have", "difficulty", "commercializing", "our", "products,", "which", "would", "adversely", "affect", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["If", "we,", "or", "our", "partners", "through", "our", "collaborations,", "are", "not", "successful", "in", "recruiting", "sales", "and", "marketing", "personnel", "or", "in", "building", "a", "sales", "and", "marketing", "infrastructure,", "we", "will", "have", "difficulty", "commercializing", "our", "products,", "which", "would", "adversely", "affect", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p38_s0", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "We rely on trade secret protection and other unpatented proprietary rights for important proprietary technologies, and any loss of such rights could harm our business, results of operations and financial condition.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p38_s4", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "Any loss of trade secret protection or other unpatented proprietary rights could harm our business, results of operations and financial condition.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "Any", "loss", "of", "trade", "secret", "protection", "or", "other", "unpatented", "proprietary", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["Any", "loss", "of", "trade", "secret", "protection", "or", "other", "unpatented", "proprietary", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p42_s2", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "Several other chemical, biotechnology and pharmaceutical companies may also be developing PEGylation technologies or technologies that have similar impact on target drug molecules.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "Several", "other", "chemical,", "biotechnology", "and", "pharmaceutical", "companies", "may", "also", "be", "developing", "PEGylation", "technologies", "or", "technologies", "that", "have", "similar", "impact", "on", "target", "drug", "molecules.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["Several", "other", "chemical,", "biotechnology", "and", "pharmaceutical", "companies", "may", "also", "be", "developing", "PEGylation", "technologies", "or", "technologies", "that", "have", "similar", "impact", "on", "target", "drug", "molecules."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s7", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "The failure to obtain timely regulatory approval of product candidates, any product marketing limitations or a product withdrawal would negatively impact our business, results of operations and financial condition.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "The", "failure", "to", "obtain", "timely", "regulatory", "approval", "of", "product", "candidates,", "any", "product", "marketing", "limitations", "or", "a", "product", "withdrawal", "would", "negatively", "impact", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["The", "failure", "to", "obtain", "timely", "regulatory", "approval", "of", "product", "candidates,", "any", "product", "marketing", "limitations", "or", "a", "product", "withdrawal", "would", "negatively", "impact", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s16", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "Our collaborative partners may also be subject to catastrophic events, such as hurricanes and tornadoes, any of which could harm our business, results of operations and financial condition.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "Our", "collaborative", "partners", "may", "also", "be", "subject", "to", "catastrophic", "events,", "such", "as", "hurricanes", "and", "tornadoes,", "any", "of", "which", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["Our", "collaborative", "partners", "may", "also", "be", "subject", "to", "catastrophic", "events,", "such", "as", "hurricanes", "and", "tornadoes,", "any", "of", "which", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p7_s3", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "Due to an ongoing supply shortage of Doxil , we do not expect to complete full enrollment of this study.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "Due", "to", "an", "ongoing", "supply", "shortage", "of", "Doxil", ",", "we", "do", "not", "expect", "to", "complete", "full", "enrollment", "of", "this", "study.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["Due", "to", "an", "ongoing", "supply", "shortage", "of", "Doxil", ",", "we", "do", "not", "expect", "to", "complete", "full", "enrollment", "of", "this", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p8_s2", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "Therefore we do not expect the FDA to accept or approve an accelerated NDA based on this Phase 2 clinical study.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "Therefore", "we", "do", "not", "expect", "the", "FDA", "to", "accept", "or", "approve", "an", "accelerated", "NDA", "based", "on", "this", "Phase", "2", "clinical", "study.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["Therefore", "we", "do", "not", "expect", "the", "FDA", "to", "accept", "or", "approve", "an", "accelerated", "NDA", "based", "on", "this", "Phase", "2", "clinical", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p9_s0", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "If the clinical studies for NKTR-102 ovarian cancer are not successful, it could significantly harm our business, results of operations and financial condition.", "type": 1, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "If", "the", "clinical", "studies", "for", "NKTR-102", "ovarian", "cancer", "are", "not", "successful,", "it", "could", "significantly", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["If", "the", "clinical", "studies", "for", "NKTR-102", "ovarian", "cancer", "are", "not", "successful,", "it", "could", "significantly", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p11_s0", "idA": "906709_11_item1a_p51_s1", "sentA": "FASB ASU No. 2010-17 provides guidance on defining a milestone and determining when it may be appropriate to apply the milestone method of revenue recognition for research and development transactions.", "sentB": "approval processes, the definitive agreement negotiation process and numerous other unpredictable factors that can delay, impede or prevent significant transactions.", "type": 1, "words": ["<tag1>", "FASB", "ASU", "No.", "2010-17", "provides", "guidance", "on", "defining", "a", "milestone", "and", "determining", "when", "it", "may", "be", "appropriate", "to", "apply", "the", "milestone", "method", "of", "revenue", "recognition", "for", "research", "and", "development", "transactions.", "<tag2>", "approval", "processes,", "the", "definitive", "agreement", "negotiation", "process", "and", "numerous", "other", "unpredictable", "factors", "that", "can", "delay,", "impede", "or", "prevent", "significant", "transactions.", "<tag3>"], "wordsA": ["FASB", "ASU", "No.", "2010-17", "provides", "guidance", "on", "defining", "a", "milestone", "and", "determining", "when", "it", "may", "be", "appropriate", "to", "apply", "the", "milestone", "method", "of", "revenue", "recognition", "for", "research", "and", "development", "transactions."], "wordsB": ["approval", "processes,", "the", "definitive", "agreement", "negotiation", "process", "and", "numerous", "other", "unpredictable", "factors", "that", "can", "delay,", "impede", "or", "prevent", "significant", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p9_s4", "idA": "906709_11_item1a_p51_s1", "sentA": "FASB ASU No. 2010-17 provides guidance on defining a milestone and determining when it may be appropriate to apply the milestone method of revenue recognition for research and development transactions.", "sentB": "In the future, an alternative chemistry technique, process or method of administration, or combination thereof, may be discovered to enable the conversion of NKTR-181 into a more abusable opioid which could significantly and negatively impact the potential of NKTR-181.", "type": 1, "words": ["<tag1>", "FASB", "ASU", "No.", "2010-17", "provides", "guidance", "on", "defining", "a", "milestone", "and", "determining", "when", "it", "may", "be", "appropriate", "to", "apply", "the", "milestone", "method", "of", "revenue", "recognition", "for", "research", "and", "development", "transactions.", "<tag2>", "In", "the", "future,", "an", "alternative", "chemistry", "technique,", "process", "or", "method", "of", "administration,", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181.", "<tag3>"], "wordsA": ["FASB", "ASU", "No.", "2010-17", "provides", "guidance", "on", "defining", "a", "milestone", "and", "determining", "when", "it", "may", "be", "appropriate", "to", "apply", "the", "milestone", "method", "of", "revenue", "recognition", "for", "research", "and", "development", "transactions."], "wordsB": ["In", "the", "future,", "an", "alternative", "chemistry", "technique,", "process", "or", "method", "of", "administration,", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p18_s2", "idA": "906709_11_item1a_p5_s2", "sentA": "We determined the carrying value of the manufacturing equipment exceeded the fair value based on a discounted cash flow model.", "sentB": "The third party often bases its assertions on a claim that its patents cover our technology platform or drug candidates or that we have misappropriated its confidential or proprietary information.", "type": 1, "words": ["<tag1>", "We", "determined", "the", "carrying", "value", "of", "the", "manufacturing", "equipment", "exceeded", "the", "fair", "value", "based", "on", "a", "discounted", "cash", "flow", "model.", "<tag2>", "The", "third", "party", "often", "bases", "its", "assertions", "on", "a", "claim", "that", "its", "patents", "cover", "our", "technology", "platform", "or", "drug", "candidates", "or", "that", "we", "have", "misappropriated", "its", "confidential", "or", "proprietary", "information.", "<tag3>"], "wordsA": ["We", "determined", "the", "carrying", "value", "of", "the", "manufacturing", "equipment", "exceeded", "the", "fair", "value", "based", "on", "a", "discounted", "cash", "flow", "model."], "wordsB": ["The", "third", "party", "often", "bases", "its", "assertions", "on", "a", "claim", "that", "its", "patents", "cover", "our", "technology", "platform", "or", "drug", "candidates", "or", "that", "we", "have", "misappropriated", "its", "confidential", "or", "proprietary", "information."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p47_s0", "idA": "906709_11_item1a_p6_s1", "sentA": "The gain on sale of pulmonary assets includes the purchase price received from Novartis less the net book value of property and equipment of $37.3 million, an equity investment in Pearl Therapeutics, Inc. of $2.7 million, transaction costs of $4.6 million, and other costs of $0.9 million.", "sentB": "agents to potentially treat colorectal cancer, including, but not limited to, products in development from Bristol-Myers Squibb Company, Pfizer, Inc., GlaxoSmithKline plc, Antigenics, Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Cell Therapeutics, Inc., Neopharm Inc., Meditech Research Ltd, Alchemia Limited, Enzon Pharmaceuticals, Inc. and others.", "type": 1, "words": ["<tag1>", "The", "gain", "on", "sale", "of", "pulmonary", "assets", "includes", "the", "purchase", "price", "received", "from", "Novartis", "less", "the", "net", "book", "value", "of", "property", "and", "equipment", "of", "$37.3", "million,", "an", "equity", "investment", "in", "Pearl", "Therapeutics,", "Inc.", "of", "$2.7", "million,", "transaction", "costs", "of", "$4.6", "million,", "and", "other", "costs", "of", "$0.9", "million.", "<tag2>", "agents", "to", "potentially", "treat", "colorectal", "cancer,", "including,", "but", "not", "limited", "to,", "products", "in", "development", "from", "Bristol-Myers", "Squibb", "Company,", "Pfizer,", "Inc.,", "GlaxoSmithKline", "plc,", "Antigenics,", "Inc.,", "F.", "Hoffmann-La", "Roche", "Ltd,", "Novartis", "AG,", "Cell", "Therapeutics,", "Inc.,", "Neopharm", "Inc.,", "Meditech", "Research", "Ltd,", "Alchemia", "Limited,", "Enzon", "Pharmaceuticals,", "Inc.", "and", "others.", "<tag3>"], "wordsA": ["The", "gain", "on", "sale", "of", "pulmonary", "assets", "includes", "the", "purchase", "price", "received", "from", "Novartis", "less", "the", "net", "book", "value", "of", "property", "and", "equipment", "of", "$37.3", "million,", "an", "equity", "investment", "in", "Pearl", "Therapeutics,", "Inc.", "of", "$2.7", "million,", "transaction", "costs", "of", "$4.6", "million,", "and", "other", "costs", "of", "$0.9", "million."], "wordsB": ["agents", "to", "potentially", "treat", "colorectal", "cancer,", "including,", "but", "not", "limited", "to,", "products", "in", "development", "from", "Bristol-Myers", "Squibb", "Company,", "Pfizer,", "Inc.,", "GlaxoSmithKline", "plc,", "Antigenics,", "Inc.,", "F.", "Hoffmann-La", "Roche", "Ltd,", "Novartis", "AG,", "Cell", "Therapeutics,", "Inc.,", "Neopharm", "Inc.,", "Meditech", "Research", "Ltd,", "Alchemia", "Limited,", "Enzon", "Pharmaceuticals,", "Inc.", "and", "others."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p8_s1", "idA": "906709_11_item1a_p8_s0", "sentA": "The decrease in interest expense during the year ended December 31, 2010 compared to the year ended December 31, 2009 is primarily attributable to the complete amortization of deferred financing costs during 2010 from our 3.25% convertible subordinated notes due September 2012 and decreased interest expense from capital leases.", "sentB": "As a result, acceptance for review or approval of an accelerated NDA submitted to the FDA based on overall response rate from our single-arm Phase 2 study in platinum-resistant/refractory ovarian cancer would be unusual and is highly unlikely.", "type": 1, "words": ["<tag1>", "The", "decrease", "in", "interest", "expense", "during", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "from", "our", "3.25%", "convertible", "subordinated", "notes", "due", "September", "2012", "and", "decreased", "interest", "expense", "from", "capital", "leases.", "<tag2>", "As", "a", "result,", "acceptance", "for", "review", "or", "approval", "of", "an", "accelerated", "NDA", "submitted", "to", "the", "FDA", "based", "on", "overall", "response", "rate", "from", "our", "single-arm", "Phase", "2", "study", "in", "platinum-resistant/refractory", "ovarian", "cancer", "would", "be", "unusual", "and", "is", "highly", "unlikely.", "<tag3>"], "wordsA": ["The", "decrease", "in", "interest", "expense", "during", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "from", "our", "3.25%", "convertible", "subordinated", "notes", "due", "September", "2012", "and", "decreased", "interest", "expense", "from", "capital", "leases."], "wordsB": ["As", "a", "result,", "acceptance", "for", "review", "or", "approval", "of", "an", "accelerated", "NDA", "submitted", "to", "the", "FDA", "based", "on", "overall", "response", "rate", "from", "our", "single-arm", "Phase", "2", "study", "in", "platinum-resistant/refractory", "ovarian", "cancer", "would", "be", "unusual", "and", "is", "highly", "unlikely."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p12_s4", "idA": "906709_11_item1a_p9_s0", "sentA": "We repurchased $100.0 million par value of our 3.25% convertible subordinated notes in the fourth quarter of 2008.", "sentB": "Material adverse changes in the final data could significantly harm our business prospects.", "type": 1, "words": ["<tag1>", "We", "repurchased", "$100.0", "million", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "in", "the", "fourth", "quarter", "of", "2008.", "<tag2>", "Material", "adverse", "changes", "in", "the", "final", "data", "could", "significantly", "harm", "our", "business", "prospects.", "<tag3>"], "wordsA": ["We", "repurchased", "$100.0", "million", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "in", "the", "fourth", "quarter", "of", "2008."], "wordsB": ["Material", "adverse", "changes", "in", "the", "final", "data", "could", "significantly", "harm", "our", "business", "prospects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p1_s0", "idA": "906709_11_item1a_p9_s0", "sentA": "We repurchased $100.0 million par value of our 3.25% convertible subordinated notes in the fourth quarter of 2008.", "sentB": "These are factors that, individually or in the aggregate, we think could cause our actual results to differ materially from expected and historical results and our forward-looking statements.", "type": 1, "words": ["<tag1>", "We", "repurchased", "$100.0", "million", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "in", "the", "fourth", "quarter", "of", "2008.", "<tag2>", "These", "are", "factors", "that,", "individually", "or", "in", "the", "aggregate,", "we", "think", "could", "cause", "our", "actual", "results", "to", "differ", "materially", "from", "expected", "and", "historical", "results", "and", "our", "forward-looking", "statements.", "<tag3>"], "wordsA": ["We", "repurchased", "$100.0", "million", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "in", "the", "fourth", "quarter", "of", "2008."], "wordsB": ["These", "are", "factors", "that,", "individually", "or", "in", "the", "aggregate,", "we", "think", "could", "cause", "our", "actual", "results", "to", "differ", "materially", "from", "expected", "and", "historical", "results", "and", "our", "forward-looking", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s16", "idA": "906709_11_item1a_p9_s0", "sentA": "We repurchased $100.0 million par value of our 3.25% convertible subordinated notes in the fourth quarter of 2008.", "sentB": "In addition, a financing could result in the issuance of new securities that may have rights, preferences or privileges senior to those of our existing stockholders.", "type": 1, "words": ["<tag1>", "We", "repurchased", "$100.0", "million", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "in", "the", "fourth", "quarter", "of", "2008.", "<tag2>", "In", "addition,", "a", "financing", "could", "result", "in", "the", "issuance", "of", "new", "securities", "that", "may", "have", "rights,", "preferences", "or", "privileges", "senior", "to", "those", "of", "our", "existing", "stockholders.", "<tag3>"], "wordsA": ["We", "repurchased", "$100.0", "million", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "in", "the", "fourth", "quarter", "of", "2008."], "wordsB": ["In", "addition,", "a", "financing", "could", "result", "in", "the", "issuance", "of", "new", "securities", "that", "may", "have", "rights,", "preferences", "or", "privileges", "senior", "to", "those", "of", "our", "existing", "stockholders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p51_s2", "idA": "906709_11_item1a_p9_s0", "sentA": "We repurchased $100.0 million par value of our 3.25% convertible subordinated notes in the fourth quarter of 2008.", "sentB": "These provisions may also discourage, delay or prevent a third party from acquiring a large portion of our securities or initiating a tender offer or proxy contest, even if our stockholders might receive a premium for their shares in the acquisition over the then current market prices.", "type": 1, "words": ["<tag1>", "We", "repurchased", "$100.0", "million", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "in", "the", "fourth", "quarter", "of", "2008.", "<tag2>", "These", "provisions", "may", "also", "discourage,", "delay", "or", "prevent", "a", "third", "party", "from", "acquiring", "a", "large", "portion", "of", "our", "securities", "or", "initiating", "a", "tender", "offer", "or", "proxy", "contest,", "even", "if", "our", "stockholders", "might", "receive", "a", "premium", "for", "their", "shares", "in", "the", "acquisition", "over", "the", "then", "current", "market", "prices.", "<tag3>"], "wordsA": ["We", "repurchased", "$100.0", "million", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "in", "the", "fourth", "quarter", "of", "2008."], "wordsB": ["These", "provisions", "may", "also", "discourage,", "delay", "or", "prevent", "a", "third", "party", "from", "acquiring", "a", "large", "portion", "of", "our", "securities", "or", "initiating", "a", "tender", "offer", "or", "proxy", "contest,", "even", "if", "our", "stockholders", "might", "receive", "a", "premium", "for", "their", "shares", "in", "the", "acquisition", "over", "the", "then", "current", "market", "prices."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p17_s9", "idA": "906709_12_item1a_p14_s4", "sentA": "If we are required to enter into a license with a third party, our potential economic benefit for the products subject to the license will be diminished.", "sentB": "In addition, we are conducting a Phase 2 study for NKTR-181 that we estimate will be completed in mid-2013 and we also plan to start a human abuse liability study for NKTR-181 during the first half of 2013.", "type": 1, "words": ["<tag1>", "If", "we", "are", "required", "to", "enter", "into", "a", "license", "with", "a", "third", "party,", "our", "potential", "economic", "benefit", "for", "the", "products", "subject", "to", "the", "license", "will", "be", "diminished.", "<tag2>", "In", "addition,", "we", "are", "conducting", "a", "Phase", "2", "study", "for", "NKTR-181", "that", "we", "estimate", "will", "be", "completed", "in", "mid-2013", "and", "we", "also", "plan", "to", "start", "a", "human", "abuse", "liability", "study", "for", "NKTR-181", "during", "the", "first", "half", "of", "2013.", "<tag3>"], "wordsA": ["If", "we", "are", "required", "to", "enter", "into", "a", "license", "with", "a", "third", "party,", "our", "potential", "economic", "benefit", "for", "the", "products", "subject", "to", "the", "license", "will", "be", "diminished."], "wordsB": ["In", "addition,", "we", "are", "conducting", "a", "Phase", "2", "study", "for", "NKTR-181", "that", "we", "estimate", "will", "be", "completed", "in", "mid-2013", "and", "we", "also", "plan", "to", "start", "a", "human", "abuse", "liability", "study", "for", "NKTR-181", "during", "the", "first", "half", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p54_s0", "idA": "906709_12_item1a_p15_s1", "sentA": "We currently derive, and expect to derive in the foreseeable future, all of our revenue from collaboration agreements with biotechnology and pharmaceutical companies.", "sentB": "consummate a merger, consolidation, reorganization or business combination, or sell, assign, transfer, lease or otherwise dispose of all or substantially all of our assets.", "type": 1, "words": ["<tag1>", "We", "currently", "derive,", "and", "expect", "to", "derive", "in", "the", "foreseeable", "future,", "all", "of", "our", "revenue", "from", "collaboration", "agreements", "with", "biotechnology", "and", "pharmaceutical", "companies.", "<tag2>", "consummate", "a", "merger,", "consolidation,", "reorganization", "or", "business", "combination,", "or", "sell,", "assign,", "transfer,", "lease", "or", "otherwise", "dispose", "of", "all", "or", "substantially", "all", "of", "our", "assets.", "<tag3>"], "wordsA": ["We", "currently", "derive,", "and", "expect", "to", "derive", "in", "the", "foreseeable", "future,", "all", "of", "our", "revenue", "from", "collaboration", "agreements", "with", "biotechnology", "and", "pharmaceutical", "companies."], "wordsB": ["consummate", "a", "merger,", "consolidation,", "reorganization", "or", "business", "combination,", "or", "sell,", "assign,", "transfer,", "lease", "or", "otherwise", "dispose", "of", "all", "or", "substantially", "all", "of", "our", "assets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p22_s0", "idA": "906709_12_item1a_p21_s4", "sentA": "The coverage claimed in a patent application can be significantly reduced before the patent is issued and, as a consequence, our patent applications may result in patents with narrow coverage that may not prevent competition from similar drugs.", "sentB": "revocation of the patent or maintenance of the patent in amended form (and potentially in a form that renders the patent without commercially relevant and/or broad coverage).", "type": 1, "words": ["<tag1>", "The", "coverage", "claimed", "in", "a", "patent", "application", "can", "be", "significantly", "reduced", "before", "the", "patent", "is", "issued", "and,", "as", "a", "consequence,", "our", "patent", "applications", "may", "result", "in", "patents", "with", "narrow", "coverage", "that", "may", "not", "prevent", "competition", "from", "similar", "drugs.", "<tag2>", "revocation", "of", "the", "patent", "or", "maintenance", "of", "the", "patent", "in", "amended", "form", "(and", "potentially", "in", "a", "form", "that", "renders", "the", "patent", "without", "commercially", "relevant", "and/or", "broad", "coverage).", "<tag3>"], "wordsA": ["The", "coverage", "claimed", "in", "a", "patent", "application", "can", "be", "significantly", "reduced", "before", "the", "patent", "is", "issued", "and,", "as", "a", "consequence,", "our", "patent", "applications", "may", "result", "in", "patents", "with", "narrow", "coverage", "that", "may", "not", "prevent", "competition", "from", "similar", "drugs."], "wordsB": ["revocation", "of", "the", "patent", "or", "maintenance", "of", "the", "patent", "in", "amended", "form", "(and", "potentially", "in", "a", "form", "that", "renders", "the", "patent", "without", "commercially", "relevant", "and/or", "broad", "coverage)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p24_s1", "idA": "906709_12_item1a_p36_s0", "sentA": "If we are unable either to create sales, marketing and distribution capabilities or to enter into agreements with third parties to perform these functions, we will be unable to commercialize our products successfully.", "sentB": "In addition, there is no guarantee that we will be the first to file a patent application directed to an invention.", "type": 1, "words": ["<tag1>", "If", "we", "are", "unable", "either", "to", "create", "sales,", "marketing", "and", "distribution", "capabilities", "or", "to", "enter", "into", "agreements", "with", "third", "parties", "to", "perform", "these", "functions,", "we", "will", "be", "unable", "to", "commercialize", "our", "products", "successfully.", "<tag2>", "In", "addition,", "there", "is", "no", "guarantee", "that", "we", "will", "be", "the", "first", "to", "file", "a", "patent", "application", "directed", "to", "an", "invention.", "<tag3>"], "wordsA": ["If", "we", "are", "unable", "either", "to", "create", "sales,", "marketing", "and", "distribution", "capabilities", "or", "to", "enter", "into", "agreements", "with", "third", "parties", "to", "perform", "these", "functions,", "we", "will", "be", "unable", "to", "commercialize", "our", "products", "successfully."], "wordsB": ["In", "addition,", "there", "is", "no", "guarantee", "that", "we", "will", "be", "the", "first", "to", "file", "a", "patent", "application", "directed", "to", "an", "invention."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p54_s3", "idA": "906709_12_item1a_p37_s4", "sentA": "In the event that we market our products without a partner, we would be required to build a sales and marketing organization and infrastructure, which would require a significant investment and we may not be successful in building this organization and infrastructure in a timely or efficient manner.", "sentB": "Our ability to comply with these covenants will likely be affected by many factors, including events beyond our control, and we may not satisfy those requirements.", "type": 1, "words": ["<tag1>", "In", "the", "event", "that", "we", "market", "our", "products", "without", "a", "partner,", "we", "would", "be", "required", "to", "build", "a", "sales", "and", "marketing", "organization", "and", "infrastructure,", "which", "would", "require", "a", "significant", "investment", "and", "we", "may", "not", "be", "successful", "in", "building", "this", "organization", "and", "infrastructure", "in", "a", "timely", "or", "efficient", "manner.", "<tag2>", "Our", "ability", "to", "comply", "with", "these", "covenants", "will", "likely", "be", "affected", "by", "many", "factors,", "including", "events", "beyond", "our", "control,", "and", "we", "may", "not", "satisfy", "those", "requirements.", "<tag3>"], "wordsA": ["In", "the", "event", "that", "we", "market", "our", "products", "without", "a", "partner,", "we", "would", "be", "required", "to", "build", "a", "sales", "and", "marketing", "organization", "and", "infrastructure,", "which", "would", "require", "a", "significant", "investment", "and", "we", "may", "not", "be", "successful", "in", "building", "this", "organization", "and", "infrastructure", "in", "a", "timely", "or", "efficient", "manner."], "wordsB": ["Our", "ability", "to", "comply", "with", "these", "covenants", "will", "likely", "be", "affected", "by", "many", "factors,", "including", "events", "beyond", "our", "control,", "and", "we", "may", "not", "satisfy", "those", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p54_s1", "idA": "906709_12_item1a_p4_s16", "sentA": "In addition, a financing could result in the issuance of new securities that may have rights, preferences or privileges senior to those of our existing stockholders.", "sentB": "In addition, the indenture governing the senior secured notes contains a financial maintenance covenant requiring us to maintain a $25.0 million segregated cash reserve account until July 1, 2015 to be applied to interest payments on the notes in the event of a default, subject to certain conditions.", "type": 1, "words": ["<tag1>", "In", "addition,", "a", "financing", "could", "result", "in", "the", "issuance", "of", "new", "securities", "that", "may", "have", "rights,", "preferences", "or", "privileges", "senior", "to", "those", "of", "our", "existing", "stockholders.", "<tag2>", "In", "addition,", "the", "indenture", "governing", "the", "senior", "secured", "notes", "contains", "a", "financial", "maintenance", "covenant", "requiring", "us", "to", "maintain", "a", "$25.0", "million", "segregated", "cash", "reserve", "account", "until", "July", "1,", "2015", "to", "be", "applied", "to", "interest", "payments", "on", "the", "notes", "in", "the", "event", "of", "a", "default,", "subject", "to", "certain", "conditions.", "<tag3>"], "wordsA": ["In", "addition,", "a", "financing", "could", "result", "in", "the", "issuance", "of", "new", "securities", "that", "may", "have", "rights,", "preferences", "or", "privileges", "senior", "to", "those", "of", "our", "existing", "stockholders."], "wordsB": ["In", "addition,", "the", "indenture", "governing", "the", "senior", "secured", "notes", "contains", "a", "financial", "maintenance", "covenant", "requiring", "us", "to", "maintain", "a", "$25.0", "million", "segregated", "cash", "reserve", "account", "until", "July", "1,", "2015", "to", "be", "applied", "to", "interest", "payments", "on", "the", "notes", "in", "the", "event", "of", "a", "default,", "subject", "to", "certain", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p3_s5", "idA": "906709_12_item1a_p5_s0", "sentA": "We have substantial future capital requirements and there is a risk we may not have access to sufficient capital to meet our current business plan.", "sentB": "For example, we understand that the FDA is exploring whether there is any evidence of a potential cardiovascular class effect related to opioid withdrawal associated with mu-opioid antagonists and naloxegol is a mu-opioid antagonist.", "type": 1, "words": ["<tag1>", "We", "have", "substantial", "future", "capital", "requirements", "and", "there", "is", "a", "risk", "we", "may", "not", "have", "access", "to", "sufficient", "capital", "to", "meet", "our", "current", "business", "plan.", "<tag2>", "For", "example,", "we", "understand", "that", "the", "FDA", "is", "exploring", "whether", "there", "is", "any", "evidence", "of", "a", "potential", "cardiovascular", "class", "effect", "related", "to", "opioid", "withdrawal", "associated", "with", "mu-opioid", "antagonists", "and", "naloxegol", "is", "a", "mu-opioid", "antagonist.", "<tag3>"], "wordsA": ["We", "have", "substantial", "future", "capital", "requirements", "and", "there", "is", "a", "risk", "we", "may", "not", "have", "access", "to", "sufficient", "capital", "to", "meet", "our", "current", "business", "plan."], "wordsB": ["For", "example,", "we", "understand", "that", "the", "FDA", "is", "exploring", "whether", "there", "is", "any", "evidence", "of", "a", "potential", "cardiovascular", "class", "effect", "related", "to", "opioid", "withdrawal", "associated", "with", "mu-opioid", "antagonists", "and", "naloxegol", "is", "a", "mu-opioid", "antagonist."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p3_s6", "idA": "906709_12_item1a_p7_s0", "sentA": "The results from the expanded Phase 2 clinical study for NKTR-102 in women with platinum-resistant/refractory ovarian cancer are unlikely to result in a review or an approval of a new drug application (NDA) by the United States Food and Drug Administration (FDA), and the future results from this trial are difficult to predict.", "sentB": "Although AstraZeneca has completed comprehensive safety studies for naloxegol as part of the KODIAC development program and the results from these studies are positive, the health authorities retain significant discretion over regulatory requirements which remain very uncertain and difficult to predict prior to obtaining approval.", "type": 1, "words": ["<tag1>", "The", "results", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "are", "unlikely", "to", "result", "in", "a", "review", "or", "an", "approval", "of", "a", "new", "drug", "application", "(NDA)", "by", "the", "United", "States", "Food", "and", "Drug", "Administration", "(FDA),", "and", "the", "future", "results", "from", "this", "trial", "are", "difficult", "to", "predict.", "<tag2>", "Although", "AstraZeneca", "has", "completed", "comprehensive", "safety", "studies", "for", "naloxegol", "as", "part", "of", "the", "KODIAC", "development", "program", "and", "the", "results", "from", "these", "studies", "are", "positive,", "the", "health", "authorities", "retain", "significant", "discretion", "over", "regulatory", "requirements", "which", "remain", "very", "uncertain", "and", "difficult", "to", "predict", "prior", "to", "obtaining", "approval.", "<tag3>"], "wordsA": ["The", "results", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "are", "unlikely", "to", "result", "in", "a", "review", "or", "an", "approval", "of", "a", "new", "drug", "application", "(NDA)", "by", "the", "United", "States", "Food", "and", "Drug", "Administration", "(FDA),", "and", "the", "future", "results", "from", "this", "trial", "are", "difficult", "to", "predict."], "wordsB": ["Although", "AstraZeneca", "has", "completed", "comprehensive", "safety", "studies", "for", "naloxegol", "as", "part", "of", "the", "KODIAC", "development", "program", "and", "the", "results", "from", "these", "studies", "are", "positive,", "the", "health", "authorities", "retain", "significant", "discretion", "over", "regulatory", "requirements", "which", "remain", "very", "uncertain", "and", "difficult", "to", "predict", "prior", "to", "obtaining", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p54_s2", "idA": "906709_12_item1a_p9_s2", "sentA": "An important objective of our NKTR-181 drug development program is to create a unique opioid molecule that does not rapidly enter a patient s central nervous system and therefore has the potential to be less susceptible to abuse than alternative opioid therapies.", "sentB": "This indenture also requires us not to permit, thereafter and through the quarter ending June 30, 2017, the aggregate balance of our unrestricted cash and cash equivalents at the end of any two consecutive fiscal quarters to be less than $25.0 million, subject to certain conditions.", "type": 1, "words": ["<tag1>", "An", "important", "objective", "of", "our", "NKTR-181", "drug", "development", "program", "is", "to", "create", "a", "unique", "opioid", "molecule", "that", "does", "not", "rapidly", "enter", "a", "patient", "s", "central", "nervous", "system", "and", "therefore", "has", "the", "potential", "to", "be", "less", "susceptible", "to", "abuse", "than", "alternative", "opioid", "therapies.", "<tag2>", "This", "indenture", "also", "requires", "us", "not", "to", "permit,", "thereafter", "and", "through", "the", "quarter", "ending", "June", "30,", "2017,", "the", "aggregate", "balance", "of", "our", "unrestricted", "cash", "and", "cash", "equivalents", "at", "the", "end", "of", "any", "two", "consecutive", "fiscal", "quarters", "to", "be", "less", "than", "$25.0", "million,", "subject", "to", "certain", "conditions.", "<tag3>"], "wordsA": ["An", "important", "objective", "of", "our", "NKTR-181", "drug", "development", "program", "is", "to", "create", "a", "unique", "opioid", "molecule", "that", "does", "not", "rapidly", "enter", "a", "patient", "s", "central", "nervous", "system", "and", "therefore", "has", "the", "potential", "to", "be", "less", "susceptible", "to", "abuse", "than", "alternative", "opioid", "therapies."], "wordsB": ["This", "indenture", "also", "requires", "us", "not", "to", "permit,", "thereafter", "and", "through", "the", "quarter", "ending", "June", "30,", "2017,", "the", "aggregate", "balance", "of", "our", "unrestricted", "cash", "and", "cash", "equivalents", "at", "the", "end", "of", "any", "two", "consecutive", "fiscal", "quarters", "to", "be", "less", "than", "$25.0", "million,", "subject", "to", "certain", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p5_s2", "idA": "906709_13_item1a_p22_s3", "sentA": "We may have to participate in interference proceedings declared by the U.S. Patent and Trademark Office, which could result in a loss of the patent and/or substantial cost to us.", "sentB": "If AstraZeneca elects to terminate the agreement only with respect to its license agreement rights in the U.S. due to a pre-approval cardiovascular safety study, then such amount would be paid through a 50% reduction of non-U.S. royalty amounts otherwise payable to us until the aggregate amount of such royalty reduction equals the total principal amount of $70.0 million plus accumulated interest at 4.5% compounded annually.", "type": 1, "words": ["<tag1>", "We", "may", "have", "to", "participate", "in", "interference", "proceedings", "declared", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "which", "could", "result", "in", "a", "loss", "of", "the", "patent", "and/or", "substantial", "cost", "to", "us.", "<tag2>", "If", "AstraZeneca", "elects", "to", "terminate", "the", "agreement", "only", "with", "respect", "to", "its", "license", "agreement", "rights", "in", "the", "U.S.", "due", "to", "a", "pre-approval", "cardiovascular", "safety", "study,", "then", "such", "amount", "would", "be", "paid", "through", "a", "50%", "reduction", "of", "non-U.S.", "royalty", "amounts", "otherwise", "payable", "to", "us", "until", "the", "aggregate", "amount", "of", "such", "royalty", "reduction", "equals", "the", "total", "principal", "amount", "of", "$70.0", "million", "plus", "accumulated", "interest", "at", "4.5%", "compounded", "annually.", "<tag3>"], "wordsA": ["We", "may", "have", "to", "participate", "in", "interference", "proceedings", "declared", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "which", "could", "result", "in", "a", "loss", "of", "the", "patent", "and/or", "substantial", "cost", "to", "us."], "wordsB": ["If", "AstraZeneca", "elects", "to", "terminate", "the", "agreement", "only", "with", "respect", "to", "its", "license", "agreement", "rights", "in", "the", "U.S.", "due", "to", "a", "pre-approval", "cardiovascular", "safety", "study,", "then", "such", "amount", "would", "be", "paid", "through", "a", "50%", "reduction", "of", "non-U.S.", "royalty", "amounts", "otherwise", "payable", "to", "us", "until", "the", "aggregate", "amount", "of", "such", "royalty", "reduction", "equals", "the", "total", "principal", "amount", "of", "$70.0", "million", "plus", "accumulated", "interest", "at", "4.5%", "compounded", "annually."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p5_s4", "idA": "906709_13_item1a_p22_s3", "sentA": "We may have to participate in interference proceedings declared by the U.S. Patent and Trademark Office, which could result in a loss of the patent and/or substantial cost to us.", "sentB": "However, if the FDA requires a post-approval cardiovascular safety study as a condition to regulatory approval, then the royalty rate payable to us from net sales of naloxegol in the U.S. by AstraZeneca would be reduced by two percentage points until the aggregate amount of such royalty payment reduction is equal to a maximum of $35.0 million.", "type": 1, "words": ["<tag1>", "We", "may", "have", "to", "participate", "in", "interference", "proceedings", "declared", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "which", "could", "result", "in", "a", "loss", "of", "the", "patent", "and/or", "substantial", "cost", "to", "us.", "<tag2>", "However,", "if", "the", "FDA", "requires", "a", "post-approval", "cardiovascular", "safety", "study", "as", "a", "condition", "to", "regulatory", "approval,", "then", "the", "royalty", "rate", "payable", "to", "us", "from", "net", "sales", "of", "naloxegol", "in", "the", "U.S.", "by", "AstraZeneca", "would", "be", "reduced", "by", "two", "percentage", "points", "until", "the", "aggregate", "amount", "of", "such", "royalty", "payment", "reduction", "is", "equal", "to", "a", "maximum", "of", "$35.0", "million.", "<tag3>"], "wordsA": ["We", "may", "have", "to", "participate", "in", "interference", "proceedings", "declared", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "which", "could", "result", "in", "a", "loss", "of", "the", "patent", "and/or", "substantial", "cost", "to", "us."], "wordsB": ["However,", "if", "the", "FDA", "requires", "a", "post-approval", "cardiovascular", "safety", "study", "as", "a", "condition", "to", "regulatory", "approval,", "then", "the", "royalty", "rate", "payable", "to", "us", "from", "net", "sales", "of", "naloxegol", "in", "the", "U.S.", "by", "AstraZeneca", "would", "be", "reduced", "by", "two", "percentage", "points", "until", "the", "aggregate", "amount", "of", "such", "royalty", "payment", "reduction", "is", "equal", "to", "a", "maximum", "of", "$35.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p4_s2", "idA": "906709_13_item1a_p26_s1", "sentA": "SUNY has filed an action in the United States District Court for the Northern District of New York.", "sentB": "The FDA is currently planning to hold an advisory committee meeting for the purposes of reviewing the cardiovascular safety study requirements for peripheral mu-opioid receptor antagonists including naloxegol.", "type": 1, "words": ["<tag1>", "SUNY", "has", "filed", "an", "action", "in", "the", "United", "States", "District", "Court", "for", "the", "Northern", "District", "of", "New", "York.", "<tag2>", "The", "FDA", "is", "currently", "planning", "to", "hold", "an", "advisory", "committee", "meeting", "for", "the", "purposes", "of", "reviewing", "the", "cardiovascular", "safety", "study", "requirements", "for", "peripheral", "mu-opioid", "receptor", "antagonists", "including", "naloxegol.", "<tag3>"], "wordsA": ["SUNY", "has", "filed", "an", "action", "in", "the", "United", "States", "District", "Court", "for", "the", "Northern", "District", "of", "New", "York."], "wordsB": ["The", "FDA", "is", "currently", "planning", "to", "hold", "an", "advisory", "committee", "meeting", "for", "the", "purposes", "of", "reviewing", "the", "cardiovascular", "safety", "study", "requirements", "for", "peripheral", "mu-opioid", "receptor", "antagonists", "including", "naloxegol."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p4_s3", "idA": "906709_13_item1a_p2_s6", "sentA": "Typically, there is a high rate of attrition for drug candidates in preclinical and clinical trials due to scientific feasibility, safety, efficacy, changing standards of medical care and other variables.", "sentB": "The advisory committee meeting, which had been originally scheduled for March 10-11, 2014, is being rescheduled due to scheduling conflicts.", "type": 1, "words": ["<tag1>", "Typically,", "there", "is", "a", "high", "rate", "of", "attrition", "for", "drug", "candidates", "in", "preclinical", "and", "clinical", "trials", "due", "to", "scientific", "feasibility,", "safety,", "efficacy,", "changing", "standards", "of", "medical", "care", "and", "other", "variables.", "<tag2>", "The", "advisory", "committee", "meeting,", "which", "had", "been", "originally", "scheduled", "for", "March", "10-11,", "2014,", "is", "being", "rescheduled", "due", "to", "scheduling", "conflicts.", "<tag3>"], "wordsA": ["Typically,", "there", "is", "a", "high", "rate", "of", "attrition", "for", "drug", "candidates", "in", "preclinical", "and", "clinical", "trials", "due", "to", "scientific", "feasibility,", "safety,", "efficacy,", "changing", "standards", "of", "medical", "care", "and", "other", "variables."], "wordsB": ["The", "advisory", "committee", "meeting,", "which", "had", "been", "originally", "scheduled", "for", "March", "10-11,", "2014,", "is", "being", "rescheduled", "due", "to", "scheduling", "conflicts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p7_s2", "idA": "906709_13_item1a_p43_s1", "sentA": "Some of these companies license or provide the technology to other companies, while others are developing the technology for internal use.", "sentB": "Each of these agreements contains complex representations and warranties, covenants and indemnification obligations.", "type": 1, "words": ["<tag1>", "Some", "of", "these", "companies", "license", "or", "provide", "the", "technology", "to", "other", "companies,", "while", "others", "are", "developing", "the", "technology", "for", "internal", "use.", "<tag2>", "Each", "of", "these", "agreements", "contains", "complex", "representations", "and", "warranties,", "covenants", "and", "indemnification", "obligations.", "<tag3>"], "wordsA": ["Some", "of", "these", "companies", "license", "or", "provide", "the", "technology", "to", "other", "companies,", "while", "others", "are", "developing", "the", "technology", "for", "internal", "use."], "wordsB": ["Each", "of", "these", "agreements", "contains", "complex", "representations", "and", "warranties,", "covenants", "and", "indemnification", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p46_s2", "idA": "906709_13_item1a_p46_s1", "sentA": "Major pharmaceutical or biotechnology companies with approved drugs or drugs in development for these cancers include, but are not limited to, Bristol-Meyers Squibb, Eli Lilly Co., Roche, GlaxoSmithKline plc, Johnson and Johnson, Pfizer, Inc.and Sanofi Aventis.", "sentB": "Eisai, Inc., and Sanofi Aventis S.A.", "type": 1, "words": ["<tag1>", "Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc.and", "Sanofi", "Aventis.", "<tag2>", "Eisai,", "Inc.,", "and", "Sanofi", "Aventis", "S.A.", "<tag3>"], "wordsA": ["Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc.and", "Sanofi", "Aventis."], "wordsB": ["Eisai,", "Inc.,", "and", "Sanofi", "Aventis", "S.A."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p14_s1", "idA": "906709_14_item1a_p11_s3", "sentA": "In the future, an alternative chemistry technique, process or method of administration, or combination thereof, may be discovered to enable the conversion of NKTR-181 into a more abusable opioid, which could significantly and negatively impact the potential of NKTR-181.", "sentB": "For example, AstraZeneca will be conducting a post-marketing, observational epidemiological study comparing MOVANTIK TM to other treatments of OIC in patients with chronic, non-cancer pain and the results of this study could at some point in the future negatively impact the labeling, regulatory status, and commercial potential of MOVANTIK TM .", "type": 1, "words": ["<tag1>", "In", "the", "future,", "an", "alternative", "chemistry", "technique,", "process", "or", "method", "of", "administration,", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid,", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181.", "<tag2>", "For", "example,", "AstraZeneca", "will", "be", "conducting", "a", "post-marketing,", "observational", "epidemiological", "study", "comparing", "MOVANTIK", "TM", "to", "other", "treatments", "of", "OIC", "in", "patients", "with", "chronic,", "non-cancer", "pain", "and", "the", "results", "of", "this", "study", "could", "at", "some", "point", "in", "the", "future", "negatively", "impact", "the", "labeling,", "regulatory", "status,", "and", "commercial", "potential", "of", "MOVANTIK", "TM", ".", "<tag3>"], "wordsA": ["In", "the", "future,", "an", "alternative", "chemistry", "technique,", "process", "or", "method", "of", "administration,", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid,", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181."], "wordsB": ["For", "example,", "AstraZeneca", "will", "be", "conducting", "a", "post-marketing,", "observational", "epidemiological", "study", "comparing", "MOVANTIK", "TM", "to", "other", "treatments", "of", "OIC", "in", "patients", "with", "chronic,", "non-cancer", "pain", "and", "the", "results", "of", "this", "study", "could", "at", "some", "point", "in", "the", "future", "negatively", "impact", "the", "labeling,", "regulatory", "status,", "and", "commercial", "potential", "of", "MOVANTIK", "TM", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p53_s0", "idA": "906709_14_item1a_p43_s0", "sentA": "Our PEGylation and advanced polymer conjugate chemistry platforms and our partnered and proprietary products and product candidates compete with various pharmaceutical and biotechnology companies.", "sentB": "The stock prices of biotechnology companies and securities markets generally have been subject to dramatic price swings in recent years.", "type": 1, "words": ["<tag1>", "Our", "PEGylation", "and", "advanced", "polymer", "conjugate", "chemistry", "platforms", "and", "our", "partnered", "and", "proprietary", "products", "and", "product", "candidates", "compete", "with", "various", "pharmaceutical", "and", "biotechnology", "companies.", "<tag2>", "The", "stock", "prices", "of", "biotechnology", "companies", "and", "securities", "markets", "generally", "have", "been", "subject", "to", "dramatic", "price", "swings", "in", "recent", "years.", "<tag3>"], "wordsA": ["Our", "PEGylation", "and", "advanced", "polymer", "conjugate", "chemistry", "platforms", "and", "our", "partnered", "and", "proprietary", "products", "and", "product", "candidates", "compete", "with", "various", "pharmaceutical", "and", "biotechnology", "companies."], "wordsB": ["The", "stock", "prices", "of", "biotechnology", "companies", "and", "securities", "markets", "generally", "have", "been", "subject", "to", "dramatic", "price", "swings", "in", "recent", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p29_s4", "idA": "906709_14_item1a_p49_s13", "sentA": "The loss of one or more members of our management team or other key employees could seriously harm our business, operating results and financial condition.", "sentB": "The cost to us in initiating or defending any litigation or other proceeding, even if resolved in our favor, could be substantial, and litigation would divert our management s attention.", "type": 1, "words": ["<tag1>", "The", "loss", "of", "one", "or", "more", "members", "of", "our", "management", "team", "or", "other", "key", "employees", "could", "seriously", "harm", "our", "business,", "operating", "results", "and", "financial", "condition.", "<tag2>", "The", "cost", "to", "us", "in", "initiating", "or", "defending", "any", "litigation", "or", "other", "proceeding,", "even", "if", "resolved", "in", "our", "favor,", "could", "be", "substantial,", "and", "litigation", "would", "divert", "our", "management", "s", "attention.", "<tag3>"], "wordsA": ["The", "loss", "of", "one", "or", "more", "members", "of", "our", "management", "team", "or", "other", "key", "employees", "could", "seriously", "harm", "our", "business,", "operating", "results", "and", "financial", "condition."], "wordsB": ["The", "cost", "to", "us", "in", "initiating", "or", "defending", "any", "litigation", "or", "other", "proceeding,", "even", "if", "resolved", "in", "our", "favor,", "could", "be", "substantial,", "and", "litigation", "would", "divert", "our", "management", "s", "attention."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p29_s1", "idA": "906709_14_item1a_p52_s4", "sentA": "The price of our common stock is expected to remain volatile.", "sentB": "The subject matter of our patent filings in this proceeding relates to Bayer s investigational PEGylated recombinant Factor VIII compound.", "type": 1, "words": ["<tag1>", "The", "price", "of", "our", "common", "stock", "is", "expected", "to", "remain", "volatile.", "<tag2>", "The", "subject", "matter", "of", "our", "patent", "filings", "in", "this", "proceeding", "relates", "to", "Bayer", "s", "investigational", "PEGylated", "recombinant", "Factor", "VIII", "compound.", "<tag3>"], "wordsA": ["The", "price", "of", "our", "common", "stock", "is", "expected", "to", "remain", "volatile."], "wordsB": ["The", "subject", "matter", "of", "our", "patent", "filings", "in", "this", "proceeding", "relates", "to", "Bayer", "s", "investigational", "PEGylated", "recombinant", "Factor", "VIII", "compound."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p29_s2", "idA": "906709_14_item1a_p7_s0", "sentA": "indemnity obligations for intellectual property infringement, product liability and certain other claims.", "sentB": "We believe that Bayer s claim to an ownership interest in these patent filings is without merit and are vigorously defending sole and exclusive ownership rights to this intellectual property.", "type": 1, "words": ["<tag1>", "indemnity", "obligations", "for", "intellectual", "property", "infringement,", "product", "liability", "and", "certain", "other", "claims.", "<tag2>", "We", "believe", "that", "Bayer", "s", "claim", "to", "an", "ownership", "interest", "in", "these", "patent", "filings", "is", "without", "merit", "and", "are", "vigorously", "defending", "sole", "and", "exclusive", "ownership", "rights", "to", "this", "intellectual", "property.", "<tag3>"], "wordsA": ["indemnity", "obligations", "for", "intellectual", "property", "infringement,", "product", "liability", "and", "certain", "other", "claims."], "wordsB": ["We", "believe", "that", "Bayer", "s", "claim", "to", "an", "ownership", "interest", "in", "these", "patent", "filings", "is", "without", "merit", "and", "are", "vigorously", "defending", "sole", "and", "exclusive", "ownership", "rights", "to", "this", "intellectual", "property."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p30_s5", "idA": "906709_15_item1a_p14_s1", "sentA": "For example, AstraZeneca will be conducting a post-marketing, observational epidemiological study comparing MOVANTIK TM to other treatments of OIC in patients with chronic, non-cancer pain and the results of this study could at some point in the future negatively impact the labeling, regulatory status, and commercial potential of MOVANTIK TM .", "sentB": "The filing is directed to one of six Orange Book listed patents covering MOVANTIK TM .", "type": 1, "words": ["<tag1>", "For", "example,", "AstraZeneca", "will", "be", "conducting", "a", "post-marketing,", "observational", "epidemiological", "study", "comparing", "MOVANTIK", "TM", "to", "other", "treatments", "of", "OIC", "in", "patients", "with", "chronic,", "non-cancer", "pain", "and", "the", "results", "of", "this", "study", "could", "at", "some", "point", "in", "the", "future", "negatively", "impact", "the", "labeling,", "regulatory", "status,", "and", "commercial", "potential", "of", "MOVANTIK", "TM", ".", "<tag2>", "The", "filing", "is", "directed", "to", "one", "of", "six", "Orange", "Book", "listed", "patents", "covering", "MOVANTIK", "TM", ".", "<tag3>"], "wordsA": ["For", "example,", "AstraZeneca", "will", "be", "conducting", "a", "post-marketing,", "observational", "epidemiological", "study", "comparing", "MOVANTIK", "TM", "to", "other", "treatments", "of", "OIC", "in", "patients", "with", "chronic,", "non-cancer", "pain", "and", "the", "results", "of", "this", "study", "could", "at", "some", "point", "in", "the", "future", "negatively", "impact", "the", "labeling,", "regulatory", "status,", "and", "commercial", "potential", "of", "MOVANTIK", "TM", "."], "wordsB": ["The", "filing", "is", "directed", "to", "one", "of", "six", "Orange", "Book", "listed", "patents", "covering", "MOVANTIK", "TM", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p14_s3", "idA": "906709_15_item1a_p15_s1", "sentA": "Our partnered drugs that have obtained regulatory approval, and the manufacturing processes for these products, are subject to continued review and periodic inspections by the FDA and other regulatory authorities.", "sentB": "For example, while data from certain pre-specified subgroups in the BEACON study was positive, the study did not achieve statistical significance for its primary endpoint and the FDA and European Medicines Agency rarely approve drugs on the basis of studies that do not achieve statistical significance on the primary endpoint.", "type": 1, "words": ["<tag1>", "Our", "partnered", "drugs", "that", "have", "obtained", "regulatory", "approval,", "and", "the", "manufacturing", "processes", "for", "these", "products,", "are", "subject", "to", "continued", "review", "and", "periodic", "inspections", "by", "the", "FDA", "and", "other", "regulatory", "authorities.", "<tag2>", "For", "example,", "while", "data", "from", "certain", "pre-specified", "subgroups", "in", "the", "BEACON", "study", "was", "positive,", "the", "study", "did", "not", "achieve", "statistical", "significance", "for", "its", "primary", "endpoint", "and", "the", "FDA", "and", "European", "Medicines", "Agency", "rarely", "approve", "drugs", "on", "the", "basis", "of", "studies", "that", "do", "not", "achieve", "statistical", "significance", "on", "the", "primary", "endpoint.", "<tag3>"], "wordsA": ["Our", "partnered", "drugs", "that", "have", "obtained", "regulatory", "approval,", "and", "the", "manufacturing", "processes", "for", "these", "products,", "are", "subject", "to", "continued", "review", "and", "periodic", "inspections", "by", "the", "FDA", "and", "other", "regulatory", "authorities."], "wordsB": ["For", "example,", "while", "data", "from", "certain", "pre-specified", "subgroups", "in", "the", "BEACON", "study", "was", "positive,", "the", "study", "did", "not", "achieve", "statistical", "significance", "for", "its", "primary", "endpoint", "and", "the", "FDA", "and", "European", "Medicines", "Agency", "rarely", "approve", "drugs", "on", "the", "basis", "of", "studies", "that", "do", "not", "achieve", "statistical", "significance", "on", "the", "primary", "endpoint."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p49_s2", "idA": "906709_15_item1a_p19_s4", "sentA": "Material adverse changes in the final data could significantly harm our business prospects.", "sentB": "Potential competitors in the TIL and CAR-T space include Kite Pharma/NCI, Adaptimmune LLC, Celgene Corporation, Juno Therapeutics, and Novartis, Alkermes, Altor, and Armo in the cytokine-based therapies space, and Tesaro, Macrogenics, Merck, BMS, and Roche in the checkpoint inhibitor space.", "type": 1, "words": ["<tag1>", "Material", "adverse", "changes", "in", "the", "final", "data", "could", "significantly", "harm", "our", "business", "prospects.", "<tag2>", "Potential", "competitors", "in", "the", "TIL", "and", "CAR-T", "space", "include", "Kite", "Pharma/NCI,", "Adaptimmune", "LLC,", "Celgene", "Corporation,", "Juno", "Therapeutics,", "and", "Novartis,", "Alkermes,", "Altor,", "and", "Armo", "in", "the", "cytokine-based", "therapies", "space,", "and", "Tesaro,", "Macrogenics,", "Merck,", "BMS,", "and", "Roche", "in", "the", "checkpoint", "inhibitor", "space.", "<tag3>"], "wordsA": ["Material", "adverse", "changes", "in", "the", "final", "data", "could", "significantly", "harm", "our", "business", "prospects."], "wordsB": ["Potential", "competitors", "in", "the", "TIL", "and", "CAR-T", "space", "include", "Kite", "Pharma/NCI,", "Adaptimmune", "LLC,", "Celgene", "Corporation,", "Juno", "Therapeutics,", "and", "Novartis,", "Alkermes,", "Altor,", "and", "Armo", "in", "the", "cytokine-based", "therapies", "space,", "and", "Tesaro,", "Macrogenics,", "Merck,", "BMS,", "and", "Roche", "in", "the", "checkpoint", "inhibitor", "space."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p47_s2", "idA": "906709_15_item1a_p20_s2", "sentA": "We currently have ongoing Phase 3 studies for etirinotecan pegol in patients with metastatic breast cancer and NKTR-181 in patients with chronic lower back pain.", "sentB": "For ADYNOVATE TM , on June 6, 2014, the FDA approved Biogen Idec s ELOCTATE for the control and prevention of bleeding episodes, perioperative (surgical) management and routine prophylaxis in adults and children with Hemophilia A, and Bayer Healthcare and Novo Nordisk have ongoing Phase 3 clinical development programs for longer acting Factor VIII proteins based on pegylation technology approaches.", "type": 1, "words": ["<tag1>", "We", "currently", "have", "ongoing", "Phase", "3", "studies", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "breast", "cancer", "and", "NKTR-181", "in", "patients", "with", "chronic", "lower", "back", "pain.", "<tag2>", "For", "ADYNOVATE", "TM", ",", "on", "June", "6,", "2014,", "the", "FDA", "approved", "Biogen", "Idec", "s", "ELOCTATE", "for", "the", "control", "and", "prevention", "of", "bleeding", "episodes,", "perioperative", "(surgical)", "management", "and", "routine", "prophylaxis", "in", "adults", "and", "children", "with", "Hemophilia", "A,", "and", "Bayer", "Healthcare", "and", "Novo", "Nordisk", "have", "ongoing", "Phase", "3", "clinical", "development", "programs", "for", "longer", "acting", "Factor", "VIII", "proteins", "based", "on", "pegylation", "technology", "approaches.", "<tag3>"], "wordsA": ["We", "currently", "have", "ongoing", "Phase", "3", "studies", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "breast", "cancer", "and", "NKTR-181", "in", "patients", "with", "chronic", "lower", "back", "pain."], "wordsB": ["For", "ADYNOVATE", "TM", ",", "on", "June", "6,", "2014,", "the", "FDA", "approved", "Biogen", "Idec", "s", "ELOCTATE", "for", "the", "control", "and", "prevention", "of", "bleeding", "episodes,", "perioperative", "(surgical)", "management", "and", "routine", "prophylaxis", "in", "adults", "and", "children", "with", "Hemophilia", "A,", "and", "Bayer", "Healthcare", "and", "Novo", "Nordisk", "have", "ongoing", "Phase", "3", "clinical", "development", "programs", "for", "longer", "acting", "Factor", "VIII", "proteins", "based", "on", "pegylation", "technology", "approaches."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p7_s1", "idA": "906709_15_item1a_p20_s3", "sentA": "In addition, our collaboration partners have several ongoing Phase 3 clinical programs including Baxter for BAX 855, Bayer for Amikacin Inhale and CIPRO Inhale, and Ophthotech for Fovista .", "sentB": "Additionally, there are also several important drugs in later stage development with collaboration partners including Amikacin Inhale, Cipro DPI, and Fovista .", "type": 1, "words": ["<tag1>", "In", "addition,", "our", "collaboration", "partners", "have", "several", "ongoing", "Phase", "3", "clinical", "programs", "including", "Baxter", "for", "BAX", "855,", "Bayer", "for", "Amikacin", "Inhale", "and", "CIPRO", "Inhale,", "and", "Ophthotech", "for", "Fovista", ".", "<tag2>", "Additionally,", "there", "are", "also", "several", "important", "drugs", "in", "later", "stage", "development", "with", "collaboration", "partners", "including", "Amikacin", "Inhale,", "Cipro", "DPI,", "and", "Fovista", ".", "<tag3>"], "wordsA": ["In", "addition,", "our", "collaboration", "partners", "have", "several", "ongoing", "Phase", "3", "clinical", "programs", "including", "Baxter", "for", "BAX", "855,", "Bayer", "for", "Amikacin", "Inhale", "and", "CIPRO", "Inhale,", "and", "Ophthotech", "for", "Fovista", "."], "wordsB": ["Additionally,", "there", "are", "also", "several", "important", "drugs", "in", "later", "stage", "development", "with", "collaboration", "partners", "including", "Amikacin", "Inhale,", "Cipro", "DPI,", "and", "Fovista", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p3_s1", "idA": "906709_15_item1a_p2_s13", "sentA": "Phase 3 clinical study outcomes remain very unpredictable and it is possible that one or more of these Phase 3 clinical studies could fail at any time due to efficacy, safety or other important clinical findings or regulatory requirements.", "sentB": "We, the FDA, IRB, an independent ethics committee, or other applicable regulatory authorities may suspend clinical trials of a product candidate at any time for various reasons, including a belief that subjects participating in such trials are being exposed to unacceptable health risks or adverse side effects.", "type": 1, "words": ["<tag1>", "Phase", "3", "clinical", "study", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "these", "Phase", "3", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements.", "<tag2>", "We,", "the", "FDA,", "IRB,", "an", "independent", "ethics", "committee,", "or", "other", "applicable", "regulatory", "authorities", "may", "suspend", "clinical", "trials", "of", "a", "product", "candidate", "at", "any", "time", "for", "various", "reasons,", "including", "a", "belief", "that", "subjects", "participating", "in", "such", "trials", "are", "being", "exposed", "to", "unacceptable", "health", "risks", "or", "adverse", "side", "effects.", "<tag3>"], "wordsA": ["Phase", "3", "clinical", "study", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "these", "Phase", "3", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements."], "wordsB": ["We,", "the", "FDA,", "IRB,", "an", "independent", "ethics", "committee,", "or", "other", "applicable", "regulatory", "authorities", "may", "suspend", "clinical", "trials", "of", "a", "product", "candidate", "at", "any", "time", "for", "various", "reasons,", "including", "a", "belief", "that", "subjects", "participating", "in", "such", "trials", "are", "being", "exposed", "to", "unacceptable", "health", "risks", "or", "adverse", "side", "effects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p3_s2", "idA": "906709_15_item1a_p2_s4", "sentA": "The start or end of a clinical study is often delayed or halted due to changing regulatory requirements, manufacturing challenges, required clinical trial administrative actions, slower than anticipated patient enrollment, changing standards of care, availability or prevalence of use of a comparator drug or required prior therapy, clinical outcomes, or our and our partners financial constraints.", "sentB": "Similarly, an IRB or ethics committee may suspend a clinical trial at a particular trial site.", "type": 1, "words": ["<tag1>", "The", "start", "or", "end", "of", "a", "clinical", "study", "is", "often", "delayed", "or", "halted", "due", "to", "changing", "regulatory", "requirements,", "manufacturing", "challenges,", "required", "clinical", "trial", "administrative", "actions,", "slower", "than", "anticipated", "patient", "enrollment,", "changing", "standards", "of", "care,", "availability", "or", "prevalence", "of", "use", "of", "a", "comparator", "drug", "or", "required", "prior", "therapy,", "clinical", "outcomes,", "or", "our", "and", "our", "partners", "financial", "constraints.", "<tag2>", "Similarly,", "an", "IRB", "or", "ethics", "committee", "may", "suspend", "a", "clinical", "trial", "at", "a", "particular", "trial", "site.", "<tag3>"], "wordsA": ["The", "start", "or", "end", "of", "a", "clinical", "study", "is", "often", "delayed", "or", "halted", "due", "to", "changing", "regulatory", "requirements,", "manufacturing", "challenges,", "required", "clinical", "trial", "administrative", "actions,", "slower", "than", "anticipated", "patient", "enrollment,", "changing", "standards", "of", "care,", "availability", "or", "prevalence", "of", "use", "of", "a", "comparator", "drug", "or", "required", "prior", "therapy,", "clinical", "outcomes,", "or", "our", "and", "our", "partners", "financial", "constraints."], "wordsB": ["Similarly,", "an", "IRB", "or", "ethics", "committee", "may", "suspend", "a", "clinical", "trial", "at", "a", "particular", "trial", "site."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p61_s0", "idA": "906709_15_item1a_p37_s5", "sentA": "We purchase some of the starting material for drugs and drug candidates from a single source or a limited number of suppliers, and the partial or complete loss of one of these suppliers could cause production delays, clinical trial delays, substantial loss of revenue and contract liability to third parties.", "sentB": "The indenture specifies a number of events of default, some of which are subject to applicable grace or cure periods, including, among other things, non-payment defaults, covenant defaults, cross-defaults to other material indebtedness, bankruptcy and insolvency defaults, non-payment of material judgments, loss of any material business license, criminal indictment of the Company, and certain civil forfeiture proceedings involving material assets of the Company.", "type": 1, "words": ["<tag1>", "We", "purchase", "some", "of", "the", "starting", "material", "for", "drugs", "and", "drug", "candidates", "from", "a", "single", "source", "or", "a", "limited", "number", "of", "suppliers,", "and", "the", "partial", "or", "complete", "loss", "of", "one", "of", "these", "suppliers", "could", "cause", "production", "delays,", "clinical", "trial", "delays,", "substantial", "loss", "of", "revenue", "and", "contract", "liability", "to", "third", "parties.", "<tag2>", "The", "indenture", "specifies", "a", "number", "of", "events", "of", "default,", "some", "of", "which", "are", "subject", "to", "applicable", "grace", "or", "cure", "periods,", "including,", "among", "other", "things,", "non-payment", "defaults,", "covenant", "defaults,", "cross-defaults", "to", "other", "material", "indebtedness,", "bankruptcy", "and", "insolvency", "defaults,", "non-payment", "of", "material", "judgments,", "loss", "of", "any", "material", "business", "license,", "criminal", "indictment", "of", "the", "Company,", "and", "certain", "civil", "forfeiture", "proceedings", "involving", "material", "assets", "of", "the", "Company.", "<tag3>"], "wordsA": ["We", "purchase", "some", "of", "the", "starting", "material", "for", "drugs", "and", "drug", "candidates", "from", "a", "single", "source", "or", "a", "limited", "number", "of", "suppliers,", "and", "the", "partial", "or", "complete", "loss", "of", "one", "of", "these", "suppliers", "could", "cause", "production", "delays,", "clinical", "trial", "delays,", "substantial", "loss", "of", "revenue", "and", "contract", "liability", "to", "third", "parties."], "wordsB": ["The", "indenture", "specifies", "a", "number", "of", "events", "of", "default,", "some", "of", "which", "are", "subject", "to", "applicable", "grace", "or", "cure", "periods,", "including,", "among", "other", "things,", "non-payment", "defaults,", "covenant", "defaults,", "cross-defaults", "to", "other", "material", "indebtedness,", "bankruptcy", "and", "insolvency", "defaults,", "non-payment", "of", "material", "judgments,", "loss", "of", "any", "material", "business", "license,", "criminal", "indictment", "of", "the", "Company,", "and", "certain", "civil", "forfeiture", "proceedings", "involving", "material", "assets", "of", "the", "Company."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p49_s0", "idA": "906709_15_item1a_p43_s0", "sentA": "There are several competitors for our proprietary product candidates currently in development.", "sentB": "There are numerous companies engaged in developing immunotherapies to be used alone, or in combination, to treat a wide range of oncology indications targeting both solid and liquid tumors.", "type": 1, "words": ["<tag1>", "There", "are", "several", "competitors", "for", "our", "proprietary", "product", "candidates", "currently", "in", "development.", "<tag2>", "There", "are", "numerous", "companies", "engaged", "in", "developing", "immunotherapies", "to", "be", "used", "alone,", "or", "in", "combination,", "to", "treat", "a", "wide", "range", "of", "oncology", "indications", "targeting", "both", "solid", "and", "liquid", "tumors.", "<tag3>"], "wordsA": ["There", "are", "several", "competitors", "for", "our", "proprietary", "product", "candidates", "currently", "in", "development."], "wordsB": ["There", "are", "numerous", "companies", "engaged", "in", "developing", "immunotherapies", "to", "be", "used", "alone,", "or", "in", "combination,", "to", "treat", "a", "wide", "range", "of", "oncology", "indications", "targeting", "both", "solid", "and", "liquid", "tumors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p48_s0", "idA": "906709_15_item1a_p45_s0", "sentA": "In addition, there are a number of companies developing potential products which are in various stages of clinical development and are being evaluated for the treatment of OIC and OBD in different patient populations, including Cubist Pharmaceuticals, Inc., Progenics Pharmaceuticals, Inc. in collaboration with Salix Pharmaceuticals, Ltd., Mundipharma Int.", "sentB": "For NKTR-181, there are numerous companies developing pain therapies designed to have less abuse potential primarily through formulation technologies and techniques applied to existing pain therapies.", "type": 1, "words": ["<tag1>", "In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Cubist", "Pharmaceuticals,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int.", "<tag2>", "For", "NKTR-181,", "there", "are", "numerous", "companies", "developing", "pain", "therapies", "designed", "to", "have", "less", "abuse", "potential", "primarily", "through", "formulation", "technologies", "and", "techniques", "applied", "to", "existing", "pain", "therapies.", "<tag3>"], "wordsA": ["In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Cubist", "Pharmaceuticals,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int."], "wordsB": ["For", "NKTR-181,", "there", "are", "numerous", "companies", "developing", "pain", "therapies", "designed", "to", "have", "less", "abuse", "potential", "primarily", "through", "formulation", "technologies", "and", "techniques", "applied", "to", "existing", "pain", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p60_s0", "idA": "906709_15_item1a_p55_s4", "sentA": "Our failure to comply with our debt-related obligations could result in an event of default under our other indebtedness and the acceleration of our other indebtedness, in whole or in part, could result in an event of default under the indenture governing the senior secured notes.", "sentB": "We have certain reporting obligations under the indenture regarding cash position and royalty revenue.", "type": 1, "words": ["<tag1>", "Our", "failure", "to", "comply", "with", "our", "debt-related", "obligations", "could", "result", "in", "an", "event", "of", "default", "under", "our", "other", "indebtedness", "and", "the", "acceleration", "of", "our", "other", "indebtedness,", "in", "whole", "or", "in", "part,", "could", "result", "in", "an", "event", "of", "default", "under", "the", "indenture", "governing", "the", "senior", "secured", "notes.", "<tag2>", "We", "have", "certain", "reporting", "obligations", "under", "the", "indenture", "regarding", "cash", "position", "and", "royalty", "revenue.", "<tag3>"], "wordsA": ["Our", "failure", "to", "comply", "with", "our", "debt-related", "obligations", "could", "result", "in", "an", "event", "of", "default", "under", "our", "other", "indebtedness", "and", "the", "acceleration", "of", "our", "other", "indebtedness,", "in", "whole", "or", "in", "part,", "could", "result", "in", "an", "event", "of", "default", "under", "the", "indenture", "governing", "the", "senior", "secured", "notes."], "wordsB": ["We", "have", "certain", "reporting", "obligations", "under", "the", "indenture", "regarding", "cash", "position", "and", "royalty", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p49_s1", "idA": "906709_15_item1a_p6_s1", "sentA": "Given these risks, the success of our current and future collaboration partnerships is highly unpredictable and can have a substantial negative or positive impact on our business in particular, we expect the commercial outcomes of MOVANTIK , and if approved, BAX 855, to have a particularly significant impact on our near to mid- term financial results and financial condition.", "sentB": "In particular, we expect to compete with therapies with tumor infiltrating lymphocytes, or TILS, chimeric antigen receptor-expressing T cells, or CAR-T, cytokine-based therapies, and checkpoint inhibitors.", "type": 1, "words": ["<tag1>", "Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", ",", "and", "if", "approved,", "BAX", "855,", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition.", "<tag2>", "In", "particular,", "we", "expect", "to", "compete", "with", "therapies", "with", "tumor", "infiltrating", "lymphocytes,", "or", "TILS,", "chimeric", "antigen", "receptor-expressing", "T", "cells,", "or", "CAR-T,", "cytokine-based", "therapies,", "and", "checkpoint", "inhibitors.", "<tag3>"], "wordsA": ["Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", ",", "and", "if", "approved,", "BAX", "855,", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition."], "wordsB": ["In", "particular,", "we", "expect", "to", "compete", "with", "therapies", "with", "tumor", "infiltrating", "lymphocytes,", "or", "TILS,", "chimeric", "antigen", "receptor-expressing", "T", "cells,", "or", "CAR-T,", "cytokine-based", "therapies,", "and", "checkpoint", "inhibitors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p12_s0", "idA": "906709_16_item1a_p29_s5", "sentA": "In December 2013, we entered into a litigation settlement with the Research Foundation of the State University of New York (SUNY) pursuant to which we agreed to pay $12.0 million and certain other terms and conditions in exchange for the full release of certain breach of contract claims by SUNY.", "sentB": "On August 14, 2015, Enzon, Inc. filed a breach of contract claim for alleged unpaid licensing fees.", "type": 1, "words": ["<tag1>", "In", "December", "2013,", "we", "entered", "into", "a", "litigation", "settlement", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "agreed", "to", "pay", "$12.0", "million", "and", "certain", "other", "terms", "and", "conditions", "in", "exchange", "for", "the", "full", "release", "of", "certain", "breach", "of", "contract", "claims", "by", "SUNY.", "<tag2>", "On", "August", "14,", "2015,", "Enzon,", "Inc.", "filed", "a", "breach", "of", "contract", "claim", "for", "alleged", "unpaid", "licensing", "fees.", "<tag3>"], "wordsA": ["In", "December", "2013,", "we", "entered", "into", "a", "litigation", "settlement", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "agreed", "to", "pay", "$12.0", "million", "and", "certain", "other", "terms", "and", "conditions", "in", "exchange", "for", "the", "full", "release", "of", "certain", "breach", "of", "contract", "claims", "by", "SUNY."], "wordsB": ["On", "August", "14,", "2015,", "Enzon,", "Inc.", "filed", "a", "breach", "of", "contract", "claim", "for", "alleged", "unpaid", "licensing", "fees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p21_s9", "idA": "906709_16_item1a_p36_s10", "sentA": "Factors that may inhibit our efforts to commercialize our products directly or indirectly with our partners include:", "sentB": "We also have ongoing trials with our partners for the following: Halozyme has trials in Pancreatic, Non-Small Cell Lung Cancer and other multiple tumor types in Phase 1, 2, and 3 development.", "type": 1, "words": ["<tag1>", "Factors", "that", "may", "inhibit", "our", "efforts", "to", "commercialize", "our", "products", "directly", "or", "indirectly", "with", "our", "partners", "include:", "<tag2>", "We", "also", "have", "ongoing", "trials", "with", "our", "partners", "for", "the", "following:", "Halozyme", "has", "trials", "in", "Pancreatic,", "Non-Small", "Cell", "Lung", "Cancer", "and", "other", "multiple", "tumor", "types", "in", "Phase", "1,", "2,", "and", "3", "development.", "<tag3>"], "wordsA": ["Factors", "that", "may", "inhibit", "our", "efforts", "to", "commercialize", "our", "products", "directly", "or", "indirectly", "with", "our", "partners", "include:"], "wordsB": ["We", "also", "have", "ongoing", "trials", "with", "our", "partners", "for", "the", "following:", "Halozyme", "has", "trials", "in", "Pancreatic,", "Non-Small", "Cell", "Lung", "Cancer", "and", "other", "multiple", "tumor", "types", "in", "Phase", "1,", "2,", "and", "3", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p14_s1", "idA": "906709_17_item1a_p13_s0", "sentA": "In 2013, we settled a breach of contract litigation matter with the Research Foundation of the State University of New York (SUNY) pursuant to which we paid an aggregate of $12.0 million.", "sentB": "On June 26, 2017, we entered into a Second Amendment to our Cross-License and Option Agreement ( Cross-License Agreement ) with Enzon in which we agreed to pay Enzon a sum of $7.0 million to satisfy all past and future obligations of royalty payments pursuant to the Cross-License Agreement and to have the Enzon Litigation dismissed.", "type": 1, "words": ["<tag1>", "In", "2013,", "we", "settled", "a", "breach", "of", "contract", "litigation", "matter", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "paid", "an", "aggregate", "of", "$12.0", "million.", "<tag2>", "On", "June", "26,", "2017,", "we", "entered", "into", "a", "Second", "Amendment", "to", "our", "Cross-License", "and", "Option", "Agreement", "(", "Cross-License", "Agreement", ")", "with", "Enzon", "in", "which", "we", "agreed", "to", "pay", "Enzon", "a", "sum", "of", "$7.0", "million", "to", "satisfy", "all", "past", "and", "future", "obligations", "of", "royalty", "payments", "pursuant", "to", "the", "Cross-License", "Agreement", "and", "to", "have", "the", "Enzon", "Litigation", "dismissed.", "<tag3>"], "wordsA": ["In", "2013,", "we", "settled", "a", "breach", "of", "contract", "litigation", "matter", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "paid", "an", "aggregate", "of", "$12.0", "million."], "wordsB": ["On", "June", "26,", "2017,", "we", "entered", "into", "a", "Second", "Amendment", "to", "our", "Cross-License", "and", "Option", "Agreement", "(", "Cross-License", "Agreement", ")", "with", "Enzon", "in", "which", "we", "agreed", "to", "pay", "Enzon", "a", "sum", "of", "$7.0", "million", "to", "satisfy", "all", "past", "and", "future", "obligations", "of", "royalty", "payments", "pursuant", "to", "the", "Cross-License", "Agreement", "and", "to", "have", "the", "Enzon", "Litigation", "dismissed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p53_s5", "idA": "906709_17_item1a_p15_s1", "sentA": "Our partnered drugs that have obtained regulatory approval, and the manufacturing processes for these products, are subject to continued review and periodic inspections by the FDA and other regulatory authorities.", "sentB": "In addition, in recent years, Congress has enacted various laws seeking to reduce the federal debt level and contain healthcare expenditures, and the Medicare and other healthcare programs are frequently identified as potential targets for spending cuts.", "type": 1, "words": ["<tag1>", "Our", "partnered", "drugs", "that", "have", "obtained", "regulatory", "approval,", "and", "the", "manufacturing", "processes", "for", "these", "products,", "are", "subject", "to", "continued", "review", "and", "periodic", "inspections", "by", "the", "FDA", "and", "other", "regulatory", "authorities.", "<tag2>", "In", "addition,", "in", "recent", "years,", "Congress", "has", "enacted", "various", "laws", "seeking", "to", "reduce", "the", "federal", "debt", "level", "and", "contain", "healthcare", "expenditures,", "and", "the", "Medicare", "and", "other", "healthcare", "programs", "are", "frequently", "identified", "as", "potential", "targets", "for", "spending", "cuts.", "<tag3>"], "wordsA": ["Our", "partnered", "drugs", "that", "have", "obtained", "regulatory", "approval,", "and", "the", "manufacturing", "processes", "for", "these", "products,", "are", "subject", "to", "continued", "review", "and", "periodic", "inspections", "by", "the", "FDA", "and", "other", "regulatory", "authorities."], "wordsB": ["In", "addition,", "in", "recent", "years,", "Congress", "has", "enacted", "various", "laws", "seeking", "to", "reduce", "the", "federal", "debt", "level", "and", "contain", "healthcare", "expenditures,", "and", "the", "Medicare", "and", "other", "healthcare", "programs", "are", "frequently", "identified", "as", "potential", "targets", "for", "spending", "cuts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p52_s2", "idA": "906709_17_item1a_p18_s0", "sentA": "The commercial potential of a drug candidate in development is difficult to predict.", "sentB": "However, eligibility for coverage does not necessarily signify that a drug candidate will be adequately reimbursed in all cases or at a rate that covers costs related to research, development, manufacture, sale, and distribution.", "type": 1, "words": ["<tag1>", "The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict.", "<tag2>", "However,", "eligibility", "for", "coverage", "does", "not", "necessarily", "signify", "that", "a", "drug", "candidate", "will", "be", "adequately", "reimbursed", "in", "all", "cases", "or", "at", "a", "rate", "that", "covers", "costs", "related", "to", "research,", "development,", "manufacture,", "sale,", "and", "distribution.", "<tag3>"], "wordsA": ["The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict."], "wordsB": ["However,", "eligibility", "for", "coverage", "does", "not", "necessarily", "signify", "that", "a", "drug", "candidate", "will", "be", "adequately", "reimbursed", "in", "all", "cases", "or", "at", "a", "rate", "that", "covers", "costs", "related", "to", "research,", "development,", "manufacture,", "sale,", "and", "distribution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p24_s8", "idA": "906709_17_item1a_p21_s7", "sentA": "We currently have several ongoing clinical studies for NKTR-181 in patients with chronic lower back pain and initiated a Phase 1/2 clinical study for NKTR-214 in December 2015.", "sentB": "We also have an ongoing Phase 1 dose-escalation study for NKTR-358 under our collaboration with Lilly, including an on-going dose-finding trial of NKTR-358 to evaluate single-ascending doses of NKTR-358 in healthy subjects, and a multiple-ascending dose trial expected to be initiated in the first half of 2018 to evaluate NKTR-358 in patients with systemic lupus erythematosus.", "type": 1, "words": ["<tag1>", "We", "currently", "have", "several", "ongoing", "clinical", "studies", "for", "NKTR-181", "in", "patients", "with", "chronic", "lower", "back", "pain", "and", "initiated", "a", "Phase", "1/2", "clinical", "study", "for", "NKTR-214", "in", "December", "2015.", "<tag2>", "We", "also", "have", "an", "ongoing", "Phase", "1", "dose-escalation", "study", "for", "NKTR-358", "under", "our", "collaboration", "with", "Lilly,", "including", "an", "on-going", "dose-finding", "trial", "of", "NKTR-358", "to", "evaluate", "single-ascending", "doses", "of", "NKTR-358", "in", "healthy", "subjects,", "and", "a", "multiple-ascending", "dose", "trial", "expected", "to", "be", "initiated", "in", "the", "first", "half", "of", "2018", "to", "evaluate", "NKTR-358", "in", "patients", "with", "systemic", "lupus", "erythematosus.", "<tag3>"], "wordsA": ["We", "currently", "have", "several", "ongoing", "clinical", "studies", "for", "NKTR-181", "in", "patients", "with", "chronic", "lower", "back", "pain", "and", "initiated", "a", "Phase", "1/2", "clinical", "study", "for", "NKTR-214", "in", "December", "2015."], "wordsB": ["We", "also", "have", "an", "ongoing", "Phase", "1", "dose-escalation", "study", "for", "NKTR-358", "under", "our", "collaboration", "with", "Lilly,", "including", "an", "on-going", "dose-finding", "trial", "of", "NKTR-358", "to", "evaluate", "single-ascending", "doses", "of", "NKTR-358", "in", "healthy", "subjects,", "and", "a", "multiple-ascending", "dose", "trial", "expected", "to", "be", "initiated", "in", "the", "first", "half", "of", "2018", "to", "evaluate", "NKTR-358", "in", "patients", "with", "systemic", "lupus", "erythematosus."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p35_s1", "idA": "906709_17_item1a_p26_s4", "sentA": "Additionally, issued patents can be subject to opposition or other proceedings that can result in the revocation of the patent or maintenance of the patent in amended form (and potentially in a form that renders the patent without commercially relevant and/or broad coverage).", "sentB": "Although we do not currently have any products on the market, once we begin commercializing our drug candidates, we will be subject to additional healthcare statutory and regulatory requirements and enforcement by the federal and state governments of the jurisdictions in which we conduct our business.", "type": 1, "words": ["<tag1>", "Additionally,", "issued", "patents", "can", "be", "subject", "to", "opposition", "or", "other", "proceedings", "that", "can", "result", "in", "the", "revocation", "of", "the", "patent", "or", "maintenance", "of", "the", "patent", "in", "amended", "form", "(and", "potentially", "in", "a", "form", "that", "renders", "the", "patent", "without", "commercially", "relevant", "and/or", "broad", "coverage).", "<tag2>", "Although", "we", "do", "not", "currently", "have", "any", "products", "on", "the", "market,", "once", "we", "begin", "commercializing", "our", "drug", "candidates,", "we", "will", "be", "subject", "to", "additional", "healthcare", "statutory", "and", "regulatory", "requirements", "and", "enforcement", "by", "the", "federal", "and", "state", "governments", "of", "the", "jurisdictions", "in", "which", "we", "conduct", "our", "business.", "<tag3>"], "wordsA": ["Additionally,", "issued", "patents", "can", "be", "subject", "to", "opposition", "or", "other", "proceedings", "that", "can", "result", "in", "the", "revocation", "of", "the", "patent", "or", "maintenance", "of", "the", "patent", "in", "amended", "form", "(and", "potentially", "in", "a", "form", "that", "renders", "the", "patent", "without", "commercially", "relevant", "and/or", "broad", "coverage)."], "wordsB": ["Although", "we", "do", "not", "currently", "have", "any", "products", "on", "the", "market,", "once", "we", "begin", "commercializing", "our", "drug", "candidates,", "we", "will", "be", "subject", "to", "additional", "healthcare", "statutory", "and", "regulatory", "requirements", "and", "enforcement", "by", "the", "federal", "and", "state", "governments", "of", "the", "jurisdictions", "in", "which", "we", "conduct", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p24_s7", "idA": "906709_17_item1a_p2_s1", "sentA": "We have a number of proprietary drug candidates and partnered drug candidates in research and development ranging from the early discovery research phase through preclinical testing and clinical trials.", "sentB": "We have ongoing trials evaluating NKTR-214 including a trial evaluating NKTR-214 as a potential combination treatment with BMS s Opdivo (nivolumab) as well as other ongoing and planned combination trials.", "type": 1, "words": ["<tag1>", "We", "have", "a", "number", "of", "proprietary", "drug", "candidates", "and", "partnered", "drug", "candidates", "in", "research", "and", "development", "ranging", "from", "the", "early", "discovery", "research", "phase", "through", "preclinical", "testing", "and", "clinical", "trials.", "<tag2>", "We", "have", "ongoing", "trials", "evaluating", "NKTR-214", "including", "a", "trial", "evaluating", "NKTR-214", "as", "a", "potential", "combination", "treatment", "with", "BMS", "s", "Opdivo", "(nivolumab)", "as", "well", "as", "other", "ongoing", "and", "planned", "combination", "trials.", "<tag3>"], "wordsA": ["We", "have", "a", "number", "of", "proprietary", "drug", "candidates", "and", "partnered", "drug", "candidates", "in", "research", "and", "development", "ranging", "from", "the", "early", "discovery", "research", "phase", "through", "preclinical", "testing", "and", "clinical", "trials."], "wordsB": ["We", "have", "ongoing", "trials", "evaluating", "NKTR-214", "including", "a", "trial", "evaluating", "NKTR-214", "as", "a", "potential", "combination", "treatment", "with", "BMS", "s", "Opdivo", "(nivolumab)", "as", "well", "as", "other", "ongoing", "and", "planned", "combination", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p38_s2", "idA": "906709_17_item1a_p2_s10", "sentA": "The risk of clinical failure for any drug candidate remains high prior to regulatory approval.", "sentB": "Although effective compliance programs can mitigate the risk of investigation and prosecution for violations of these laws, these risks cannot be entirely eliminated.", "type": 1, "words": ["<tag1>", "The", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval.", "<tag2>", "Although", "effective", "compliance", "programs", "can", "mitigate", "the", "risk", "of", "investigation", "and", "prosecution", "for", "violations", "of", "these", "laws,", "these", "risks", "cannot", "be", "entirely", "eliminated.", "<tag3>"], "wordsA": ["The", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval."], "wordsB": ["Although", "effective", "compliance", "programs", "can", "mitigate", "the", "risk", "of", "investigation", "and", "prosecution", "for", "violations", "of", "these", "laws,", "these", "risks", "cannot", "be", "entirely", "eliminated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p2_s5", "idA": "906709_17_item1a_p2_s12", "sentA": "Clinical study outcomes remain very unpredictable and it is possible that one or more of our clinical studies could fail at any time due to efficacy, safety or other important clinical findings or regulatory requirements.", "sentB": "Failures in NKTR-214 studies could jeopardize such milestone payments.", "type": 1, "words": ["<tag1>", "Clinical", "study", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "our", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements.", "<tag2>", "Failures", "in", "NKTR-214", "studies", "could", "jeopardize", "such", "milestone", "payments.", "<tag3>"], "wordsA": ["Clinical", "study", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "our", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements."], "wordsB": ["Failures", "in", "NKTR-214", "studies", "could", "jeopardize", "such", "milestone", "payments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p2_s0", "idA": "906709_17_item1a_p2_s7", "sentA": "The risk of failure increases for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to ONZEALD TM , NKTR-181, NKTR-214 and other drug candidates currently in discovery research or preclinical development.", "sentB": "In general, most early stage investigatory drugs, including oncology drug candidates such as NKTR-214, do not become approved drugs.", "type": 1, "words": ["<tag1>", "The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "ONZEALD", "TM", ",", "NKTR-181,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag2>", "In", "general,", "most", "early", "stage", "investigatory", "drugs,", "including", "oncology", "drug", "candidates", "such", "as", "NKTR-214,", "do", "not", "become", "approved", "drugs.", "<tag3>"], "wordsA": ["The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "ONZEALD", "TM", ",", "NKTR-181,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "wordsB": ["In", "general,", "most", "early", "stage", "investigatory", "drugs,", "including", "oncology", "drug", "candidates", "such", "as", "NKTR-214,", "do", "not", "become", "approved", "drugs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p16_s4", "idA": "906709_17_item1a_p2_s8", "sentA": "For example, while we believe our NKTR-181 Phase 3 clinical program employs the most appropriate clinical trial design, we were unable to identify a single cause for the Phase 2 study for NKTR-181 not meeting its primary efficacy endpoint, and therefore there is increased risk in effectively designing a Phase 3 clinical program for NKTR-181.", "sentB": "Further, while the results from the Phase 3 study of NKTR-181 were positive, NKTR-181 has Fast Track designation and we intend to file an NDA following our pre-NDA meetings with FDA, the regulatory pathway for NKTR-181 remains subject to substantial uncertainty including the amount of data required to support an approval of NKTR-181.", "type": 1, "words": ["<tag1>", "For", "example,", "while", "we", "believe", "our", "NKTR-181", "Phase", "3", "clinical", "program", "employs", "the", "most", "appropriate", "clinical", "trial", "design,", "we", "were", "unable", "to", "identify", "a", "single", "cause", "for", "the", "Phase", "2", "study", "for", "NKTR-181", "not", "meeting", "its", "primary", "efficacy", "endpoint,", "and", "therefore", "there", "is", "increased", "risk", "in", "effectively", "designing", "a", "Phase", "3", "clinical", "program", "for", "NKTR-181.", "<tag2>", "Further,", "while", "the", "results", "from", "the", "Phase", "3", "study", "of", "NKTR-181", "were", "positive,", "NKTR-181", "has", "Fast", "Track", "designation", "and", "we", "intend", "to", "file", "an", "NDA", "following", "our", "pre-NDA", "meetings", "with", "FDA,", "the", "regulatory", "pathway", "for", "NKTR-181", "remains", "subject", "to", "substantial", "uncertainty", "including", "the", "amount", "of", "data", "required", "to", "support", "an", "approval", "of", "NKTR-181.", "<tag3>"], "wordsA": ["For", "example,", "while", "we", "believe", "our", "NKTR-181", "Phase", "3", "clinical", "program", "employs", "the", "most", "appropriate", "clinical", "trial", "design,", "we", "were", "unable", "to", "identify", "a", "single", "cause", "for", "the", "Phase", "2", "study", "for", "NKTR-181", "not", "meeting", "its", "primary", "efficacy", "endpoint,", "and", "therefore", "there", "is", "increased", "risk", "in", "effectively", "designing", "a", "Phase", "3", "clinical", "program", "for", "NKTR-181."], "wordsB": ["Further,", "while", "the", "results", "from", "the", "Phase", "3", "study", "of", "NKTR-181", "were", "positive,", "NKTR-181", "has", "Fast", "Track", "designation", "and", "we", "intend", "to", "file", "an", "NDA", "following", "our", "pre-NDA", "meetings", "with", "FDA,", "the", "regulatory", "pathway", "for", "NKTR-181", "remains", "subject", "to", "substantial", "uncertainty", "including", "the", "amount", "of", "data", "required", "to", "support", "an", "approval", "of", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p33_s6", "idA": "906709_17_item1a_p31_s3", "sentA": "In addition, Bayer has filed a claim in the U.S. against Baxalta and Nektar in which Bayer alleges ADYNOVATE infringes a Bayer patent.", "sentB": "In another U.S. proceeding, Bayer is seeking a declaratory judgement that BAY 94-9027 does not infringe specified Nektar patents or in the alternative that the specified patents are invalid.", "type": 1, "words": ["<tag1>", "In", "addition,", "Bayer", "has", "filed", "a", "claim", "in", "the", "U.S.", "against", "Baxalta", "and", "Nektar", "in", "which", "Bayer", "alleges", "ADYNOVATE", "infringes", "a", "Bayer", "patent.", "<tag2>", "In", "another", "U.S.", "proceeding,", "Bayer", "is", "seeking", "a", "declaratory", "judgement", "that", "BAY", "94-9027", "does", "not", "infringe", "specified", "Nektar", "patents", "or", "in", "the", "alternative", "that", "the", "specified", "patents", "are", "invalid.", "<tag3>"], "wordsA": ["In", "addition,", "Bayer", "has", "filed", "a", "claim", "in", "the", "U.S.", "against", "Baxalta", "and", "Nektar", "in", "which", "Bayer", "alleges", "ADYNOVATE", "infringes", "a", "Bayer", "patent."], "wordsB": ["In", "another", "U.S.", "proceeding,", "Bayer", "is", "seeking", "a", "declaratory", "judgement", "that", "BAY", "94-9027", "does", "not", "infringe", "specified", "Nektar", "patents", "or", "in", "the", "alternative", "that", "the", "specified", "patents", "are", "invalid."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p2_s4", "idA": "906709_17_item1a_p32_s10", "sentA": "As a result, we could incur substantial costs and damages and any product sales or royalty revenue that we would otherwise be entitled to receive could be reduced, delayed or eliminated.", "sentB": "For example, upon the effective date of the strategic collaboration agreement with Bristol-Myers Squibb, we would be entitled to up to $1.43 billion in development milestones that are based upon clinical and regulatory successes from the NKTR-214 development program.", "type": 1, "words": ["<tag1>", "As", "a", "result,", "we", "could", "incur", "substantial", "costs", "and", "damages", "and", "any", "product", "sales", "or", "royalty", "revenue", "that", "we", "would", "otherwise", "be", "entitled", "to", "receive", "could", "be", "reduced,", "delayed", "or", "eliminated.", "<tag2>", "For", "example,", "upon", "the", "effective", "date", "of", "the", "strategic", "collaboration", "agreement", "with", "Bristol-Myers", "Squibb,", "we", "would", "be", "entitled", "to", "up", "to", "$1.43", "billion", "in", "development", "milestones", "that", "are", "based", "upon", "clinical", "and", "regulatory", "successes", "from", "the", "NKTR-214", "development", "program.", "<tag3>"], "wordsA": ["As", "a", "result,", "we", "could", "incur", "substantial", "costs", "and", "damages", "and", "any", "product", "sales", "or", "royalty", "revenue", "that", "we", "would", "otherwise", "be", "entitled", "to", "receive", "could", "be", "reduced,", "delayed", "or", "eliminated."], "wordsB": ["For", "example,", "upon", "the", "effective", "date", "of", "the", "strategic", "collaboration", "agreement", "with", "Bristol-Myers", "Squibb,", "we", "would", "be", "entitled", "to", "up", "to", "$1.43", "billion", "in", "development", "milestones", "that", "are", "based", "upon", "clinical", "and", "regulatory", "successes", "from", "the", "NKTR-214", "development", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p53_s4", "idA": "906709_17_item1a_p36_s2", "sentA": "Drug/device combination products are particularly complex, expensive and time-consuming to develop due to the number of variables involved in the final product design, including ease of patient and doctor use, maintenance of clinical efficacy, reliability and cost of manufacturing, regulatory approval requirements and standards and other important factors.", "sentB": "Federal agencies, Congress and state legislatures have continued to show interest in implementing cost containment programs to limit the growth of health care costs, including price controls, restrictions on reimbursement and other fundamental changes to the healthcare delivery system.", "type": 1, "words": ["<tag1>", "Drug/device", "combination", "products", "are", "particularly", "complex,", "expensive", "and", "time-consuming", "to", "develop", "due", "to", "the", "number", "of", "variables", "involved", "in", "the", "final", "product", "design,", "including", "ease", "of", "patient", "and", "doctor", "use,", "maintenance", "of", "clinical", "efficacy,", "reliability", "and", "cost", "of", "manufacturing,", "regulatory", "approval", "requirements", "and", "standards", "and", "other", "important", "factors.", "<tag2>", "Federal", "agencies,", "Congress", "and", "state", "legislatures", "have", "continued", "to", "show", "interest", "in", "implementing", "cost", "containment", "programs", "to", "limit", "the", "growth", "of", "health", "care", "costs,", "including", "price", "controls,", "restrictions", "on", "reimbursement", "and", "other", "fundamental", "changes", "to", "the", "healthcare", "delivery", "system.", "<tag3>"], "wordsA": ["Drug/device", "combination", "products", "are", "particularly", "complex,", "expensive", "and", "time-consuming", "to", "develop", "due", "to", "the", "number", "of", "variables", "involved", "in", "the", "final", "product", "design,", "including", "ease", "of", "patient", "and", "doctor", "use,", "maintenance", "of", "clinical", "efficacy,", "reliability", "and", "cost", "of", "manufacturing,", "regulatory", "approval", "requirements", "and", "standards", "and", "other", "important", "factors."], "wordsB": ["Federal", "agencies,", "Congress", "and", "state", "legislatures", "have", "continued", "to", "show", "interest", "in", "implementing", "cost", "containment", "programs", "to", "limit", "the", "growth", "of", "health", "care", "costs,", "including", "price", "controls,", "restrictions", "on", "reimbursement", "and", "other", "fundamental", "changes", "to", "the", "healthcare", "delivery", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p14_s2", "idA": "906709_17_item1a_p48_s4", "sentA": "For ADYNOVATE , on June 6, 2014, the FDA approved Biogen Idec s ELOCTATE for the control and prevention of bleeding episodes, perioperative (surgical) management and routine prophylaxis in adults and children with Hemophilia A, and Bayer Healthcare and Novo Nordisk have ongoing Phase 3 clinical development programs for longer acting Factor VIII proteins based on polymer conjugation technology approaches.", "sentB": "The Enzon Litigation was dismissed with prejudice on June 30, 2017.", "type": 1, "words": ["<tag1>", "For", "ADYNOVATE", ",", "on", "June", "6,", "2014,", "the", "FDA", "approved", "Biogen", "Idec", "s", "ELOCTATE", "for", "the", "control", "and", "prevention", "of", "bleeding", "episodes,", "perioperative", "(surgical)", "management", "and", "routine", "prophylaxis", "in", "adults", "and", "children", "with", "Hemophilia", "A,", "and", "Bayer", "Healthcare", "and", "Novo", "Nordisk", "have", "ongoing", "Phase", "3", "clinical", "development", "programs", "for", "longer", "acting", "Factor", "VIII", "proteins", "based", "on", "polymer", "conjugation", "technology", "approaches.", "<tag2>", "The", "Enzon", "Litigation", "was", "dismissed", "with", "prejudice", "on", "June", "30,", "2017.", "<tag3>"], "wordsA": ["For", "ADYNOVATE", ",", "on", "June", "6,", "2014,", "the", "FDA", "approved", "Biogen", "Idec", "s", "ELOCTATE", "for", "the", "control", "and", "prevention", "of", "bleeding", "episodes,", "perioperative", "(surgical)", "management", "and", "routine", "prophylaxis", "in", "adults", "and", "children", "with", "Hemophilia", "A,", "and", "Bayer", "Healthcare", "and", "Novo", "Nordisk", "have", "ongoing", "Phase", "3", "clinical", "development", "programs", "for", "longer", "acting", "Factor", "VIII", "proteins", "based", "on", "polymer", "conjugation", "technology", "approaches."], "wordsB": ["The", "Enzon", "Litigation", "was", "dismissed", "with", "prejudice", "on", "June", "30,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p36_s1", "idA": "906709_17_item1a_p54_s11", "sentA": "Furthermore, if adequate funds are not available, we may be required to obtain funds through arrangements with partners or other sources that may require us to relinquish rights to certain of our technologies, products or future economic rights that we would not otherwise relinquish or require us to enter into other financing arrangements on unfavorable terms.", "sentB": "Our future arrangements with third-party payors and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business or financial arrangements and relationships through which we market, sell and distribute our therapeutic candidates for which we obtain marketing approval.", "type": 1, "words": ["<tag1>", "Furthermore,", "if", "adequate", "funds", "are", "not", "available,", "we", "may", "be", "required", "to", "obtain", "funds", "through", "arrangements", "with", "partners", "or", "other", "sources", "that", "may", "require", "us", "to", "relinquish", "rights", "to", "certain", "of", "our", "technologies,", "products", "or", "future", "economic", "rights", "that", "we", "would", "not", "otherwise", "relinquish", "or", "require", "us", "to", "enter", "into", "other", "financing", "arrangements", "on", "unfavorable", "terms.", "<tag2>", "Our", "future", "arrangements", "with", "third-party", "payors", "and", "customers", "may", "expose", "us", "to", "broadly", "applicable", "fraud", "and", "abuse", "and", "other", "healthcare", "laws", "and", "regulations", "that", "may", "constrain", "the", "business", "or", "financial", "arrangements", "and", "relationships", "through", "which", "we", "market,", "sell", "and", "distribute", "our", "therapeutic", "candidates", "for", "which", "we", "obtain", "marketing", "approval.", "<tag3>"], "wordsA": ["Furthermore,", "if", "adequate", "funds", "are", "not", "available,", "we", "may", "be", "required", "to", "obtain", "funds", "through", "arrangements", "with", "partners", "or", "other", "sources", "that", "may", "require", "us", "to", "relinquish", "rights", "to", "certain", "of", "our", "technologies,", "products", "or", "future", "economic", "rights", "that", "we", "would", "not", "otherwise", "relinquish", "or", "require", "us", "to", "enter", "into", "other", "financing", "arrangements", "on", "unfavorable", "terms."], "wordsB": ["Our", "future", "arrangements", "with", "third-party", "payors", "and", "customers", "may", "expose", "us", "to", "broadly", "applicable", "fraud", "and", "abuse", "and", "other", "healthcare", "laws", "and", "regulations", "that", "may", "constrain", "the", "business", "or", "financial", "arrangements", "and", "relationships", "through", "which", "we", "market,", "sell", "and", "distribute", "our", "therapeutic", "candidates", "for", "which", "we", "obtain", "marketing", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p37_s0", "idA": "906709_17_item1a_p56_s8", "sentA": "We have not undertaken a systematic analysis of the potential consequences to our business, results of operations and financial condition from a major earthquake or other catastrophic event, such as a fire, sustained loss of power, terrorist activity or other disaster, and do not have a recovery plan for such disasters.", "sentB": "state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may apply to items or services reimbursed by any third-party payor, including commercial insurers, state transparency reporting and compliance laws; and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and which may not have the same effect, thus complicating compliance efforts.", "type": 1, "words": ["<tag1>", "We", "have", "not", "undertaken", "a", "systematic", "analysis", "of", "the", "potential", "consequences", "to", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "from", "a", "major", "earthquake", "or", "other", "catastrophic", "event,", "such", "as", "a", "fire,", "sustained", "loss", "of", "power,", "terrorist", "activity", "or", "other", "disaster,", "and", "do", "not", "have", "a", "recovery", "plan", "for", "such", "disasters.", "<tag2>", "state", "law", "equivalents", "of", "each", "of", "the", "above", "federal", "laws,", "such", "as", "anti-kickback", "and", "false", "claims", "laws", "which", "may", "apply", "to", "items", "or", "services", "reimbursed", "by", "any", "third-party", "payor,", "including", "commercial", "insurers,", "state", "transparency", "reporting", "and", "compliance", "laws;", "and", "state", "laws", "governing", "the", "privacy", "and", "security", "of", "health", "information", "in", "certain", "circumstances,", "many", "of", "which", "differ", "from", "each", "other", "in", "significant", "ways", "and", "which", "may", "not", "have", "the", "same", "effect,", "thus", "complicating", "compliance", "efforts.", "<tag3>"], "wordsA": ["We", "have", "not", "undertaken", "a", "systematic", "analysis", "of", "the", "potential", "consequences", "to", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "from", "a", "major", "earthquake", "or", "other", "catastrophic", "event,", "such", "as", "a", "fire,", "sustained", "loss", "of", "power,", "terrorist", "activity", "or", "other", "disaster,", "and", "do", "not", "have", "a", "recovery", "plan", "for", "such", "disasters."], "wordsB": ["state", "law", "equivalents", "of", "each", "of", "the", "above", "federal", "laws,", "such", "as", "anti-kickback", "and", "false", "claims", "laws", "which", "may", "apply", "to", "items", "or", "services", "reimbursed", "by", "any", "third-party", "payor,", "including", "commercial", "insurers,", "state", "transparency", "reporting", "and", "compliance", "laws;", "and", "state", "laws", "governing", "the", "privacy", "and", "security", "of", "health", "information", "in", "certain", "circumstances,", "many", "of", "which", "differ", "from", "each", "other", "in", "significant", "ways", "and", "which", "may", "not", "have", "the", "same", "effect,", "thus", "complicating", "compliance", "efforts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p18_s4", "idA": "906709_17_item1a_p59_s0", "sentA": "The price of our common stock is expected to remain volatile.", "sentB": "The closings under the two agreements, subject to satisfaction of certain closing conditions, are expected to occur during the second quarter of 2018.", "type": 1, "words": ["<tag1>", "The", "price", "of", "our", "common", "stock", "is", "expected", "to", "remain", "volatile.", "<tag2>", "The", "closings", "under", "the", "two", "agreements,", "subject", "to", "satisfaction", "of", "certain", "closing", "conditions,", "are", "expected", "to", "occur", "during", "the", "second", "quarter", "of", "2018.", "<tag3>"], "wordsA": ["The", "price", "of", "our", "common", "stock", "is", "expected", "to", "remain", "volatile."], "wordsB": ["The", "closings", "under", "the", "two", "agreements,", "subject", "to", "satisfaction", "of", "certain", "closing", "conditions,", "are", "expected", "to", "occur", "during", "the", "second", "quarter", "of", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p36_s2", "idA": "906709_17_item1a_p59_s3", "sentA": "A variety of factors may have a significant effect on the market price of our common stock, including the risks described in this section titled Risk Factors and the following:", "sentB": "Restrictions under applicable federal and state healthcare laws and regulations, include the following:", "type": 1, "words": ["<tag1>", "A", "variety", "of", "factors", "may", "have", "a", "significant", "effect", "on", "the", "market", "price", "of", "our", "common", "stock,", "including", "the", "risks", "described", "in", "this", "section", "titled", "Risk", "Factors", "and", "the", "following:", "<tag2>", "Restrictions", "under", "applicable", "federal", "and", "state", "healthcare", "laws", "and", "regulations,", "include", "the", "following:", "<tag3>"], "wordsA": ["A", "variety", "of", "factors", "may", "have", "a", "significant", "effect", "on", "the", "market", "price", "of", "our", "common", "stock,", "including", "the", "risks", "described", "in", "this", "section", "titled", "Risk", "Factors", "and", "the", "following:"], "wordsB": ["Restrictions", "under", "applicable", "federal", "and", "state", "healthcare", "laws", "and", "regulations,", "include", "the", "following:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p53_s3", "idA": "906709_17_item1a_p5_s0", "sentA": "Our reliance on collaboration partners poses a number of significant risks to our business, including risks that:", "sentB": "For example, Congress passed the Affordable Care Act in 2010 which enacted a number of reforms to expand access to health insurance while also reducing or constraining the growth of healthcare spending, enhancing remedies against fraud and abuse, adding new transparency requirements for healthcare industries, and imposing new taxes on fees on healthcare industry participants, among other policy reforms.", "type": 1, "words": ["<tag1>", "Our", "reliance", "on", "collaboration", "partners", "poses", "a", "number", "of", "significant", "risks", "to", "our", "business,", "including", "risks", "that:", "<tag2>", "For", "example,", "Congress", "passed", "the", "Affordable", "Care", "Act", "in", "2010", "which", "enacted", "a", "number", "of", "reforms", "to", "expand", "access", "to", "health", "insurance", "while", "also", "reducing", "or", "constraining", "the", "growth", "of", "healthcare", "spending,", "enhancing", "remedies", "against", "fraud", "and", "abuse,", "adding", "new", "transparency", "requirements", "for", "healthcare", "industries,", "and", "imposing", "new", "taxes", "on", "fees", "on", "healthcare", "industry", "participants,", "among", "other", "policy", "reforms.", "<tag3>"], "wordsA": ["Our", "reliance", "on", "collaboration", "partners", "poses", "a", "number", "of", "significant", "risks", "to", "our", "business,", "including", "risks", "that:"], "wordsB": ["For", "example,", "Congress", "passed", "the", "Affordable", "Care", "Act", "in", "2010", "which", "enacted", "a", "number", "of", "reforms", "to", "expand", "access", "to", "health", "insurance", "while", "also", "reducing", "or", "constraining", "the", "growth", "of", "healthcare", "spending,", "enhancing", "remedies", "against", "fraud", "and", "abuse,", "adding", "new", "transparency", "requirements", "for", "healthcare", "industries,", "and", "imposing", "new", "taxes", "on", "fees", "on", "healthcare", "industry", "participants,", "among", "other", "policy", "reforms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p13_s2", "idA": "906709_17_item1a_p61_s2", "sentA": "On October 5, 2015, we issued $250.0 million in aggregate principal amount of 7.75% senior secured notes due October 2020.", "sentB": "On December 12, 2017, Nektar, MAP and Allergan entered into a Settlement Agreement and Release, for which MAP paid us $15.0 million in December 2017.", "type": 1, "words": ["<tag1>", "On", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020.", "<tag2>", "On", "December", "12,", "2017,", "Nektar,", "MAP", "and", "Allergan", "entered", "into", "a", "Settlement", "Agreement", "and", "Release,", "for", "which", "MAP", "paid", "us", "$15.0", "million", "in", "December", "2017.", "<tag3>"], "wordsA": ["On", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020."], "wordsB": ["On", "December", "12,", "2017,", "Nektar,", "MAP", "and", "Allergan", "entered", "into", "a", "Settlement", "Agreement", "and", "Release,", "for", "which", "MAP", "paid", "us", "$15.0", "million", "in", "December", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
